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ABBREVIATION KEY 
 
A  adenine 
aa  amino acids 
Apaf-1  apoptotic protease activating factor-1 
BAFF  B cell activating factor 
Bcl  B cell lymphoma 
bp  base pairs 
C  cytosine 
C3a  complement factor 3a 
C5a  complement factor 5a 
CD  cluster of differentiation 
cDNA  complementary DNA 
CFU  colony-forming unit 
Cl-  chloride ion 
CNS  coagulase-negative staphylococci 
CO2  carbon dioxide 
CR  complement receptor 
Da  dalton 
DD  death domain 
DED  death effector domain 
DEVD  Asp-Glu-Val-Asp 
DNA  deoxyribonucleic acid 
E. coli  Escherichia coli 
EDTA  ethylenediaminetetraacetic acid 
ELISA  enzyme-linked immunosorbent assay 
EMSA  electrophoretic mobility shift assay 
FADD  Fas-associated death domain 
FITC  fluorescein isothiocyanate 
G  guanine 
GM-CSF granulocyte-macrophage colony-stimulating factor 
GRR  glycine-rich region 
h  hours 
H2O2  hydrogen peroxide 
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HOCl  hypochlorous acid 
HRP  horseradisch peroxidase 
IAP  inhibitor of apoptosis 
ICAM  intracellular adhesion molecule 
ICE  IL-1β converting enzyme 
Ig  immunoglobulin 
IKK  IκB kinase 
IL  interleukin 
IL-1R  interleukin-1 receptor 
IRAK  IL-1 receptor-associated kinase 
IRAP  IL-1 receptor accessory protein 
IκB  inhibitor of NF-κB 
LBP  LPS binding protein 
LPS  lipopolysaccharide 
LRR  leucin-rich region 
LT  lymphotoxin 
MAA  milk amyloid A 
Mac-1  macrophage-1 
mCD14 membrane CD14 
Mcl  myeloid cell leukemia 
MD  myeloid differentiation protein 
MHC  major histocompatibility 
min  minutes 
MPO  myeloperoxidase 
mRNA messenger RNA 
MyD88 myeloid differentiation factor 88 
NADPH nicotinamide adenine dinucleotide phosphate, reduced form 
NAG  N-acetylglucosamine 
NAM  N-acetylmuramic acid 
NEMO NF-κB essential modulator 
NES  nuclear export signal 
NET  neutrophil extracellular trap 
NF-κB  nuclear factor-κB 
NIK  NF-κB inducing kinase 
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NLS  nuclear localization signal 
NO  nitric oxide 
NP-40  Nonidet P-40 
O2  oxygen 
O2-  superoxide 
OH  hydroxyl radical 
ONOO- peroxynitrate 
P  phosphate 
P  probability 
PAMP  pathogen-associated microbial pattern 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
PI  propidium iodide 
PID  processing inhibitory domain 
PKA  protein kinase A 
PRR  pathogen recognition receptor 
PS  phosphatidylserine 
r  correlation 
RANKL receptor activator of NF-κB ligand 
RHD  Rel homology domain 
RIP  receptor-interacting protein 
RLU  relative light units 
RNA  ribonucleic acid 
RNS  reactive nitrogen species 
ROS  reactive oxygen species 
RPMI  Roswell Park Memorial Institute 
s  second 
S. agalactiae Streptococcus agalactiae 
S. aureus Staphylococcus aureus 
S. uberis Streptococcus uberis 
SAA  serum amyloid A 
SARM  sterile α- and armadillo-motif-containing protein 
SAS  Statistical Analysis Software 
SCC  somatic cell count 
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sCD14  soluble CD14 
SCV  small-colony variant 
SEM  standard error of the mean 
SOD  superoxide dismutase 
SPSS  Statistical Package for the Social Sciences 
STAT  signal transducer and activator of transcription 
T  thymine 
TAD  transactivation domain 
TBS  Tris buffered saline 
TBS-T  TBS with Tween 20 
TICAM TIR-containing adaptor molecule 
TIR  Toll/IL-1 receptor 
TIRAP TIR-containing adaptor protein 
TLR  Toll-like receptor 
TNFR  TNF receptor 
TNF-α  tumor necrosis factor-α 
TRADD TNF receptor-associated death domain protein 
TRAF  TNF receptor-associated factor 
U  units 
Ub  ubiquitin 
UV  ultraviolet 
VCAM vascular cellular adhesion molecule 
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1. The transcription factor NF-κB 
 
1.1. NF-κB family 
 
Nuclear factor (NF)-κB was discovered in 1986 as a transcription factor regulating the 
formation of the kappa variety of the immunoglobulin light chain in B lymphocytes (Sen and 
Baltimore, 1986). Nowadays, it is known to be present in nearly all eukaryotic cell types 
where it regulates the expression of a numerous amount of genes, in particular those of which 
the products are involved in immune processes and inflammatory diseases (Liou, 2002). 
 
The NF-κB family comprises proteins which are structurally and functionally related (May 
and Ghosh, 1997; Hayden and Ghosh, 2004; Hayden and Ghosh, 2008). Each member 
contains a conserved amino-terminal region called the Rel homology domain (RHD). This 
motif is responsible for dimerization with other NF-κB family members and for the 
interaction with the inhibitor proteins of NF-κB (IκB). Furthermore, it contains the nuclear 
localization signal (NLS) and controls binding to the κB elements on the DNA. 
 
To date, five NF-κB family members have been identified in mammalian cells: RelA (also 
known as p65), RelB, c-Rel, NF-κB1 (p50) and NF-κB2 (p52) (Figure 1). RelA, RelB and c-
Rel are produced as transcriptionally active proteins. They contain one or more carboxy-
terminal transactivation domains (TADs). NF-κB1 and NF-κB2 are synthesized as longer 
precursor molecules of 105 and 100 kDa, known as p105 and p100, respectively, which are 
further processed to the smaller, transcriptionally active forms. 
 
NF-κB dimers are sequestered in the cytosol of unstimulated cells via interactions with their 
inhibitors. The IκB family also comprises structurally and functionally related proteins. To 
date, eight members have been identified: IκB-α, IκB-β, IκB-γ (which corresponds to the 
carboxy-terminal part of p105), IκB-ε, IκB-ζ, Bcl-3 and the NF-κB precursor molecules p105 
and p100 (Figure 1). They share ankyrin repeats which interact with the NLS of the RHD of 
NF-κB family members, thereby preventing their nuclear translocation. As an exception, IκB-
ζ is a nuclear protein of which the inhibitory action lies within the prevention of NF-κB 
binding to the DNA. Finally, Bcl-3 is not an inhibitor, but rather an activator of NF-κB. It 
delivers TAD to transcriptionally inactive NF-κB complexes, such as p50 or p52 homodimers, 
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or removes such complexes from the DNA in order to allow active dimers to bind to the κB 
elements to initiate transcription. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Structures of the NF-κB and IκB protein family members. RHD: Rel homology domain, TAD: 
transactivation domain, GRR: glycine-rich region, aa: amino acids. 
 
 
1.2. NF-κB activation 
 
1.2.1. Classical NF-κB activation pathway 
 
NF-κB activation occurs very rapidly upon cell activation mediated by extracellular signals 
(Karin and Ben-Neriah, 2000). It mainly involves the degradation of IκB so that the NLS is 
exposed and the NF-κB dimer translocates to the nucleus to initiate transcription (Figure 2). 
In the classical NF-κB activation pathway, the degradation of the inhibitor is preceded by the 
phosphorylation of two conserved amino-terminal serine residues (Ser32 and Ser36 for IκB-
α). These modifications trigger polyubiquitination (of Lys21 and Lys22 from IκB-α) which 
leads to the degradation by the 26S proteasome (May and Ghosh, 1998). 
 
RHD TAD 551 aa
579
619
317
356
500
607
728
446
GRR 969
435
405
900
Ankyrin repeats
RelA (p65)
RelB
c-Rel
NF-κB1 (p50)
NF-κB2 (p65)
N
F-
κ
B
 
fa
m
ily
IκB-α
IκB-β
IκB-ε
IκB-γ
IκB-ζ
Bcl-3
p105
p100
Iκ
B 
fa
m
ily
N
F-
κ
B
 
fa
m
ily
Iκ
B 
fa
m
ily
General introduction 
 9 
The phosphorylation of IκB is mediated by the IκB kinase (IKK) complex, which is activated 
by different stimuli (Rothwarf and Karin, 1999; Karin and Delhase, 2000) (Figure 2). This 
complex consists of three important subunits: two catalytic subunits IKK-α (IKK-1) and IKK-
β (IKK-2) and a regulatory subunit IKK-γ which is also called NF-κB essential modulator 
(NEMO). A fully active IKK complex is composed of the IKK-α/IKK-β heterodimer 
associated with one or several IKK-γ molecules. The presence of the regulatory subunit is 
indispensable for the activity of IKK. IKK activation depends on phosphorylation of its 
catalytic subunits, which might be mediated by the NF-κB inducing kinase (NIK) (Hayden 
and Ghosh, 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: The classical NF-κB activation pathway. The IKK complex becomes activated in response to different 
extracellular stimuli. This leads to the phosphorylation of IκB-α and its subsequent polyubiquitination. 
Following the degradation of the inhibitor by the 26S proteasome, the NF-κB p65/p50 heterodimer translocates 
to the nucleus where it initiates transcription. IKK: IκB kinase, IκB: inhibitor of NF-κB, P: phosphate, Ub: 
ubiquitin. 
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The most abundant and best studied NF-κB complex is the p65/p50 heterodimer. This 
complex is continuously shuttling between the nucleus and the cytoplasm upon interaction 
with IκB-α (Birbach et al., 2002). Due to the nuclear export signal (NES) of IκB-α, nuclear 
NF-κB complexes immediately return to the cytoplasm (Huang et al., 2000). Since its rate of 
nuclear export exceeds the rate of its nuclear import, this complex is generally cytoplasmic. 
This nucleo-cytoplasmic shuttling is only feasible upon association with IκB-α. IκB-β 
preserves the cytoplasmic localization of NF-κB by a more efficient blockage of the NLS of 
NF-κB (Malek et al., 2001). In addition, IκB-β can not export active NF-κB complexes to the 
cytoplasm. On the contrary, IκB-α binds to NF-κB in the nucleus, which then dissociates from 
the DNA and returns to the cytoplasm (Tam and Sen, 2001). Newly synthesized IκB-α, of 
which the expression is under control of NF-κB itself, therefore plays an important role in the 
termination of NF-κB activation. 
 
1.2.2. Atypical NF-κB activation pathways 
 
Phosphorylation by IκB-α of other amino acids than the serine residues, such as Tyr42, has 
been described (May and Ghosh, 1998). This modification results in dissociation of the 
inhibitor from the NF-κB complex without its subsequent degradation by the proteasome. 
Without its inhibitor, NF-κB enters the nucleus to initiate transcription. Remarkably, it has 
also been demonstrated that tyrosine phosphorylation of IκB-α is not coupled to NF-κB 
activation. This modification then prevents phosphorylation of the serine residues, perhaps by 
altering the substrate sequence that is recognized by IKK, and thereby abolishes NF-κB 
activation in response to classical stimuli. A second atypical NF-κB activation pathway is 
characterized by the degradation of IκB-α by the proteasome following its ubiquitination, but 
in the absence of IKK activation or phosphorylation of its serine or tyrosine residues (Bender 
et al., 1998; Li and Karin, 1998). 
 
1.2.3. Alternative NF-κB activation pathway 
 
Both NF-κB1 and NF-κB2 are synthesized as larger precursor molecules. The precursor p105 
mainly undergoes constitutive processing, which is reported to be co-translational (Lin et al., 
1998), while the degradation of the precursor p100 is a tightly regulated event, which 
generally occurs post-translational (Heusch et al., 1999). Processing requires proteolysis by 
the proteasome and is therefore comparable to the IκB degradation. Unprocessed p105 and 
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p100 ggg gggg ddddd bbbbbbbbbbbb bbbb nnnnnn ffffffffff ddddddddddddddddd nn bbvff 
ddx. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: The alternative NF-κB activation pathway. NIK phosphorylates and activates IKK-α in response to 
specific extracellular stimuli. This leads to the phosphorylation of p100 and its subsequent polyubiquitination. 
Following the processing of p100 into p52, the NF-κB p52/RelB heterodimer translocates to the nucleus where it 
initiates transcription. LT: lymphotoxin, BAFF: B cell activating factor, RANKL: receptor activator of NF-κB 
ligand, NIK: NF-κB inducing kinase, IKK: IκB kinase, P: phosphate, Ub: ubiquitin. 
 
 
p100 form stable dimers with other NF-κB family members which are retained in the 
cytoplasm due to their ankyrin repeats. Following phosphorylation and ubiquitination, the 
carboxy-terminal domain of the precursor is degraded by the 26S proteasome. Complete 
destruction of NF-κB1 is prohibited by a glycine-rich region (GRR) which acts as a physical 
barrier preventing entry of p50 into the cavity of the proteasome. This GRR might also be a 
recognition site for an endoproteolytic enzyme, which separates the N-terminus, p50, from the 
ubiquitinated C-terminus, which is then degraded (Hayden and Ghosh, 2004). Processing of 
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p100 into p52 probably occurs by similar mechanisms (Dejardin, 2006) (Figure 3). The 
presence of a processing inhibitory domain (PID) in p100 ensures the inducible degradation 
instead of a constitutive processing. A role for NIK and IKK-α, but not for IKK-β or IKK-γ, is 
apparent in this process (Senftleben et al., 2001). In contrast to the classical NF-κB pathway, 
the activation of this alternative pathway appears to be restricted to a limited number of 
inducers such as lymphotoxin (LT) α/β, B cell activating factor (BAFF), CD40 and receptor 
activator of NF-κB ligand (RANKL) (Dejardin, 2006). 
 
1.2.4. NF-κB transactivation 
 
NF-κB translocation to the nucleus is dependent upon IκB degradation. Additionally, the 
activity of NF-κB is regulated by post-translational modifications. They enhance the 
efficiency of DNA binding and ensure recruitment of co-activators to the enhancer regions. 
Stimulus-dependent phosphorylation of p65 was the first regulatory event that was recognized 
to occur downstream from IκB degradation (Naumann and Scheidereit, 1994). Protein kinase 
A (PKA) is the classical example of an enzyme able to phosphorylate p65 (Zhong et al., 
1998). Its catalytic subunit is associated with cytosolic complexes of NF-κB and IκB. 
Degradation of IκB upon stimulation activates PKA, which then phosphorylates Ser276 of 
p65. This modification prevents the intramolecular association of the N- and C-terminus of 
p65, thereby facilitating the interaction with co-activators and DNA. Many other protein 
kinases are known to modulate NF-κB transcriptional activity through the phosphorylation of 
different sites on NF-κB complexes (Li and Verma, 2002; Hayden and Ghosh, 2004; Perkins, 
2006). In addition, other modifications such as acetylation of NF-κB might also regulate its 
activity (Hayden and Ghosh, 2004; Perkins, 2006). 
 
1.2.5. Specificity in NF-κB activation 
 
NF-κB is activated in response to numerous stimuli and regulates the expression of a large 
amount of target genes which are involved in a broad range of cellular and physiological 
processes. A tight regulation of a specific response towards a specific stimulus is therefore 
crucial. Some stimuli favor the degradation of a certain IκB molecule over another. Not all 
inhibitors are as efficiently phosphorylated by the IKKs. In addition, some inhibitors more 
strongly inhibit specific NF-κB dimers than others. Within various cell types, different NF-κB 
dimers are present. Different NF-κB complexes display distinct affinities for different κB sites 
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present in promoters of various NF-κB-regulated genes. Finally, in response to a certain 
stimulus, only specific post-translational modifications and interactions with other 
transcription factors or signaling pathways occur which influence the transcription of only a 
subset of genes. Clearly, the specificity of a particular response is regulated at various levels 
within the NF-κB activation pathway (Perkins, 1997; Perkins, 2007). 
 
1.3. NF-κB function in innate immunity 
 
NF-κB plays an important role in the regulation of innate and adaptive immune responses 
during infection (Bonizzi and Karin, 2004; Liang et al., 2004). The innate immunity typically 
comprises cells and general mechanisms that provide immediate defense against pathogens, 
while the adaptive immune response is composed of highly specialized cells and processes 
which recognize, eliminate and remember specific invaders via antigens (Vivier and Malissen, 
2005). The classical NF-κB activation pathway is mostly involved in innate immunity 
whereas the alternative pathway may be involved in adaptive immune responses. 
 
1.3.1. NF-κB activators in innate immunity 
 
To date, a large number of NF-κB inducers is identified (Pahl, 1999). In the context of innate 
immunity, NF-κB is activated by bacteria and bacterial products, such as lipopolysaccharide 
(LPS), cytokines like interleukin (IL)-1 and tumor necrosis factor (TNF)-α, and stress 
molecules such as oxygen radicals. The major signaling pathways in response to LPS, IL-1 
and TNF-α converge on the activation of IKK, which leads to the degradation of IκB, the 
subsequent nuclear translocation of NF-κB and the initiation of target gene transcription 
(Hayden and Ghosh, 2004) (Figure 4). 
 
1.3.1.1. Toll-like receptor signaling to NF-κB 
 
NF-κB plays an essential role in early events of innate immune responses through Toll-like 
receptor (TLR) signaling pathways (Carmody and Chen, 2007). TLRs are evolutionarily 
conserved pattern recognition receptors (PRRs) that recognize conserved pathogen-associated 
microbial patterns (PAMPs) present on various microbes (Janeway and Medzhitov, 2002). To 
date, 13 mammalian TLRs have been identified and each of these receptors signal to NF-κB 
(Albiger et al., 2007) (Table 1). TLRs are transmembrane proteins that are characterized by an 
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extracellular leucin-rich region (LRR) and an intracellular domain which is homologous to the 
IL-1 receptor (IL-1R) and is therefore called Toll/IL-1 receptor (TIR) domain. The LRR is 
responsible for the recognition of PAMPs. At least one bacterial ligand has been described for 
most TLRs (Akira and Takeda, 2004; Takeda and Akira, 2005) (Table 1). 
 
Table 1: TLRs and their species-dependent expression, subcellular location and most important ligands 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TLR signaling is initiated by the recruitment of adapter molecules that all share the TIR 
domain. To date, 4 adapter proteins have been identified: myeloid differentiation factor 88 
(MyD88), TIR-containing adaptor protein (TIRAP), TIR-containing adaptor molecule-1 
(TICAM-1) and TICAM-2. Recently, a fifth TIR domain-containing protein known as sterile 
α- and armadillo-motif-containing protein (SARM) has been shown to negatively regulate 
TLR signaling via TICAM-1 (O’Neill and Bowie, 2007). Differential recruitment of the 
Mouse
Mouse
Mouse
Human
Human & mouse
Human & mouse
Human & mouse
Human & mouse
Human & mouse
Human & mouse
Human & mouse
Human & mouse
Human & mouse
Species
Unknown
Unknown
Cell surface
Cell surface
Cell compartment
Cell compartment
Cell compartment
Cell surface
Cell surface
Cell surface
Cell compartment
Cell surface
Cell surface
Location
Diacyl lipopeptides (Mycobacteria), lipoteichoic acid 
(Gram-positive bacteria) and zymosan (Fungi) 
TLR6
Single-stranded RNA (Viruses)TLR7
Single-stranded RNA (Viruses)TLR8
CpG-containing DNA (Bacteria & Viruses)TLR9
UnknownTLR10
Profilin (Protozoa)TLR11
UnknownTLR12
UnknownTLR13
Flagellin (Bacteria)TLR5
LPS (Gram-negative bacteria), fusion & envelope 
proteins (Viruses) and taxol (Plants)
TLR4
Double-stranded RNA (Viruses)TLR3
Peptidoglycan (Gram-positive bacteria), lipoteichoic 
acid (Gram-positive bacteria), porins (Gram-negative 
bacteria), atypical LPS (Gram-negative bacteria) and 
zymosan (Fungi) 
TLR2
Triacyl lipopeptides (Bacteria & Mycobacteria)TLR1
Ligand (origin)Receptor
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adapter molecules by different TLRs forms the basis for the specificity in gene expression 
profiles. 
 
TLR4 is the most extensively studied PRR and is best known as the LPS receptor. LPS is a 
main component of the outer membrane of Gram-negative bacteria. LPS first binds CD14, 
which is optimally achieved in the presence of LPS binding protein (LBP) (Wright et al., 
1990). This complex is then presented to TLR4 of which the extracellular portion is 
associated with myeloid differentiation protein (MD)-2. Upon ligation, receptor dimerization 
occurs. The formation of this multiprotein complex induces two distinct signaling pathways, 
based on the requirement of MyD88 (Figure 4). This adaptor protein is recruited to TLR4 via 
TIRAP through interactions betweens TIR domains. IL-1 receptor-associated kinase-4 
(IRAK-4) is then activated through the interaction with MyD88 via death domains (DDs). 
IRAK-4 phosphorylates IRAK-1 which then associates with TNF receptor-associated factor-6 
(TRAF-6). Both IRAK-4 and IRAK-1 are essential for MyD88-dependent signaling, but 
whether or not their kinase activity is required for TLR signaling is still a matter of debate. 
Activated TRAF-6 initiates a kinase cascade involving IKK. This leads to the activation of 
NF-κB and the up-regulation of the expression of pro-inflammatory cytokines. TRAF-6 is 
required in MyD88-dependent signaling since its deficiency leads to a complete loss of the 
NF-κB-mediated cytokine response towards TLR4 (Takeda and Akira, 2005; Carmody and 
Chen, 2007). 
 
In response to LPS, a MyD88-independent signaling pathway leading to NF-κB activation 
also exists (Figure 4). Again as a result, the expression of pro-inflammatory mediators is 
induced, which occurs after the up-regulation of cytokine expression via the MyD88-
dependent signaling pathway, since the kinetics of NF-κB activation in response to LPS are 
delayed in MyD88-deficient cells. However, when both MyD88 and TICAM-1 are lacking, 
NF-κB activation is completely abrogated, indicating that the latter adapter protein is 
indispensable for the MyD88-independent signaling pathway (Akira and Takeda, 2004; 
Takeda and Akira, 2005). TICAM-1 is recruited to TLR4 via TICAM-2. NF-κB activation is 
induced by TRAF-6 and/or receptor-interacting protein (RIP) (Barton and Medzhitov, 2003; 
Carmody and Chen, 2007). 
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Figure 4: Toll/IL-1 and TNF signaling pathways. LPS binds to LPB and CD14 to form a complex that interacts 
with TLR4 and MD-2. Both a MyD88-dependent and -independent pathway trigger the activation of the IKK 
complex in response to LPS. The MyD88-dependent pathway involves IRAK-4 and -1 and TRAF-6. The MyD88-
independent pathway engages TICAM-1 and -2, RIP and TRAF-6. Upon binding of IL-1 to its receptor, IRAP 
and MyD88 are recruited. Again, IRAK molecules as well as TRAF-6 are involved in IL-1 signaling towards NF-
κB. Finally, upon binding of TNF to its receptor, TRADD and TRAF-2 mediate the activation of RIP. In response 
to all three stimuli, IκB is degraded and NF-κB translocates to the nucleus to initiate transcription. LPS: 
lipopolysaccharide, LBP: LPS binding protein, TLR: Toll-like receptor, MD: myeloid differentiation protein, 
TIR: Toll/IL-1 receptor, TICAM: TIR-containing adaptor molecule, TIRAP: TIR-containing adaptor protein, 
MyD88: myeloid differentiation factor 88, DD: death domain, IRAK: IL-1 receptor-associated kinase, RIP: 
receptor-interacting protein, TRAF: TNF receptor-associated factor, IL: interleukin, IL-1R: IL-1 receptor, 
IRAP: IL-1 receptor accessory protein, TNF-α: tumor necrosis factor-α, TNFR: TNF receptor, TRADD: TNF 
receptor-associated death domain protein, IKK: IκB kinase, IκB: inhibitor of NF-κB, P: phosphate, Ub: 
ubiquitin. 
 
 
1.3.1.2. IL-1 receptor signaling to NF-κB 
 
NF-κB is activated in response to the pro-inflammatory cytokine IL-1. This interleukin binds 
to the extracellular immunoglobulin-like structure of the IL-1R. Since the intracellular domain 
of IL-1R is strongly homologous to the intracellular domain of TLRs, the downstream 
signaling pathway that leads to NF-κB activation is very similar to the one described above 
(Figure 4). IL-1R is associated with the IL-1R accessory protein (IRAP) and upon ligation, 
MyD88 is recruited and IRAK molecules are activated and phosphorylated. Again, TRAF-6 is 
recruited and IKK is activated, leading to NF-κB activation (Dunne and O’Neill, 2003). 
 
1.3.1.3. TNF receptor signaling to NF-κB 
 
TNF-α-mediated NF-κB activation has been studied intensively (Chen and Goeddel, 2002; 
Aggarwal, 2003, Wajant et al., 2003). The TNF receptor (TNFR) family consists of more than 
20 members. As many ligands were identified of which TNF-α performs multiple roles in 
innate immunity. Upon ligation with TNF-α, the TNFR undergoes trimerization and recruits 
TNFR-associated death domain protein (TRADD) as an adaptor molecule via interaction 
between DDs. TRADD subsequently interacts with TRAF-2 and RIP. Both proteins are able 
to recruit IKK, which is probably activated by additional kinases. As a result, NF-κB is 
activated (Figure 4). 
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1.3.2. NF-κB target genes in innate immunity 
 
Numerous genes of which the transcription is under control of NF-κB are nowadays identified 
(Pahl, 1999). Within the innate immunity, the activation of NF-κB results in the increased 
expression of proteins regulating host immune responses. They include cytokines and 
chemokines, immunoreceptors and cell adhesion molecules, acute phase and stress-related 
proteins, apoptosis regulators and inducible enzymes and antimicrobial peptides (Liou, 2002) 
(Table 2). 
 
Table 2: NF-κB target genes involved in innate immunity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cyclooxygenase (COX)-2, nitric oxide synthase (NOS)Stress molecules
LBP, C-reactive protein (CRP), serum amyloid A (SAA)Acute phase proteins
E-selectin, intracellular adhesion molecule (ICAM)-1, vascular cell adhesion 
molecule (VCAM)-1
Adhesion molecules
TNFR, TLRReceptors
macrophage colony-stimulating factor (M-CSF), granulocyte colony-stimulating 
factor (G-CSF), granulocyte macrophage colony-stimulating factor (GM-CSF)
Growth factors
TNF-α, IL-1α and β, IL-6, IL-8Cytokines and chemokines
Target genesClass of gene
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2. Bovine intramammary infections 
 
2.1. Biology of the bovine mammary gland 
 
The udder of a cow consists of four separate glands each with a single teat. The right and left 
side of the udder are devided by a median ligament, while the front and hind quarters are 
more diffusely separated. A mammary gland consists of secreting tissue and connective 
tissue, which is fibrous and adipose. The amount of secreting tissue determines the milk 
producing capacity of the cow. The milk is synthesized in secretory epithelial cells that are 
arranged as a single layer on a basal membrane and surrounded by myoepithelial cells in a 
spherical structure called the alveolus (Figure 5B). Several alveoli together form a lobule. 
Each lobule has a milk duct that opens into the gland cistern. The teat consists of a teat 
cistern, which is continuous with the gland cistern, and a teat canal. Prior to secretion via the 
teat canal, milk is stored in the alveoli, the milk ducts, the gland and teat cistern (Figure 5A). 
Upon pressure developed by the accumulation of milk, mucosal folds of the teat cistern close 
the way to the teat canal. In addition, sphincter muscles keep the teat canal itself closed. This 
canal is also the main physical barrier against infection. The mammary gland is densely 
innervated, especially in the teat. The udder also contains a vascular and lymphatic system 
(Sandholm, 1995). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
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Figure 5A: Diagram of the right half of the bovine udder (from Garrett, 1988) and B: Diagram of a cluster of 
alveoli in the mammary gland (from Cunningham and Klein, 2007). 
 
 
2.2. Innate immunity of the bovine mammary gland 
 
2.2.1. Initiation of innate immunity 
 
The first line of defense against invading pathogens is considered to be the teat canal since 
this is the route by which micro-organisms gain entrance to the mammary gland (Rainard and 
Riollet, 2006). Besides the sphincter muscles, the teat end also contains keratin, a protein 
derived from the epithelium that enables trapping of invading bacteria (Hibbitt et al., 1969). 
Pathogens that are able to traverse the teat end, must escape the antibacterial activities of the 
mammary gland micro-environment in order to establish an intramammary infection. 
 
In milk and tissue of healthy lactating mammary glands, macrophages represent the dominant 
cell type (Concha, 1986). These leukocytes are able to destroy bacteria following 
phagocytosis (Jensen and Eberhart, 1975). However, their ability to secrete pro-inflammatory 
cytokines, such as TNF-α and IL-1, that facilitate the migration and enhance the bactericidal 
activities of neutrophils, is believed to be of greater importance to the defense of the 
mammary gland than their bactericidal competence (Paape et al., 2000). In addition, cytokines 
B 
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are known to elicit the acute phase response during mastitis. Activated macrophages are also 
triggered to release prostaglandins and leukotrienes, which increase the local inflammatory 
reaction (Riollet et al., 2000). Finally, they play a role in the development of adaptive immune 
responses through antigen processing and presentation in association with major 
histocompatibility (MHC) class II molecules (Rainard and Riollet, 2006; Oviedo-Boyso et al., 
2007). 
 
Besides macrophages, also mammary epithelial cells are in direct contact with invading 
bacteria. Synthesis of TNF-α, IL-6 and the chemokine IL-8 by epithelial cells encountering 
bacteria or their toxins additionally leads to the recruitment and activation of neutrophils 
(Persson et al., 1993). Furthermore, activated macrophages and epithelial cells are able to 
induce the expression of cellular adhesion molecules on vascular endothelial cells, such as E-
selectin, intracellular adhesion molecule-1 (ICAM-1) and vascular cellular adhesion 
molecule-1 (VCAM-1) (Burton and Erskine, 2003; Rainard and Riollet, 2006). This causes 
the binding of blood neutrophils to the endothelium, their migration through the epithelial and 
subepithelial matrix and their localization in milk. 
 
Neutrophils are the principal cell type found in mammary tissues and secretions during the 
early stage of the inflammatory process associated with bacterial infection (Oviedo-Boyso et 
al., 2007). During mastitis, their numbers can constitute more than 90 % of the total 
mammary leukocyte population (Paape et al., 1981). Their main function at the site of 
infection is to ingest and kill bacterial pathogens. In addition, by producing cytokines, they 
are able to recruit and activate neutrophils themselves (Rainard and Riollet, 2003). If the 
invading bacteria survive, neutrophil infiltration is replaced by an influx of T and B 
lymphocytes that are key components of the adaptive immune response towards infection 
(Oviedo-Boyso et al., 2007). However, neutrophils remain the most important cell type found 
in chronic intramammary infections (Rainard and Riollet, 2003). Following elimination of 
bacteria, neutrophil influx subsides and these cells are replaced by macrophages, which also 
actively participate in their removal. The rapid elimination of neutrophils is essential to 
minimize inflammatory-derived injury to the mammary tissue (Paape et al., 2003). 
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2.2.2. Neutrophil function in innate immunity 
 
2.2.2.1. Neutrophil migration to the mammary gland 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Migration of neutrophils from blood into the mammary gland upon infection. The binding of selectins 
with their ligands mediates the initial interaction between neutrophils and endothelial cells. In response to signs 
of infection, a more adhesive contact involving β2-integrins and ICAM-1 molecules originates which allows 
neutrophils to transmigrate across the endothelium into the mammary gland. E. coli: Escherichia coli, ICAM-1: 
intracellular adhesion molecule-1. 
 
Neutrophil migration from blood into the infected mammary gland proceeds through a series 
of sequential steps (Adams and Shaw, 1994) (Figure 6). The initial neutrophil-endothelial 
interaction is mainly mediated by the low-affinity binding of L- and E-selectins with their 
ligands (Kansas, 1996). This slows the neutrophil down thereby creating a marginating pool 
of cells at the endothelium. After this first contact, neutrophils roll along vascular endothelia 
as they survey the vessel wall for signs of infection. Signals obtained during rolling lead to 
the expression of a neutrophil adhesion molecule called Mac-1 or CD11b/CD18, which is a 
member of the β2-integrin family of leukocyte adhesion molecules (Kishimoto and Rothlein, 
1994). When the expression of Mac-1 increases, L-selectin is proteolytically shed from the 
macrophageE. coli
neutrophil
blood flow
endothelium
endothelium
blood vessel lumen
extracellular matrix
mammary gland lumen
mammary epithelium
selectin
chemokine receptor
β2 integrin
selectin ligand
chemokine
ICAM-1
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neutrophil surface. The Mac-1 molecule allows neutrophils to bind tightly to activated 
endothelium via ICAM-1. This adhesive interaction allows neutrophils to transmigrate across 
the endothelial surface into mammary tissues along a concentration gradient of 
chemoattractants. The most important mediators in this process are the complement 
components C5a and C3a, the cytokines TNF-α, IL-1 and IL-6, the chemokine IL-8 and also 
LPS (Burton and Erskine, 2003; Paape et al., 2003). 
 
2.2.2.2. Neutrophil phagocytosis 
 
Upon arrival at the mammary gland, neutrophils encounter both opsonized and non-opsonized 
bacteria (Ohman et al., 1988; Burton and Erskine, 2003). Without opsonization, bacteria are 
recognized by their PAMPs. LPS for example, is bound to CD14 molecules which are stored 
in granules and externalized to the cell surface of bovine neutrophils upon migration to the 
infected gland. Other PRRs such as TLRs might also play a role in phagocytosis of non-
opsonized bacteria (Burton and Erskine, 2003). Opsonization greatly facilitates recognition 
and phagocytosis of the pathogen. It comprises binding of immunoglobulins (Igs) or 
complement components to the surface of the pathogen. Fcγ receptors on neutrophils interact 
with IgG antibodies, while complement receptors (CRs) recognize complement factors 
(Figure 7). A special receptor called the Fcγ2 receptor is present on bovine neutrophils and is 
able to recognize IgG2, one of the main opsonizing antibodies in cattle (Miller et al., 1988; 
Zhang et al., 1995). The expression of CR1, CR3 and Fc receptors is up-regulated in bovine 
neutrophils in response to pro-inflammatory signals encountered upon migration to the udder 
(Paape et al., 2000). Receptor binding to the pathogen leads to internalization, which is mostly 
initiated by the vigorous extension of pseudopods that surround and ultimately entrap the 
bacterium in the so called phagosome (Burton and Erskine, 2003) (Figure 7). 
 
2.2.2.3. Neutrophil killing 
 
The antimicrobial activity of bovine neutrophils against ingested pathogens represents a 
collaboration of multiple agents, including those prefabricated during neutrophil development 
in the bone marrow and those generated de novo following activation. Antimicrobial events 
are conventionally distinguished as being oxygen-dependent or oxygen-independent, although 
both systems typically operate simultaneously (Segal, 2005). 
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Figure 7: Neutrophil phagocytosis, killing and apoptosis. E. coli bacteria are opsonized by Igs and complement 
components. Specific receptors at the neutrophil surface recognize the opsonized bacteria which are internalized 
through the formation of a phagosome. Both oxygen-dependent and -independent antimicrobial events occur that 
kill the bacteria. Finally, the neutrophil undergoes an apoptotic cell death and is then removed by macrophages. 
E. coli: Escherichia coli, O2: oxygen, O2-: superoxide, H2O2: hydrogen peroxide, HOCl: hypochlorous acid. 
 
 
Following phagocytosis, cytoplasmic granules fuse with the nascent phagosome and release 
their contents into the phagosome, thereby exposing the ingested microbe to an array of toxic 
agents (Hirsch and Cohn, 1960) (Figure 7). In neutrophils, various granule subsets have been 
identified and they mainly differ in protein content (Borregaard and Cowland, 1997; 
Faurschou and Borregaard, 2003). Proteins synthesized at a given stage of myelopoiesis 
typically localize within the same type of granules (Borregaard and Cowland, 1997; Gullberg 
et al., 1999; Faurschou and Borregaard, 2003). The primary or azurophilic granules and the 
secondary or specific granules participate in the antimicrobial activity of neutrophils by 
mobilization of their arsenal of toxic compounds to the phagosome and to the exterior of the 
cell. The tertiary or gelatinase granules and the secretory vesicles are important primarily as a 
reservoir of matrix-degrading enzymes and membrane receptors needed during neutrophil 
extravasation and diapedesis. Logically, these last two types of granules are mobilized more 
rapidly than the first two (Faurschou and Borregaard, 2003). 
 
Coincident with degranulation, stimulated neutrophils exhibit an abrupt increase in oxygen 
consumption. This phagocyte respiratory burst is caused by an NADPH oxidase complex 
which assembles at the phagosomal membrane (Babior et al., 2002). As a result, reactive 
oxygen species (ROS) are formed which are highly antimicrobial (Figure 7). They include 
oxygen ions and radicals as well as peroxides. First, the NADPH oxidase complex generates 
superoxide (O2-) out of molecular oxygen (O2) (Vignais, 2002). This anion is used by 
superoxide dismutase (SOD) to produce hydrogen peroxide (H2O2). The hydroxyl radical 
(OH) is formed by combining O2- with H2O2. Alternatively, H2O2 is consumed by 
myeloperoxidase (MPO), an enzyme present in the azurophilic granules, to form different 
halogenated products. For example, in combination with the chloride ion (Cl-), hypochlorous 
acid (HOCl) is produced, which is considered to be the most bactericidal oxidant in 
neutrophils. Different ROS are generated in different amounts and have distinct reactivities 
and toxicities. In addition, their radius of action varies, and so does their life time (Hampton 
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et al., 1998). Interestingly, reactive nitrogen species (RNS), such as nitric oxide (NO) and 
peroxynitrate (ONOO-) might also be potent antimicrobial agents (Fialkow et al., 2007). 
Besides their role in the bactericidal activity of neutrophils, both ROS and RNS participate as 
signaling molecules that regulate diverse physiological responses in neutrophils (Fialkow et 
al., 2007). 
 
Recently, an alternative way of killing pathogens has been described for human neutrophils. 
Upon activation, they release granule proteins and chromatin, which together form 
extracellular fibers that bind bacteria (Brinkmann et al., 2004). These neutrophil extracellular 
traps (NETs) prevent the pathogens from spreading and ensure a high local concentration of 
antimicrobial agents that degrade virulence factors and kill bacteria even before they are 
engulfed. Clearly, sequestering the granule proteins into NETs may also keep these toxic 
compounds from diffusing and thereby inducing damage to host tissues (Brinkmann and 
Zychlinsky, 2007). 
 
2.2.2.4. Neutrophil apoptosis 
 
Under normal physiological conditions, neutrophils die to guarantee cellular homeostasis. 
This constitutive or spontaneous cell death shares many features of apoptosis, such as 
exteriorization of phosphatidylserine (PS) from the inner to the outer leaflet of the plasma 
membrane, vacuolated cytoplasm, nuclear condensation and cell body shrinkage (Luo and 
Loison, 2007). Apoptotic changes are accompanied by the downregulation of cellular 
functions. Apoptotic neutrophils of the human and bovine species lose their ability of 
chemotaxis, phagocytosis, respiratory burst and degranulation (Whyte et al., 1993; Haslett et 
al., 1994; Van Oostveldt et al., 2002). Cell surface receptors and adhesion molecules are 
downregulated as well (Jones and Morgan, 1995). Apoptotic cells are easily recognized and 
cleared by tissue macrophages and fibroblasts, as they express PS receptors (Savill et al., 
1989; Savill et al., 1993) (Figure 7). 
 
Many proteins are involved in the control of neutrophil apoptosis (Edwards et al., 2003; 
Maianski et al., 2004). Caspase activation is a well documented event during neutrophil cell 
death. These cysteine-aspartic acid proteases are activated by either the extrinsic or the 
intrinsic apoptosis pathway (Creagh et al., 2003) (Figure 8). The first pathway is death 
receptor-mediated and might be triggered by TNF-α. Besides its anti-apoptotic action, which 
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Figure 8: Molecular events occuring during apoptosis. The intrinsic pathway of apoptosis is triggered in 
response to stress. Following its release from the mitochondria, cytochrome c interacts with Apaf-1 and 
caspase-9 to promote the activation of caspase-3. The extrinsic pathway of apoptosis is initiated by death 
receptor engagement. Caspase-8 is recruited and activated through the interaction with FADD. Again, caspase-
3 is activated. As a result, phosphatidylserine is exposed on the outer leaflet of the cytoplasmic membrane. Apaf-
1: apoptotic protease activating factor-1, DD: death domain, DED: death effector domain, FADD: Fas-
associated death domain, TNF-α: tumor necrosis factor-α, TNFR: TNF receptor. 
 
is in part dependent upon NF-κB activation, this cytokine possesses a pro-apoptotic activity, 
which is demonstrated in both human and bovine neutrophils (van den Berg et al., 2001; 
Gupta, 2002; Mak and Yeh, 2002; Van Oostveldt et al., 2002). Upon ligation with TNF-α, 
Fas-associated death domain (FADD) is recruited through the interaction between DDs. This 
adaptor molecule subsequently binds to the initiator caspase-8 via death effector domains 
(DEDs). This leads to the activation of caspase-8, which in turn activates effector caspases 
such as caspase-3 that ultimately results into the breakdown of cellular components. The 
intrinsic pathway occurs in response to stress and is based upon the release of cytochrome c 
by the mitochondria and the subsequent activation of the initiator caspase-9 in the 
apoptosome. This large protein complex also contains apoptotic protease activating factor-1 
(Apaf-1). The integrity of the mitochondrial membrane is thought to be regulated by members 
of the pro-apoptotic subfamily of Bcl-2 proteins. As the Bcl-2 protein family also comprises a 
subfamily of anti-apoptotic members, mainly changes in expression levels of members of 
both subgroups determines the control over the cell’s fate (Moulding et al., 2001). 
 
Neutrophil cell death is also an essential event during infection. Upon migration to infected 
tissues, neutrophils encounter various pro-inflammatory cytokines and chemokines which 
significantly prolong their life span (Lee et al., 1993). In addition, LPS suppresses apoptosis 
of neutrophils through the activation of TLR4. This effect has also been demonstrated for 
bovine neutrophils in mammary glands injected with LPS (Sládek and Rysánek, 2001). 
Signaling via TLRs leads to increased levels of Mcl-1 and A1, the most important pro-
survival Bcl-2 family members in human neutrophils (François et al., 2005). A delay in 
apoptosis coincides with preservation of neutrophil functions (Lee et al., 1993). However, the 
antimicrobial compounds and ROS released by neutrophils to kill invading pathogens, may 
also damage tissues. Activated neutrophils thus become apoptotic. Their subsequent removal 
is essential for the resolution of inflammation in both humans and cows. Prolonged 
inflammation results in injury of bovine mammary epithelium (Ward, 1983; Zhao and 
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Lacasse, 2007). Clearly, the balance between the bactericidal function and the elimination of 
neutrophils needs to be well controlled in order to overcome the infection and simultaneously 
prevent unwanted and exaggerated inflammation (Maianski et al., 2004). 
 
2.3. Bovine intramammary infections 
 
2.3.1. Bovine mastitis pathogens 
 
Intramammary infections in dairy cows have received a lot of attention because of their major 
economic impact on the dairy farm through decreases in the quality and quantity of milk 
production, increases in the cost of treatment and veterinary services, and animal waste 
(Halasa et al., 2007). In addition, animal welfare has become increasingly important, 
especially for clinical mastitis. Furthermore, potential harms of antibiotic treatment are 
significant animal and human health issues as well (Hillerton and Berry, 2005). 
 
Mastitis is mainly caused by bacteria, although fungi, viruses or spores can induce 
intramammary infections as well. Bacteria causing mastitis are divided into three different 
groups. The contagious pathogens are transmitted from cow to cow and exposure mainly 
occurs during the milking process (Fox and Gay, 1993). The best known representative of this 
class is Staphylococcus aureus (S. aureus). This agent is responsible for the largest share of 
all ruminant intramammary infections. Additionally, these staphylococcal infections are of 
particular interest as they are the most difficult ones to cure. Antimicrobial treatment is often 
ineffective so that the subclinical infections tend to become chronic. 
 
A second group of bacteria causing intramammary infections are the environmental pathogens 
(Smith and Hogan, 1993). As opposed to contagious bacteria, these agents can survive and 
multiply outside the cow’s body. Therefore, infection with an environmental pathogen can 
occur at any time during the animal’s life by chance entrance of the bacterium. Rather than 
subclinical infections, these bacteria mainly cause clinical mastitis in cattle. Escherichia coli 
(E. coli) is an important bacterium causing coliform mastitis (Hogan and Smith, 2003). 
 
The common distinction between contagious and environmental mastitis pathogens knows 
many exceptions and therefore has become less appropriate. Contagious transmission during 
the milking process has been suggested for some strains of Streptococcus uberis (S. uberis), 
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which previously has been categorized as an environmental pathogen (Zadoks et al., 2003). 
For E. coli, transmission between cows has not been documented, but some strains are able to 
adapt to survival in the mammary gland, leading to transmissions within cows and chronic 
infections (Bradley and Green, 2001). Furthermore, contagious pathogens such as S. aureus 
and Streptococcus agalactiae (S. agalactiae) can on rare occasions also originate from 
environmental sources (Sukhnanand et al., 2005). Instead of the well known dichotomous 
classification, a sliding scale should therefore be used that accounts for niche adaptation of 
mastitis pathogens (Zadoks and Schukken, 2006). 
 
A last and third group consists of the so-called minor pathogens such as Corynebacterium 
bovis and the coagulase-negative staphylococci (CNS) (Rainard, 1987). The presence of these 
pathogens in the mammary gland does not elicit a strong inflammatory reaction like the one 
that is observed with major pathogens such as S. aureus and E. coli. In fact, it has even been 
postulated that these bacteria may provide protection against infection by other pathogens 
(Matthews et al., 1991; Nickerson and Boddie, 1994; Lam et al., 1997). They may either 
stimulate a limited cellular response in the udder which is beneficial to the udder health, or 
protection could arise from competitive exclusion (Woodward et al., 1987) or from the 
production of bacteriocins (dos Santos Nascimento et al., 2005). Occasionally, some CNS 
infections do elicit severe clinical signs or become persistent, and therefore not all CNS 
should be classified as minor pathogens (Taponen et al., 2006). 
 
2.3.2. E. coli intramammary infections in cows 
 
2.3.2.1. Escherichia coli 
 
E. coli is a Gram-negative, facultative anaerobic, non-spore-forming rod, which belongs to the 
family of Enterobacteriaceae. Gram-negative bacteria have a cell envelope which consists of 
three layers: the cytoplasmic membrane, the periplasmic space and the outer membrane (Bos 
et al., 2007) (Figure 9A). A thin peptidoglycan layer is present in the periplasmic space. The 
peptidoglycan is connected to the outer membrane via lipoprotein molecules. The outer 
membrane contains phospholipids, membrane proteins and LPS. The latter comprises a 
hydrophobic region, which is called lipid A, and a hydrophilic polysaccharide region, with the 
core polysaccharide and the O-antigen repeats (Seydel et al., 2000) (Figure 9B). Lipid A is the 
toxic component of LPS. Porins also exist in the outer membrane, which act like pores for 
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particular molecules. Both fimbriae and flagellae may protrude from the cell envelope. 
Finally, the surface may also be covered with a thick polysaccharide layer, called a capsule 
(Bos et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9A: Structure of the cell envelope of Gram-negative bacteria and B: Structure of LPS of E. coli. NAM: N-
acetylmuramic acid, NAG: N-acetylglucosamine, P: phosphate. 
 
 
E. coli bacteria are normal colonists of the intestinal tracts of humans and animals. They are 
constantly excreted in the faeces to the environment. Still, E. coli bacteria are also responsible 
for several diseases. This pathogen is known to cause gastroenteritis (Vallance et al., 2002) 
and is involved in urinary tract infections. E. coli might even cause more invasive infections, 
such as bacteraemia and meningitis (Smith et al., 2007). 
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2.3.2.2. E. coli intramammary infections in cows 
 
E. coli is one of the most important environmental bacteria causing bovine mastitis 
(Burvenich et al., 2003; Hogan and Smith, 2003). Intramammary infections caused by this 
bacterium are characterized by a warm, swollen and sensitive quarter or udder which secretes 
abnormal or sometimes watery milk with flakes or clots. Infected cows may suffer from fever, 
a rapid pulse, loss of appetite, dehydration, depression and weakness. Death might also occur. 
Until recently, intramammary infections with E. coli were generally considered to be acute 
and of short duration. Recurrence of clinical signs was believed to be the result of reinfection. 
However, multiple clinical episodes might also be explained by intramammary persistence of 
the causative strain (Döpfer et al., 2000; Bradley and Green, 2001). Nowadays, the existence 
of chronic E. coli intramammary infections is well accepted. Even single cases of clinical E. 
coli mastitis have been shown to be manifestations of pre-existing chronic sub-clinical 
infections (Bradley and Green, 2000). 
 
In order to initiate an intramammary infection, E. coli bacteria must invade the udder through 
the teat canal. They multiply inside the gland cistern and then spread all over the mammary 
tissue, where an inflammatory reaction originates (Hogan and Smith, 2003). It is generally 
believed that E. coli bacteria do not adhere to and subsequently invade mammary epithelium. 
Instead, this micro-organism remains in the lumen of the gland and mutiplies in milk 
secretions. However, recent studies show the formation of intracellular bacterial 
microcolonies following invasion of mammary epithelial cells (Döpfer et al., 2000; Döpfer et 
al., 2001; Gonen et al., 2007). These observations might partially explain the pathogenesis of 
chronic E. coli mastitis. 
 
The role of LPS as a key molecule in the pathogenesis of E. coli intramammary infections is 
well defined (Burvenich et al., 2003; De Schepper et al., 2008). LPS is released as a result of 
bacteriolysis and growth of E. coli. This toxin accounts for many pathophysiological signs 
observed during intramammary infections in ruminants. It initiates the acute phase reponse 
and causes fever. It also activates the complement system and stimulates immune cells to 
synthesize and release pro-inflammatory mediators. It increases venular permeability and 
influences the number of circulating leukocytes. These responses are initiated upon 
recognition of LPS by the host as a danger signal. LPS interacts with membrane CD14 
(mCD14) and soluble CD14 (sCD14) molecules that are expressed in and secreted by bovine 
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macrophages and neutrophils (Paape et al., 1996). In contrast, mammary epithelial and 
endothelial cells are not able to synthesize CD14. Still, they are believed to recognize the 
complex of LPS, LBP and sCD14 (Van Amersfoort et al., 2003). Bovine mammary tissue 
contains mRNA for TLR4 and its expression is increased in infected quarters (Goldammer et 
al., 2004). Even though the expression of TLR4 remains to be documented at the protein 
level, its presence in the membrane is very likely since bovine mammary epithelial cells are 
able to produce several important cytokines and chemokines upon stimulation with LPS 
(Srandberg et al., 2005). Human neutrophils are known to express TLR4, but at lower levels 
than macrophages (Hayashi et al., 2003). TLR4 agonists regulate neutrophil migration and 
function (Sabroe et al., 2005). Upon LPS stimulation of neutrophils, a wide range of 
transcriptional responses has also been demonstrated such as the up-regulation of cytokines, 
chemokines and proteins important for cell growth and survival (Sabroe et al., 2005).  
 
The role of neutrophils in the defense of the mammary gland against E. coli is crucial (Paape 
et al., 2003; Rainard and Riollet, 2006). The time point of neutrophil recruitment and the 
amount of engaged cells determines the outcome of the infection (Burvenich et al., 2003). 
Neutrophil phagocytosis and their bactericidal activity are enhanced upon stimulation with 
pro-inflammatory mediators present at the site of infection (Sample and Czuprynski, 1991; 
Sordillo and Babiuk, 1991). Still, milk neutrophils as well as milk macrophages tend to be 
less functional than their circulating counterparts (Mullan et al., 1985). The ingestion of milk 
fat globules and milk proteins results in a loss of cytoplasmic granules and the subsequent 
reduction in antimicrobial activity. In addition, pseudopods needed for phagocytosis are 
thereby eliminated (Paape et al., 1975; Paape and Guidry, 1977). Moreover, it has been shown 
that diapedesis of neutrophils across the mammary epithelium reduces their bactericidal 
activity (Smits et al., 1999). In addition, the functional competences of neutrophils are 
reduced around parturition and during early lactation (Kehrli et al., 1989; Cai et al., 1994). 
Bovine intramammary infections caused by E. coli mainly occur in these time periods 
(Vangroenweghe et al., 2005). The underlying mechanisms involved in this 
immunosuppression are still unclear but hormonal and metabolic changes associated with 
pregnancy, parturition and the onset of lactation might influence the inflammatory reaction 
(Paape et al., 2002). 
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B A 
3. Mouse model of intramammary infections 
 
3.1. Biology of the mouse mammary gland 
 
Mice have 5 pairs of mammary glands, each with a single nipple. They are typically 
numbered according to their position on the body, starting from anterior to posterior (Figure 
10A). Similar to cows, two pairs of glands are located in the inguinal region, while three 
additional pairs which are not present in cattle, are lying within the thoracic body area 
(Hummel et al., 1966). Mouse mammary glands are functionally and anatomically 
independent from each other, like bovine mammary glands. The only externally visible 
portion of the mammary gland is the nipple. The rest of the gland extends dorsolaterally as 
flat subcutaneous sheets of secreting and fibroadipose tissue. One major duct connects the teat 
to the mammary tissue, which is mainly a branching of smaller ducts. The smallest ducts 
terminate in alveoli, of which the epithelial cells are responsible for milk secretion in lactating 
glands (Daniel and Silberstein, 1987) (Figure 10B). 
 
 
 
 
Figure 10A: Anatomical location of mouse mammary glands and their numbering (adapted from Popesko et al., 
1990) and B: Anatomical structure of a rodent mammary gland (adapted from Russo and Russo, 1980). 
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3.2. Mouse model of intramammary infections 
 
3.2.1. Introduction 
 
When intramammary infections are studied in cows, major costs and management problems 
are inevitable. For this reason, the experimental mouse model of mastitis was developed and 
characterized already in the 1970s (Chandler, 1969; Chandler, 1970a). This alternative is 
relatively inexpensive as it requires only standard animal care facilities and basic laboratory 
animal experience. Currently, the mouse is still considered to be a very suitable tool for 
research focusing on the pathogenesis and control of bovine intramammary infections. The 
anatomical structure of the mammary gland of both species is very similar. As in cows, the 
mouse mastitis model also provides the unique pathogen growth environment of milk. It 
allows interaction of the micro-organism with the host cells and immune components, besides 
offering physical factors such as suckling. In in vitro models, these features are not taken into 
account. Finally, observations in mice concerning bacterial counts, neutrophil numbers and 
histological changes during intramammary infections are similar to those in cows (Chandler, 
1970a). 
 
Despite the similarities, some differences also exist between the mammary glands of both 
species. For example, the bovine udder contains far more resident phagocytic cells than the 
mouse mammary gland (Anderson and Heneghan, 1979) and milk composition differs 
significantly in terms of protein, fat and carbohydrate shares (Johnson, 1974). Additionally, 
another approach for the study of murine mastitis is necessary. As opposed to cows, somatic 
cell count (SCC) analysis is typically not perfomed since milk collection is a difficult 
procedure in mice. Nevertheless, milking devices for small animals do exist and milk is then 
mainly collected following administration of oxytocin (Temple and Kon, 1973). Still, in 
mouse the intensity of inflammation is primarily assessed indirectly, by observing the 
resulting tissue damage. However, neutrophil quantification based on the use of mammary 
gland sections has been described (Brouillette et al., 2005a). The small size of the mouse 
mammary gland allows it to be removed completely and fixed intact. Alternatively, semi-
quantitative observations to evaluate neutrophil infiltration have also been reported (Owens et 
al., 1992; Sanchez et al., 1994; Guhad et al., 2000). Finally, since the incidence of mastitis is 
high in early lactating mammals, this disease is well correlated with the animal’s reproductive 
system which is very diverse between cows and mice. 
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Because of these differences, results obtained from experiments with mice are not necessarily 
applicable to cattle. Several authors underline the importance of the final assessment in cows 
following studies with the mouse model of intramammary infections. Still, results obtained in 
the latter species are highly suggestive for similar findings in cattle. Furthermore, the murine 
infection model offers additional and very attractive perspectives for the study of mastitis. 
The availability of a much larger number of animals permits screening of numerous potential 
antimicrobial and immunomodulatory compounds. In cows such experiments would be very 
expensive and time-consuming. In addition, to get valid statistics the minimal number of 
animals is readily accessible using mice. Another critical issue is that promising agents are 
sometimes only available in limited quantities and can therefore never be appropriately tested 
in cows. New technologies like real-time in vivo imaging are also only applicable to small 
laboratory animals. Most importantly, the generation of mutant, transgenic or knock-out mice 
has now made profound mastitis research possible (Kerr et al., 2001). Compared to their wild-
type counterparts, these mice offer the unique opportunity to study the contribution of specific 
host genes to inflammatory diseases. Moreover, short-term delivery of genes to mouse 
mammary cells holds great promise for both research and therapeutic purposes (Russell et al., 
2003). 
 
3.2.2. Methodology 
 
3.2.2.1. Intramammary inoculation techniques in mice 
 
For the induction of mastitis in mice, the pathogen is inoculated via the intramammary route. 
Inoculation is performed under general anaesthesia of the animals, which is typically obtained 
by single intraperitoneal injection. Certainly, gas anaesthesia is a safer and more controllable 
alternative but an investment in specific equipment is then required. 
 
Several variations in the intramammary inoculation technique are described in literature. A 
first method is to deposit the pathogen on the tip of the teat (Anderson, 1979b). A drop of a 
highly concentrated bacterial suspension is then needed since only a very small number of 
organisms are likely to enter the primary duct. In addition, the incidence of mastitis is 
particularly variable as infections depend on the chance of entrance. Infection also varies with 
the type of agent inoculated and whether or not the nipples are damaged and suckling by the 
pups is allowed. 
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A second method consists of inserting the pathogen through a micropipette of which the tip 
has entered the primary duct (Nguyen et al., 2000; Lee et al., 2003). Hence, a diameter of less 
than 75 micrometer is required. The correct positioning of the micropipette and the insertion 
of its tip into the duct orifice is guided by a micromanipulator and carried out under minor 
magnification with a dissecting microscope and fibre-optic illumination. For lactating mice, 
the opening of the primary duct should be apparent but in non-lactating mice it is ofter 
covered with a layer of dead skin which must be removed prior to injection. 
 
A third possibility is to cut the very near end of the teat with small scissors before injecting 
the inoculum with a syringe and a needle with a diameter not bigger than 30 gauge 
(Brouillette and Malouin, 2005) (Figure 11). The insertion depth does not exceed a few 
millimeters and the use of a blunt needle is recommended in order to assure that injection is 
directly into the primary duct without penetration of the mammary tissue. For the last two 
techniques challenge numbers as low as 10 colony-forming units (CFUs) can be used to 
induce mastitis while the incidence easily reaches a hundred percent (Anderson, 1979b; Lee et 
al., 2003). Still, the reduction in inoculation numbers also results in a broader spectrum of 
immune responses. Therefore, higher numbers, up to 105 CFU, are applied as well (Anderson, 
1983; Brouillette et al., 2003a). However, it should be pointed out that administration of low 
bacterial numbers better represents what happens in vivo in cattle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Photograph showing the entrance of a small needle in the teat canal of the right fourth mammary 
gland of an anaesthetised mouse after the teat end removal and before the injection of the bacterial inoculum. 
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Small quantities of pathogens are also used in the last and fourth alternative inoculation 
technique. In this case the gland is surgically exposed and the pathogen is injected into the 
primary duct by means of a needle, again with a diameter smaller than 30 gauge (Nguyen et 
al., 2000). This method can not be performed on pregnant or lactating animals as the duct 
becomes invisible due to extensive proliferation of mammary tissue. 
 
As mentioned above, five pairs of mammary glands are defined on mice. The fourth pair is 
commonly used for infection studies because these glands are the biggest and therefore the 
easiest to observe and harvest after exposure. Inoculated organisms are preferably isolates 
from cases of bovine intramammary infections, but bacteria from other animals such as 
infected sheep (Buddle et al., 1984; Watkins et al., 1992) and even isolates from milk of 
nursing women have been used (Thomsen et al., 1985). Generally, only one type of pathogen 
is inoculated, but the possibility exists to inject different strains into separate glands on one 
mouse (Anderson, 1974a). Besides mammary glands receiving the pathogen, control glands 
are also required in the experimental set-up. Injection of heat-killed bacteria, culture-filtrate, 
medium or saline solution has been reported (Chandler, 1970a). The volume tolerated by the 
mouse mammary gland varies with the age of the animal and the extent of gland development 
(Nguyen et al., 2000), but does normally not exceed one hundred microliters. A variety of 
mouse lineages has been utilised in mastitis studies and generally lactating mice are 
employed. Inoculation is typically carried out within the first two weeks of lactation. At 
necropsy, the success rate of infusion can be confirmed by the addition of sterile India ink to 
the inoculum (Kerr et al., 2001; Lee et al., 2003). 
 
3.2.2.2. Mouse mastitis pathogens 
 
As mastitis in cows is mainly caused by bacteria, these pathogens are also mostly inoculated 
in mice. One research group has used fungi for the induction of mastitis in mouse mammary 
glands (Guhad et al., 1995). However, it should be remarked that in this mycotic study the 
mouse mastitis model was utilized as a suitable tool for the investigation of candidiasis. Table 
3 gives an overview of the pathogens that have been employed to induce mastitis in the 
mouse. 
 
S. aureus is responsible for the largest share of all ruminant intramammary infections and this 
observation is reflected in the number of mouse mastitis studies involving this contagious 
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pathogen. Staphylococcal infections are the most difficult ones to cure since antimicrobial 
treatment is often ineffective. Some authors suggest that this phenomenon might be due to the 
ability of S. aureus to invade and persist within certain types of host cells such as bovine 
mammary epithelial cells (Almeida et al., 1996). The maintenance of an intracellular pool of 
bacteria is likely since antibiotics do not always penetrate the gland and host cells completely 
and if they do, their concentration might be too low to kill the pathogen (Sanchez et al., 1988; 
Gruet et al., 2001). Lately, more interest goes into the so-called small-colony variants (SCVs) 
of S. aureus. This phenotype is defined as a slow-growing or quiescent, non-toxigenic 
pathogen with a reduced susceptibility towards antimicrobial agents. The reversion into the 
virulent phenotype might explain the reappearance of inflammation. SCVs of S. aureus have 
been isolated from the bovine udder (Sompolinsky et al., 1974) and the role of these variants 
in the persistence of infectious mastitis has been studied in the murine model (Brouillette et 
al., 2004b). In addition, the localization of bacteria in epithelial cells, neutrophils and 
macrophages in the mouse mammary glands has been reported (Brouillette et al., 2003a). 
Interestingly, mouse mastitis caused by S. aureus is mainly acute as animals typically die 
within a few days post-infection because of the presence of bacterial toxins such as the α-
toxin, the best characterized and most potent staphylococcal toxin (Anderson, 1979b). In 
order to stimulate the chronic infection observed in cows, LPS can be injected before bacterial 
inoculation in mice (Anderson, 1976). The subsequent mammary gland involution and 
phagocyte infiltration will reduce colonisation leading to a more chronic course of the 
infection. Likewise, neutrophil infiltration can be induced by the presence of a pathogen of 
low virulence such as Staphylococcus epidermidis (Anderson, 1978a). Another well-known 
contagious mastitis pathogen is S. agalactiae. In contrast to S. aureus, this pathogen is very 
sensitive to antibiotic treatment and can thus be more controlled. Consequently, only a few 
studies in mice used S. agalactiae as mastitis pathogen (Chandler, 1970a/b; Chandler, 1973; 
Anderson, 1978b; Smith and Chandler, 1978; Anderson and Craven, 1984). Finally, some 
Mycoplasma species can also induce mastitis in cattle and these infections rapidly spread in 
herds. Treatment is generally ineffective as most antibiotics are useless due to the absence of 
a cell wall in Mycoplasma bacteria. Since these contagious pathogens are difficult to identify, 
many infections may remain undiagnosed and research in this field thus deserves more 
attention. A few reports present data on mastitis induced by Mycoplasma in mice (Anderson 
et al., 1976; Thorns and Boughton, 1980; Buddle et al., 1984). 
  
 
Table 3: Pathogens used in the mouse mastitis model (in alphabetical order) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thomsen et al., 1985saprophyticus
Anderson et al., 1985; Honkanen-Buzalski et al.,1985bovis
Corynebacterium
Minor pathogens
Chandler, 1970pyogenes
Anderson, 1978a & b; Anderson and Holmberg, 1977; Thomsen et al., 1985epidermidis
Staphylococcus
Environmental 
pathogens
Contagious 
pathogens
Candida
Streptococcus
Pseudomonas
Escherichia
Campylobacter
Ureaplasma
Streptococcus
Staphylococcus
Pasteurella
Mycoplasma
Acholeplasma
Genus
albicans, krusei
uberis
aeruginosa
coli
coli
agalactiae
aureus
haemolytica
bovis
argini, ovipneumoniae
agalactiae, bovigenitalium, 
bovirhinis, dispar, mycoides
laidlawii
Species
Anderson, 1974, 1975, 1978, 1979a & b, 1982, 1987; Anderson and Chandler, 
1975; Anderson and Craven, 1984; Anderson and Holmberg, 1977; Bramley 
and Foster, 1990; Brouillette et al., 2002, 2003, 2004a & b, 2005 a & b; 
Buddle et al., 1977; Buzzola et al., 2006; Chandler, 1970 & 1971; Chandler et 
al., 1976; Chesbro et al., 1972; Chew et al., 1984 & 1985; Cooray and 
Jonsson, 1990; Craven and Anderson, 1979, 1981 & 1983; Craven et al., 1982 
& 1983; Diarra et al., 2003; Garcia et al., 1996; Gomez et al., 1998 & 2002; 
Haraldsson and Jonsson, 1984; Honkanen-Buzalski et al., 1985; Jonsson et al., 
1985; Kerr et al., 2001; Malouin et al., 2005; Mamo et al., 1994a & b, 1995 & 
2000; Odierno et al., 1994; Owens and Nickerson, 1989; Owens et al., 1992; 
Reid et al., 1976; Sanchez et al., 1994; Yancey et al., 1985 & 1987
Anderson, 1978; Anderson and Craven, 1984; Chandler, 1970a & b; Smith 
and Chandler, 1978
Howard et al., 1975
Diker et al., 1992
Anderson, 1978, 1979b & 1986; Anderson et al., 1977; Anderson and Craven, 
1984; Chandler 1970 & 1971; Chandler and Anger, 1977; Cooray and
Jonsson, 1990; Gonen et al., 2007; Lee et al., 2003; Yancey et al., 1985
Anderson and Craven, 1984; Chandler, 1970 & 1971
Anderson and Craven, 1984; Sordillo and Nickerson, 1986
Guhad et al., 1995, 1998a & b, 1999 & 2000Fungi
Watkins et al., 1992
Thorns and Boughton, 1980
Buddle et al., 1984
Anderson et al., 1976
Anderson et al., 1976
Bacteria
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Of the environmental pathogens, E. coli is often inoculated in mouse mammary glands. In 
contrast to contagious mastitis, the characteristics of this type of intramammary infection very 
closely resemble those in cattle and thus do not require any modification (Chandler, 1970a). 
In addition, of importance are the systemic symptoms caused by LPS. Intraperitoneal 
injection of this toxin has also been reported but appeared to be lethal in mice (Lee et al., 
2003). Interestingly, this severe endotoxin shock usually does not occur when challenging 
mice with the bacterium itself since the mammary gland probably detoxifies the coliform 
toxin before it can enter the circulation (Dosogne et al., 2002). 
 
The pathogenesis and virulence of different minor pathogens, which appear to provide 
protection against intramammary infections caused by other micro-organisms, have also been 
tested in mice (Chandler, 1970a; Anderson and Holmberg, 1977; Anderson, 1978b; Anderson 
et al., 1985; Honkanen-Buzalski, 1985; Thomsen et al., 1985). Furthermore, these agents are 
used to convert an acute reaction into a chronic one by inoculating them prior to the major 
pathogen (Anderson, 1978a).  
 
3.2.3. Areas of application 
 
3.2.3.1. Study of the pathogenesis of mastitis 
 
The mouse mastitis model was originally designed to study the pathogenesis of this infectious 
disease. Mastitis in mice can be assesed in terms of clinical appearance, macroscopic and 
microscopic changes and the recovery of the inoculated organisms (Chandler, 1970a). 
Clinical symptoms arise in local responses, such as darkening of the skin of the nipple and the 
obvious swelling of the mammary gland, and generalized reactions, which include a ruffled 
coat, a hunched appearance, weakness and sometimes death. At necropsy, infected glands are 
characterized by enlargement, discolouration and exudation or abscess formation. 
Histopathological changes such as the presence of neutrophils in the alveoli and ducts, 
detached epithelial cells, lesions and necrosis of the mammary tissue can also be observed. A 
large number of pathogens are recovered from the mammary gland and occasionally, 
dissemination of bacteria to visceral organs is detected as well (Anderson, 1987; Brouillette et 
al., 2004a). Nowadays, a more molecular approach to the study of the induced inflammatory 
reaction by intramammary pathogens is also applied (Gonen et al., 2007). 
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In the establishment of intramammary infections, not only the entrance in the gland, but also 
the adhesion of the organism to the mammary epithelium and the subsequent bacterial 
multiplication are essential. For the study of bacterial adherence and virulence mechanisms, a 
novel approach within the murine mastitis model has been used extensively. Mutants of 
pathogens lacking specific adhesion proteins were designed and inoculated in mice to 
evaluate their significance in the onset of infection. By these means, it could be demonstrated 
that the adhesion antigen K88 does not play a significant role in the potential of E. coli to 
cause mastitis (Anderson et al., 1977). In contrast, the contribution of fibronectin-binding 
proteins as members of the class of adhesins to the colonisation of murine mammary glands 
by S. aureus was unequivocally established (Brouillette et al., 2003b). The virulence of 
mutants which fail to express α-toxin, β-toxin or both was also assessed in mice (Bramley et 
al., 1989). The absence of these staphylococcal toxins delayed the colonisation by S. aureus 
bacteria and the subsequent infection of the mammary gland. The pathogenicity of other 
factors as the coagulase enzyme and the cell wall constituent protein A was evaluated as well 
(Haraldsson and Jonsson, 1984; Jonsson et al., 1985). Whereas the first factor was identified 
as an important virulent recombinant, the latter one is likely not essential for mastitis 
infections in mice. In addition, exoprotein synthesis is only vaguely correlated with pathogen 
virulence (Odierno et al., 1994). Finally, by the use of mutant strains two virulence factors 
were determined in the mycotic mouse mastitis model (Guhad et al., 1998a/b). Importantly, 
not only mutant pathogen strains are employed to study the relevance of bacterial proteins in 
the pathogenesis of intramammary infections, also single proteins can be inoculated 
(Anderson, 1974b; Anderson and Mason, 1974; Calvinho et al., 1993). As an example, the 
injection of partially purified β-toxin was reported (Calvinho et al., 1993). This protein was 
found not to be of major importance since only mild pathological effects were observed. As 
this result is contradictory to the abovementioned conclusion of the study with β-toxin 
deficient S. aureus, care must be taken with the interpretation of observations from molecular 
approaches used in pathogenesis studies. 
 
3.2.3.2. Strategies to control mastitis 
 
Besides its suitability for the study of the pathogenesis process, the mouse model of 
intramammary infections is also a very elegant tool to screen the capacity of many 
compounds to overcome infection. An overview of control strategies is given in Figure 12. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Control of murine mastitis
Curative measures Preventive measures
Antimicrobial agents Immunomodulatory compounds Vaccination
- AroA mutant of S. aureus (Buzzola et al., 2006)
- Temperature-sensitive S. aureus (Garcia et al., 1996; Gomez et al., 1998 & 2002)
- Fibrinogen-binding protein (Mamo et al., 1994a)
- Fibronectin-binding protein (Mamo et al., 1994b & 1995)
- Collagen-binding protein & α-toxoid (Mamo et al., 2000)
- Clumping factor A (Brouillette et al., 2002)- Vitamin A (Chew et al., 1984 & 1985)
- T-2 toxin (Cooray and Jonsson, 1990)
- Lactoferrin (Diarra et al., 2003)
- CD14 (Lee et al., 2003)
- TNF-α (Sanchez et al., 1994)
- Milk-derived factor (Owens and Nickerson, 1989; Owens et al., 1992)
- Pokeweed mitogen (Sordillo and Nickerson, 1986)
- Flunixin (Anderson, 1986)
- Antibiotics (Anderson, 1977 & 1987; Anderson and Craven, 1984; 
Anderson and Kirby, 1986; Brouillette et al., 2004a & b; Chandler, 1971; 
Craven and Anderson, 1979, 1981, 1982 & 1983; Craven et al., 1982 & 
1983; Yancey et al., 1985 & 1987)
- Cyclic dinucleotides (Brouillette et al., 2005b)
- Lysostaphin (Bramley and Foster, 1990; Kerr et al., 2001)
- Amphotericin (Guhad et al., 1999)
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Figure 12: Curative and preventive stategies employed to control mouse mastitis. S. aureus: Staphylococcus 
aureus, TNF-α: tumor necrosis factor-α. 
 
 
The treatment of mouse mastitis started by the use of antibiotics. Bactericidal penicillins and 
cephalosporins are often employed as inhibitors of bacterial cell wall synthesis (Chandler, 
1971; Anderson, 1977; Craven and Anderson, 1979; Craven and Anderson, 1981; Craven and 
Anderson, 1982; Craven et al., 1982; Craven et al., 1983; Anderson and Craven, 1984; 
Anderson and Kirby, 1986; Anderson, 1987; Yancey et al., 1987; Brouillette et al., 2004a/b). 
Occasionally, bacteriostatic agents such as lincosamide and macrolide antibiotics, which 
restrain general protein synthesis, are tested in mice (Craven and Anderson, 1981; Craven and 
Anderson, 1983; Yancey et al., 1985). In several studies, the application of these therapeutic 
compounds by intramammary injection led to a significant reduction in bacterial numbers, in 
the subsequent neutrophil infiltration and the ultimate inflammation. As mentioned before, 
this is not the case for intracellular staphylococci, which are not susceptible to the action of 
inhibitors of cell wall synthesis since they are metabolically dormant (Brouillette et al., 
2004b). Hence, intensive research is now performed to discover new agents having 
bactericidal activity against these intracellular bacteria (Malouin et al., 2005). In addition, 
novel formulations that allow uptake of active components by cells with an intracellular 
reservoir of S. aureus are tested (Anderson and Kirby, 1986). Next to the intramammary route 
of administration, other routes such as intravenous, intramuscular and intraperitoneal injection 
have also been applied since they provide information about the capacity of the compound to 
reach the mammary gland (Brouillette et al., 2004a). These alternatives are promising since 
intramammary administration can be complicated due to the presence of keratin in the 
mammary duct. Moreover, injections in the mammary gland increase the risk of 
contamination. Hence, drugs with strong affinity for the mammary gland as well as those with 
a long retention period in the gland are searched for (Yancey et al., 1985). In addition to 
variations in the route of administration, antibiotics were also applied at different time points 
following bacterial inoculation (Chandler, 1971). From these kinetic studies, it could be 
concluded that treatment should be initiated as soon as possible after the onset of the infection 
process since antibiotics may not be effective if administration is delayed until 24 hours post-
infection. In this context, it should be remarked that the detection and diagnosis of ruminant 
mastitis, which includes also the identification of the causative organism, typically exceeds 
one day. 
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Besides antibiotics, other bactericidal agents and even one with antifungal properties have 
been tested in the murine model of intramammary infections (Guhad et al., 1999). A recent 
paper describes effective treatment by cyclic dinucleotides such as 3',5'-cyclic diguanylic acid 
which are small molecules intervening with important signaling pathways in bacteria 
(Brouillette et al., 2005b). Very innovative research has been carried out on lysostaphin, a 
natural compound produced by Staphylococcus simulans which seems to have considerable 
potential for the therapeutic control of staphylococcal mastitis (Bramley and Foster, 1990). 
This enzyme specifically hydrolyses the peptidoglycan that is found in the cell wall of 
staphylococci. Intramammary infusion of lysostaphin reduced the number of bacteria 
recovered from the mouse mammary gland as well as the concomitant pathological changes. 
Furthermore, the secretion of lysostaphin in milk of transgenic mice protects them against 
intramammary challenge with S. aureus (Kerr et al., 2001). Remarkably, even cows 
expressing lysostaphin in their milk are now generated and again increased resistance to S. 
aureus has been observed (Wall et al., 2005). These studies show the benefits of the murine 
mastitis model for genetic-engineering and the potential of lactation-specific transgenesis of 
antibacterial proteins to obtain enhanced mastitis resistance in different target species. 
 
In the mouse mastitis model not only compounds which suppress pathogen growth and 
survival have been tested, but also agents that enhance host resistance through their 
immunomodulatory activity. Retinoid metabolites are proposed to positively influence host 
defense mechanisms. Mice fed a diet supplemented with vitamin A showed less severe 
mammary gland inflammation after intramammary inoculation (Chew et al., 1984). In 
addition, vitamin A-deficient animals had increased pathological damage to the mammary 
gland (Chew et al., 1985). Another modulator could be the T-2 toxin, naturally produced by 
Fusarium species. Treatment of mice with this mycotoxin reduced the virulence of both S. 
aureus and E. coli and limited the inflammatory reaction (Cooray and Jonsson, 1990). The 
authors suggest an activation of macrophages as the mechanism behind the increased 
resistance to mastitis. Enhancement of phagocytosis and intracellular killing might also be a 
possible feature of lactoferrin, next to a decreased capacity of adherence to extracellular 
matrix proteins and the subsequent invasiveness of S. aureus into mammary epithelial cells 
(Diara et al., 2003). This important protein can be found in milk and in neutrophil granules 
and its bactericidal activity was already well-established before the investigation of its 
possible immunomodulating properties. Remarkably, mice expressing the lactoferrin 
transgene in milk were engineered but challenge studies are not yet reported (Platenburg et 
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al., 1994). Another interesting approach is the inoculation of E. coli together with the soluble 
form of the LPS receptor CD14. The reduced mammary inflammation observed in the latter 
study is likely the result of the early infiltration of neutrophils (Lee et al., 2003). A similar 
enhanced recruitment was observed after single treatment with the cytokine TNF-α. 
Subsequent injection of S. aureus also led to a faster elimination of the bacteria (Sanchez et 
al., 1994). Interestingly, the species-specific recombinant cytokine proved to be more 
powerful in this control than the human protein. Moreover, combining TNF-α with various 
antibiotics resulted in an even greater reduction of bacterial counts. An improved resistance 
and reduced inflammation was reported after challenge with S. aureus and infusion of a yet to 
be identified milk-derived factor (Owens and Nickerson, 1989; Owens et al., 1992). Another 
paper describes the enhanced antimicrobial defense after injection of pokeweed mitogen 
(Sordillo and Nickerson, 1986). Mammary gland susceptibility towards S. uberis infection 
seemed to be beneficially modified by this plant lectin. Finally, the anti-inflammatory drug 
flunixin was tested without success in the mouse model of S. aureus mastitis (Anderson, 
1986). 
 
A third approach of controlling mastitis is prevention by vaccination. Commercially available 
vaccines for cattle have shown limited efficacy, especially against S. aureus intramammary 
infections. Instead of preventing the disease, these vaccines are mostly only capable of 
improving cure rates and diminishing the severity of infection. The mouse mastitis model has 
become a feasible tool also in this field of mastitis control. Intramammary immunization of a 
temperature-sensitive mutant of S. aureus has led to a decreased severity of mammary gland 
infection by the wild-type bacterium (Garcia et al., 1996; Gomez et al., 1998). Significantly 
lower numbers of pathogens in the gland were observed as well as an increase of specific milk 
and serum antibodies. A T cell-mediated immune response is also induced which might be 
indispensable in combating S. aureus mastitis due to the possible inefficient humoral 
immunity towards these intracellular bacteria (Gomez et al., 2002). The best results were 
obtained when immunization occurred in late pregnant mice or during early lactation, but not 
before gestation (Gomez et al., 1998). In a more recent report, similar results were shown 
with a different mutant of S. aureus (Buzzola et al., 2006). Other studies describe the 
immunization with the complete fibrinogen-binding protein or domains of the fibronectin-
binding protein, both present on the surface of S. aureus, and the subsequent protection 
obtained in the mouse model (Mamo et al., 1994a/b). Furthermore, inoculation of bacteria 
opsonised with fibronectin-binding protein antisera of immunised mice also led to milder 
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forms of mastitis (Mamo et al., 1995). In addition, the same group tested vaccines with 
combinations of proteins such as collagen-binding protein and α-toxoid, again with some 
success (Mamo et al., 2000). Besides injection of proteins, a promising DNA vaccine which 
contains the adhesin clumping factor A of S. aureus has recently been developed (Brouillette 
et al., 2002). Less severe mastitis was observed in mice inoculated with bacteria opsonised 
with sera of immunized animals. Induction of mastitis in these vaccinated mice would be an 
interesting next step to perform. In conclusion, despite these remarkable reports, vaccination 
studies carried out in mice are still in their infancy since prevention, which is the ultimate 
goal of vaccination, remains to be achieved. 
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HYPOTHESES 
 
Neutrophils are the most important cells within innate immune responses towards bovine 
intramammary E. coli infections (Rainard and Riollet, 2006). These leukocytes are terminally 
differentiated, short-lived cells with an extensive array of surface receptors for response to 
inflammatory stimuli (Burton and Erskine, 2003) and an arsenal of antimicrobial compounds 
in their granules to combat invading pathogens (Segal, 2005). Until recently, it was widely 
assumed that these phagocytes are transcriptionally inactive since they seem to be fully 
equipped upon their release from the bone marrow into the blood in order to perform their 
function. Nowadays, complex changes in gene and protein expression profiles within 
activated neutrophils have been identified (Borregaard et al., 2007). These findings support 
the emerging concept of an active regulatory role of neutrophils besides their defense 
function, in the progression of the innate immune response. 
 
Upon invasion of E. coli bacteria in the bovine mammary gland, neutrophils are recruited 
from blood into the milk. Mammary epithelial cells and milk macrophages most likely initiate 
this event, since they represent the two main cell types that invading pathogens encounter at 
first (Rainard and Riollet, 2006). To date, several pro-inflammatory cytokines and 
chemokines have been identified as major regulators of bovine neutrophil migration (Burton 
and Erskine, 2003; Paape et al., 2003). Moreover, some of these proteins are known to be 
secreted by bovine mammary epithelial cells and macrophages upon their exposure to bacteria 
or bacterial toxins (Politis et al., 1991; Boudjellab et al., 1998; Okada et al., 1999; Wellnitz 
and Kerr, 2004; Pareek et al., 2005). 
 
Gene expression within innate immune responses is highly mediated by the transcription 
factor NF-κB (Liou, 2002). NF-κB activation has been demonstrated in bovine mammary 
epithelial cells following in vitro stimulation (Safieh-Garabedian et al., 2004; Strandberg et 
al., 2005; Yang et al., 2006; Fitzgerald et al., 2007). Studies regarding the role of NF-κB in 
neutrophils have been mainly carried out with human cells. NF-κB is known to regulate the 
neutrophil’s life span (Akgul et al., 2001; Ward et al., 2004) and its contribution in 
neutrophils under in vitro inflammatory conditions is identified as well (McDonald et al., 
1997; McDonald and Cassatella, 1997; Kettritz et al., 2004). One ex vivo study illustrates NF-
κB activation in milk cells of bovine mammary glands infected with contagious mastitis 
pathogens such as S. aureus (Boulanger et al., 2003). However, no reports exist on the role of 
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this transcription factor in bovine coliform intramammary infections. It is therefore suggested 
that NF-κB activation in the mammary gland contributes to the development of 
intramammary innate immune responses towards E. coli bacteria. Additional experimental 
work is necessary to conclusively support this attractive hypothesis. 
 
In this doctoral thesis, the assumption that NF-κB plays a key role in both the regulation of 
the bovine neutrophil life span and in mediating its immune response is investigated. 
Additionally, NF-κB activation is suggested to be crucial to the establishment of the local 
inflammatory environment and the systemic acute phase response during intramammary 
infection of E. coli in mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypotheses and objectives 
 73 
OBJECTIVES 
 
The general objective of this doctoral thesis was to investigate the activation of the 
transcription factor NF-κB in relation to intramammary E. coli infections in cows and mice. A 
first part covers the in vitro experimental studies performed on bovine blood neutrophils. The 
possible role of NF-κB in bovine neutrophil survival and in the regulation of the inflammatory 
response mediated by activated neutrophils through cytokine production was revealed. The 
second part deals with the involvement of NF-κB in the pathogenesis of E. coli intramammary 
infections in mice. The contribution of NF-κB to the establishment of the inflammatory 
response in the mammary gland and the systemic acute phase response was examined. 
Throughout this thesis, a number of specific objectives can be distinguished (Figure 1): 
 
 To demonstrate the presence of the important NF-κB subunits p65 and p50 in bovine 
neutrophils (1). 
 
 To study active NF-κB complexes in bovine neutrophils under normal (2) and 
inflammatory conditions following incubation with E. coli bacteria (3). 
 
 To gain insight in the mechanisms by which NF-κB mediates the host immune 
response in mice following intramammary infection with E. coli bacteria (). 
 
 To determine the cellular localization of the induced NF-κB activity in mouse 
mammary glands upon infection with E. coli bacteria (). 
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Figure 1: Diagram representing the hypotheses of the thesis. Black numbers on white background are the 
objectives within the bovine species, while white numbers on black background represent the objectives for the 
mouse as a host. 
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Abstract 
 
Apoptosis is one of the major events that contribute to the regulation of the immune system. 
For human neutrophils, evidence has been produced that the nuclear transcription factor (NF)-
κB is critical in influencing the ultimate outcome of a cell’s fate. However, such research has 
not yet been performed on bovine neutrophils. This urged us to examine the possible 
involvement of NF-κB in apoptosis of these cells. At first, we investigated whether p65 and 
p50, the most important members of the NF-κB family, are expressed in isolated blood 
neutrophils. The presence of both members was demonstrated on the mRNA and protein 
level. Then the effect on bovine neutrophil apoptosis of gliotoxin, a potent and specific 
inhibitor of NF-κB, was examined. The rate of constitutive apoptosis was found to be greatly 
accelerated by inhibition of NF-κB. Furthermore, gliotoxin dramatically augmented the 
limited pro-apoptotic effect of tumor necrosis factor (TNF)-α, an important inflammatory 
mediator. Results were obtained in 6 cows by annexin-V-FITC staining of externalized 
phosphatidylserine (PS) and subsequent flow cytometric analysis. Additional measurement of 
caspase-3/7 activity and evaluation of morphological criteria confirmed the outcome of this 
experiment. Finally, NF-κB activity was assessed under these conditions. The activity of p50 
was found to be minimally affected by gliotoxin, while significantly lower active p65 values 
were observed. Still, the highest percentage of apoptosis, which was caused by incubation 
with both gliotoxin and TNF-α, did not correspond to the lowest activity of p65. We conclude 
that NF-κB p65 promotes survival of bovine neutrophils by delaying initiation of apoptosis. 
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1. Introduction 
 
Neutrophils play a critical role in the first line of defense against invading micro-organisms. 
These cells circulate in the blood vessels until they are attracted to inflamed tissue, where the 
neutrophil life span is extended by inflammatory mediators in order to destroy the pathogen. 
Once the infection is cleared, residual neutrophils die by apoptosis ensuring their removal by 
phagocytes and the rapid resolution of inflammation. Neutrophil apoptosis minimizes the risk 
of loss of toxic cell contents to the surrounding tissues and thus clearly controls the duration 
and intensity of an inflammatory response (Kobayashi et al., 2003). 
 
Apoptotic cell death represents a complex sequential process involving different cellular 
events to which many factors contribute. If apoptosis is defined by morphological features, 
nuclear condensation (Rogalinska, 2002) and cell shrinking (Bortner and Cidlowski, 2002) 
are mentioned in particular. However, characterisation of the molecular events makes a more 
valuable contribution to the understanding of this kind of programmed cell death. Many 
studies have reported caspases as being central regulators of apoptosis (Denault and Salvesen, 
2002). Following proteolysis of pro-caspases, specific substrates are cleaved and thereby 
activated or inactivated, resulting in a proper execution of the apoptotic program. 
 
Several cellular proteins are capable of inhibiting apoptosis. Since NF-κB controls the 
expression of many survival genes (Barkett and Gilmore, 1999; Karin and Lin, 2002), this 
transcription factor is known to prevent the induction of programmed cell death. In resting 
cells, NF-κB family members are sequestered in the cytoplasm, bound to their inhibitors 
which belong to the IκB family. Following cell activation, IκB proteins become 
phosphorylated, ubiquitinated and degraded by the proteasome. Subsequently, NF-κB can 
enter the nucleus and bind to the DNA in order to promote transcription (Rothwarf and Karin, 
1999). 
 
In vitro studies with human neutrophils have shown that a range of inflammatory mediators 
known to be present at inflamed sites inhibit the apoptosis process in these cells (Brach et al. 
1992; Colotta et al., 1992; Lee et al., 1993; Pericle et al., 1994). It has also been reported that 
incubation with some of these agents leads to the activation of NF-κB (McDonald et al., 
1997). Furthermore, a major induction of human neutrophil apoptosis was seen after 
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inhibiting NF-κB (Ward et al., 1999; Niwa et al., 2000; Nolan et al., 2000; Liu et al., 2003). 
These data strongly suggest that NF-κB is a major regulator of the human neutrophil life span. 
 
There is accumulating evidence that, also in neutrophils, the anti-apoptotic activity of NF-κB 
would depend on gene induction. More specifically, the expression of A1 (Bfl-1) and Mcl-1, 
two anti-apoptotic members of the Bcl-2 family of proteins (Borner, 2003; Burlacu, 2003), 
seems to be up-regulated by anti-apoptotic stimuli and down-regulated when apoptosis is 
induced (Chuang et al., 1998; Leuenroth et al., 2000; Moulding et al., 1998 and 2001). At 
least the expression of A1 has been shown to be dependent upon activation of NF-κB 
(Grumont et al., 1999; Zong et al., 1999). In addition, the use of gliotoxin as a specific 
inhibitor of NF-κB (Pahl et al., 1996) leads to depletion of A1 and Mcl-1 (Moulding et al., 
2001), even though the expression of the latter protein is not NF-κB regulated (Akgul et al., 
2000). Furthermore, the loss of the expression of inhibitor of apoptosis (IAP) may facilitate 
the induction of neutrophil apoptosis (O’Neill et al., 2004). The transcription of IAP is also 
under control of NF-κB (You et al., 1997; Stehlik et al., 1998). 
 
A key role for bovine neutrophil apoptosis in the resolution of an inflammatory response has 
been documented in a growing number of reports (Paape et al., 2003). Still, in contrast to 
human, research into the role of NF-κB in regulating the life span of bovine neutrophils has 
not yet been carried out. Therefore, we first investigated whether bovine blood neutrophils 
express p65 and p50, the most important members of the NF-κB family. Still, the major 
purpose of the present study was to examine the in vitro effect of gliotoxin, a potent and 
specific inhibitor of NF-κB (Pahl et al., 1996), on bovine neutrophil apoptosis and on the NF-
κB activity of p65 and p50. 
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2. Experimental procedures 
 
2.1. Isolation and culture of bovine blood neutrophils 
 
In this study, 6 healthy heifers of the Holstein-Friesian breed were selected from the Ghent 
University dairy farm (Biocentrum Agri-Vet, Melle, Belgium). Bovine peripheral blood was 
collected using sterile polypropylene tubes (IMI, Montegrotto Terme, Italy) pre-filled with an 
equal volume of Alsever’s as an anticoagulans solution (3 mM citric acid monohydrate, 27 
mM trisodium citrate dehydrate, 72 mM sodium chloride and 125 mM D-glucose, pH 6.1). 
After centrifugation (300 g, 15 min) plasma and the buffy coat were removed. Red blood cells 
were lysed during incubation with an ice-cold isotonic ammonium chloride solution (138 mM 
ammonium chloride and 21 mM Tris, pH 7.4) for 10 min. The remaining cell suspension was 
washed twice with phosphate buffered saline (PBS) (200 g, 10 min). Contaminating 
mononuclear cells were then removed by density gradient centrifugation (1,000 g; 20 min) 
over Percoll with a specific gravity of 1.094 g/ml, prepared according to the manufacturer’s 
protocol (Sigma-Aldrich, Bornem, Belgium). The remaining cell pellet was again washed 
twice with PBS and used for further applications. Over 98 % of the isolated cells were 
granulocytes, of which less than 5 % were eosinophils. 
 
Isolated neutrophils were resuspended at a final concentration of 3 x 106 cells/ml in RPMI 
1640 with 10 % fetal calf serum (both from Invitrogen, Merelbeke, Belgium). Cultures were 
supplemented with 0.1 µg/ml gliotoxin (Sigma-Aldrich), 10 ng/ml rhTNF-α (Alexis, 
Zandhoven, Belgium) or with both effectors. Incubation was performed at 37 °C in a 5 % CO2 
incubator (Binder, Tuttlingen, Germany) for 6 h. 
 
2.2. NF-κB p65 and p50 mRNA detection following polymerase chain reaction (PCR) 
 
Total cellular RNA was extracted from 1 x 106 neutrophils after cell lysis with Trizol® 
reagent (Invitrogen). First, mRNA was converted into cDNA by reverse transcriptase (60 min, 
42 °C) and then the cDNA was screened with specific primer pairs (Eurogentec, Seraing, 
Belgium). The primer sequences used were: for p65: GGACTTCTCAGCCCTTCT and 
CCATCAGTGTGTGCTTTG; for p50: CTTGCTGCTAAATGCTGCTC and 
CCAGGTTCTGTAGGACTGTATCTTC. For amplification, 40 cycles were applied (30 s at 
94 °C, 45 s at 59 °C for p50 or 60 °C for p65 and 45 s at 72 °C) on a Mastercycler 
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(Eppendorf, Hamburg, Germany). Finally, amplification products were loaded on a 2.5 % 
agarose gel (Helena Biosciences, Sunderland, UK) and visualised after electrophoresis under 
UV-light using ethidium bromide (Sigma-Aldrich). A 100 base pairs (bp) marker (Genecraft, 
Münster, Germany) was used for sizing the fragments. 
 
2.3. NF-κB p65 and p50 protein detection following western blotting 
 
Total cell extracts were prepared by resuspending 5 x 106 neutrophils in 500 µl Laemmli 
buffer (62.5 mM Tris HCl, pH 6.8; 50 mM dithiotreitol, 10 % glycerol, 2 % sodium dodecyl 
sulphate and 0.1 % bromophenol blue) supplemented with a cocktail of protease inhibitors 
(Calbiochem, La Jolla, USA). Samples were sonicated and boiled for 5 min at 95 °C and 20 µl 
was loaded on a 10 % denaturing polyacrylamide gel followed by blotting on a nitrocellulose 
membrane (both from Bio-Rad Life Science, Nazareth, Belgium). After blocking in Tris 
buffered saline with 1 % Tween 20 (TBS-T) and 5 % milk powder for 1 h, overnight 
incubation with primary anti-p65 (sc-372) or anti-p50 (sc-8414) antibodies (Santa Cruz 
Biotechnology, Heidelberg, Germany) was carried out. Membranes were then washed and a 
secondary antibody conjugated to horseradish peroxidase (HRP) was applied for 1 h. Finally, 
proteins were detected with a ChemiDocTM System (Bio-Rad Life Science) using 
Supersignal® West Dura (Perbio Science, Erembodegem, Belgium). A molecular weight 
ladder with bands from 10 to 200 kDa (Westburg, Leusden, The Netherlands) was used for 
sizing the proteins. 
 
2.4. Phosphatidylserine translocation assay 
 
Flow cytometric detection of exposed PS was used to quantify the percentage of apoptotic 
neutrophils. After centrifugation (200 g, 10 min) of 1 x 106 neutrophils, the cell pellet was 
resuspended in 100 µl incubation buffer (10 mM Hepes, 140 mM sodium chloride and 5 mM 
calcium chloride, pH 7.4) containing 2 µl annexin-V-Fluos labeling reagent (Roche 
Diagnostics, Vilvoorde, Belgium) and 2 µl propidium iodide (PI) (50 µg/ml; Sigma-Aldrich). 
Following 10 min incubation in the dark, 400 µl PBS was added and samples were 
immediately analysed using a FACScan flow cytometer (Becton Dickinson Biosciences, 
Erembodegem, Belgium). Cells positive for annexin-V-FITC and negative for PI were 
defined as apoptotic. 
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2.5. Morphological cell death assessment 
 
After cytocentrifugation (55 g, 5 min) of 2 x 105 neutrophils, slides were air dried, fixed with 
pure methanol and stained with Hemacolor® (Merck, Darmstadt, Germany) according to 
Pappenheim. Evaluation of apoptotic morphology was based on cell shrinking and chromatin 
condensation characteristics. 
  
2.6. Caspase-3/7 activation assay 
 
For the assessment of the caspases-3 and -7 activity, the Caspase-GloTM Assay (Promega, 
Leiden, The Netherlands) was used according to the manufacturer’s protocol. Briefly, 2 x 106 
neutrophils were lysed on ice during an incubation of 30 min with 100 µl PBS supplemented 
with 1 % saponin (Sigma-Aldrich) and a cocktail of protease inhibitors (Calbiochem). After 
centrifugation (8,000 g; 10 min), the supernatant was frozen at -80 °C until further analysis. In 
a 96-well plate, 5 µl of freshly thawn protein lysate was diluted with lysis buffer to a final 
volume of 100 µl. Subsequently, the same volume of Caspase-GloTM 3/7 reagent was added. 
After an incubation of 1 h at room temperature, chemiluminescence was measured with a 
Microlumat LB96P luminometer (Berthold Technologies, Vilvoorde, Belgium) and expressed 
in relative light units per second (RLU/s). 
 
2.7. NF-κB activation assay 
 
For the detection and quantification of the activity of NF-κB p65 and p50, the TransAMTM 
Transcription Factor Assay Kits (Active Motif, Rixensart, Belgium) were used according to 
the manufacturer’s protocol. In brief, 2 x 106 neutrophils were lysed on ice during an 
incubation of 30 min with 100 µl PBS supplemented with 1 % saponin (Sigma-Aldrich) and a 
cocktail of protease inhibitors (Calbiochem). After centrifugation (8,000 g; 10 min), the 
supernatant was frozen at -80 °C until further analysis. For each sample, 5 µl of freshly thawn 
protein lysate was incubated for 1 h in wells of a 96-well plate containing immobilized NF-κB 
consensus oligonucleotide. After extensive washing, the NF-κB complex bound to the 
oligonucleotide was identified using the supplied anti-p65 or anti-p50 antibody. Addition of a 
secondary antibody conjugated to HRP allowed a chemiluminescent readout on a Microlumat 
LB96P luminometer (Berthold Technologies) and an expression in RLU/s. 
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2.8. Statistical analysis 
 
Data are expressed as the mean ± standard error of the mean (SEM). For the percentage of 
apoptosis, the caspase activity and the NF-κB activity, pairwise comparisons between the 
control group and the three other treatment groups were made after 6 h of incubation using a 
mixed model with cow as random effect and treatment as fixed effect. The Bonferroni’s 
multiple comparisons adjustment technique was used with a global confidence level of 95 %. 
The correlation study was conducted according to Pearson. The SAS System software (SAS 
Institute GmbH, Heidelberg, Germany) was used for all analyses. 
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3. Results 
 
3.1. Constitutive expression of NF-κB p65 and p50 in bovine neutrophils 
 
In freshly isolated bovine neutrophils of 3 cows, the presence of p65 and p50 as important 
members of the NF-κB family was investigated on the mRNA as well as on the protein level. 
Using specific primer pairs in PCR, bands of 111 bp and 104 bp were detected, corresponding 
to mRNA from p65 and p50 respectively (Figure 1). After western blotting analysis, both p65 
and p50 could also be detected as protein bands at their corresponding molecular weight 
(Figure 2). When using the anti-p50 antibody, an additional protein band was visualised as 
this antibody also recognizes the p50 precursor p105. Taken together, these experiments 
demonstrate the presence of p65 and p50 mRNA and protein in bovine neutrophils. 
 
 
 
 
 
 
 
 
 
 
Figure 1: PCR analysis of neutrophils of 3 cows. mRNA of p65 and p50 are seen as bands of 111 and 104 bp, 
respectively. M represents the 100 bp DNA marker. 
 
 
 
 
 
 
 
 
Figure 2: Western blotting analysis of neutrophils of 3 cows for A: the p65 protein and B: the p50 and p105 
protein. M represents the molecular weight marker with bands from 10 to 200 kDa. 
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3.2. Effect of gliotoxin on phosphatidylserine exposure in bovine neutrophils 
 
PS exposure in bovine neutrophils was measured directly after isolation and at different time 
points (2, 4 and 6 h) following incubation with 0.1 µg/ml gliotoxin and/or 10 ng/ml TNF-α 
(Figure 3). A time-dependent increase of the percentage of annexin-V-FITC-positive/PI-
negative neutrophils was observed in all samples. The constitutive rate of apoptosis was 
greatly increased when gliotoxin was added. After 6 h of incubation, a significant difference 
in the percentage of apoptotic cells between control (on average 6.34 %, n = 6) and gliotoxin 
(41.05 %) was seen (P < 0.01). A remarkably higher percentage of apoptosis was observed in 
neutrophils incubated with a combination of gliotoxin and TNF-α (83.73 %; P < 0.01). TNF-α 
alone did not cause a significant increase in neutrophil apoptosis as compared to control (9.25 
%). Annexin-V-FITC-positive/PI-positive values were less than 2 % in all samples. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Effect of gliotoxin and/or TNF-α on cell surface exposure of PS in bovine neutrophils after isolation 
and after 2, 4 and 6 h of culture. Data are means ± SEM of 6 cows. Statistically significant differences compared 
to the control at 6 h are indicated with an asterisk. 
 
 
3.3. Effect of gliotoxin on bovine neutrophil morphology 
 
Cytospin slides of neutrophils incubated for 6 h in control medium were compared to slides of 
cells cultured in medium supplemented with gliotoxin in combination with TNF-α for the 
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clearly seen (Figure 4). Whereas non-apoptotic neutrophils were characterised by a 
polysegmented nucleus, apoptotic cells had a shrunken appearance with condensed nuclei. 
These qualitative results were in accordance with the flow cytometric data of PS exposure. 
 
 
 
 
 
 
 
 
 
Figure 4: Cytocentrifuge preparations of neutrophils from one representative cow after 6 h of culture 
(magnification: 1,000 x). A: neutrophils incubated in control medium, B: neutrophils incubated in medium 
supplemented with gliotoxin and TNF-α. 
 
 
3.4. Effect of gliotoxin on caspase-3/7 activity in bovine neutrophils 
 
In all samples of freshly isolated neutrophils, caspase activity was minimal (Figure 5). This 
result was in accordance with the flow cytometric data of PS exposure which showed that an 
average of more than 98 % of the cells were viable at that time point. After 6 h of incubation, 
caspase activity increased and cells incubated in control medium showed a 10-fold higher 
activity as compared to freshly isolated neutrophils. The highest values of caspase activity 
were obtained when cells were incubated with gliotoxin in combination with TNF-α (n = 6, P 
< 0.01). Treatment with gliotoxin alone also significantly induced caspase activity (P < 0.01). 
Treatment with TNF-α resulted in minimal caspase activity with values being comparable to 
the control at the same time point. In general, these data again fit well with the PS 
observations. Indeed, a striking correlation (r = 0.9326) was obtained between both apoptosis 
parameters. 
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Figure 5: Caspase-3/7 activity of bovine neutrophils after isolation and after 6 h of culture with gliotoxin and/or 
TNF-α. Data are means ± SEM of 6 cows. Statistically significant differences compared to the control at 6 h are 
indicated with an asterisk. 
 
 
3.5. Effect of gliotoxin on NF-κB p65 and p50 activity 
 
In all cell extracts of freshly isolated neutrophils and of neutrophils incubated for 6 h, NF-κB 
p65 and p50 activities were measured. The highest p65 activity was seen in freshly isolated 
neutrophils (Figure 6). This activity decreased after 6 h of incubation, with the lowest values 
obtained in extracts of cells incubated in the presence of gliotoxin (n = 6, P < 0.01). Treatment 
with TNF-α alone did not result in a significantly lower p65 activity in comparison with the 
control at 6 h. Addition of TNF-α to gliotoxin abrogated the inhibition of the p65 activity by 
gliotoxin alone. This latter effect is not in accordance with the results obtained for the 
apoptosis parameters. No significant changes in p50 activity were found after 6 h of 
incubation in the different culture conditions. Values were even systematically comparable to 
those of the blank (data not shown). 
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Figure 6: NF-κB activity of p65 in bovine neutrophils after isolation and after 6 h of culture with gliotoxin 
and/or TNF-α. Data are means ± SEM of 6 cows. Statistically significant differences compared to the control at 
6 h are indicated with an asterisk. 
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4. Discussion 
 
In neutrophils the major inducible NF-κB protein complex has been shown to consist of p65 
and p50 (McDonald et al., 1997). At least one transactivation domain is present in p65 which 
makes this heterodimer responsible for gene induction (Moore et al., 1993). As these 
observations were obtained in the human species, the need exists to demonstrate the presence 
of both proteins in their bovine counterpart. In this study, we report that p65 and p50 are 
constitutively present in bovine blood neutrophils on mRNA level as well as on protein level. 
Subsequently, we set out to examine their function in these cells. 
 
Since gliotoxin is a potent and specific inhibitor of NF-κB (Pahl et al., 1996), it was used as a 
pharmacological tool to investigate the involvement of the transcription factor in the 
regulation of bovine neutrophil apoptosis. PS exposure on the outer leaflet of the plasma 
membrane is a feature characteristic of apoptotic cells that can be flow cytometrically 
detected with annexin-V-FITC which binds the phospholipid in a calcium-dependent way 
(van Engeland et al., 1998). Our data obtained with this assay show that at least 98 % of 
freshly isolated neutrophils were viable and that incubation gave rise to spontaneous 
apoptosis. Gliotoxin significantly increased this constitutive rate of apoptosis over a time 
course of 6 h. Moreover, gliotoxin greatly enhanced the limited pro-apoptotic effect of TNF-
α. These observations are consistent with results of similar experiments in human neutrophils 
(Ward et al., 1999; Liu et al., 2003; Renshaw et al., 2003). In addition to annexin-V-FITC, PI 
was used as a measure of necrosis in our flow cytometric analysis. Less than 2 % of 
neutrophils were PI-positive. Therefore we can conclude that treatment induced a purely 
apoptotic form of cell death. 
 
As an additional apoptosis parameter, caspase activity was measured in all samples made after 
6 h of incubation. Because inhibition of caspases-3 and -7 blocks human neutrophil apoptosis 
(Lee et al., 2000 and 2001; Daigle and Simon, 2001), the combined activity of both these 
effector caspases was assessed. The obtained results were in agreement with our flow 
cytometric PS exposure data: gliotoxin increased caspase activity compared to control at 6 h 
and together with TNF-α maximal activity was achieved. This demonstrates that apoptosis 
induced in the different culture conditions is dependent on caspase activation. The 
morphological study also confirmed that gliotoxin acts synergistically with TNF-α to 
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stimulate bovine neutrophil apoptosis. Taken together, our investigation of multiple 
complementary apoptosis parameters yielded indisputable results. 
 
Various studies with human neutrophils have shown that NF-κB plays a crucial protective 
role against apoptosis (Ward et al., 1999; Niwa et al., 2000; Nolan et al., 2000; Liu et al., 
2003). In the next part of the current study, p65 and p50 activities were therefore examined to 
evaluate whether this also applies to bovine neutrophils. We used a novel ELISA-based assay 
(TransAMTM Transcription Factor Assay Kit), which is known to correlate well with the 
traditional electrophoretic mobility shift assay (EMSA) (Renard et al., 2001). Based on this 
assay, it was demonstrated that the activity of p65 was highest in freshly isolated bovine 
neutrophils and decreased after 6 h of incubation. Values of p65 activity were lowest in 
neutrophils cultured with gliotoxin. Treatment with TNF-α did not result in a significanlty 
lower p65 activity. These results are in agreement with our apoptosis data and support the 
working hypothesis that NF-κB promotes survival in bovine neutrophils. In contrast, 
following incubation with gliotoxin and TNF-α the p65 activity increased, an observation 
which is not in accordance with our apoptosis data. As for the p50 activity, no changes were 
found between the different culture conditions after 6 h of incubation. It was pointed out that 
p50 values were comparable to those of the blank. Interpretation of these data must be 
performed with care as the anti-human p50 antibody might not have recognized the active p50 
protein of bovine origin in our samples. Indeed, this option can not be excluded as no cross-
reactivity has been reported so far for the bovine species. 
 
Gliotoxin belongs to the continuously growing group of selective NF-κB inhibitors. Although 
widely used, the precise mechanism by which this fungal metabolite inhibits NF-κB is still 
largely unknown. Some reports suggest the inhibition of the proteasome-mediated IκB 
degradation and the blockage of NF-κB DNA binding activity (Pahl et al., 1996; Kroll et al., 
1999). In our study, administration of gliotoxin induced apoptosis in bovine neutrophils and 
decreased their basal p65 activity. In human neutrophils, inhibition of the basal NF-κB 
activity by gliotoxin also seems to be responsible for the induction of apoptosis (Ward et al., 
1999). Because of the agreement between our observations and those in human neutrophils, 
the same conclusion can be drawn, namely that NF-κB promotes neutrophil survival. To the 
best of our knowledge, the identification of the family members composing the basal NF-κB 
complex in human neutrophils based on supershift experiments has remained unsuccessful 
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(McDonald et al., 1997; McDonald and Cassatella, 1997). According to our results obtained 
with the ELISA-based assay, at least p65 is part of the bovine basal NF-κB complex. 
 
TNF-α is one of the most important orchestrators of inflammation and therefore a logical 
choice for the study of mediators in the context of neutrophil apoptosis. When evaluating the 
role of this cytokine on the neutrophil life span one should be aware that this cytokine can 
exert either an anti- or a pro-apoptotic effect, depending upon the concentration used and the 
time of exposure (Murray et al., 1997; van den Berg et al., 2001). Interestingly, the anti-
apoptotic effect of TNF-α is partly ascribed to the stimulation of a survival pathway involving 
activation of NF-κB (Liu et al., 1996). In the current study, TNF-α was not found to promote 
bovine neutrophil apoptosis. Nevertheless, the dose and incubation time chosen have been 
previously reported to be pro-apoptotic. Furthermore, TNF-α did not seem to decrease p65 
activity in our study. However, in comparison with gliotoxin alone, the increase in p65 
activity following incubation with gliotoxin and TNF-α seems contradictory to the maximal 
percentage of apoptosis observed under these conditions. Indeed, in human neutrophils, the 
synergistic effect of gliotoxin and TNF-α on apoptosis was correlated with a major reduction 
of NF-κB activity (Ward et al., 1999). The authors even suggest that gliotoxin enhances TNF-
α-induced apoptosis by inhibiting the production of a survival factor possibly mediated by 
NF-κB. Remarkably, in this report only the expression of an inducible form of NF-κB was 
down-regulated. This inducible NF-κB complex arose following TNF-α administration, but as 
in our study TNF-α alone did not induce p65 activity, it would appear that the combined 
effect of gliotoxin and TNF-α can not be visible on the level of NF-κB activity. 
 
In conclusion, our data suggest that NF-κB p65 is active and promotes survival in bovine 
neutrophils. Still, is should be kept in mind that neutrophils in circulation will only survive for 
a few hours. Indeed, blood neutrophils are programmed to die spontaneously. We believe that 
a decrease in p65 activity probably represents an essential trigger for the onset of constitutive 
apoptosis. In contrast, tissue neutrophils can temporarily loose their susceptibility to apoptosis 
under inflammatory conditions. In human neutrophils, this loss seems to be associated with 
the appearance of an inducible NF-κB complex (Hotta et al., 2001). Importantly, NF-κB 
activity was shown to be increased in environments of inflammation (Sandersen et al., 2001; 
Boulanger et al., 2003). As we have now observed and partly characterised the basal activity 
of NF-κB in bovine neutrophils, our future prospect is to investigate the existence of inducible 
NF-κB complexes in these innate defense cells. 
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Abstract 
 
Neutrophils are imperative to the innate immune response against bacterial pathogens. Upon 
activation they are stimulated to initiate and execute the acute inflammatory reaction. In this 
process, the nuclear transcription factor (NF)-κB plays a central role through the induction of 
the expression of numerous pro-inflammatory mediators. Nevertheless, an apoptosis 
differentiating program is additionally initiated to facilitate the resolution of inflammation. 
For bovine neutrophils, research in relation to these two opposing stages within the cell’s life 
remains to be performed. We therefore investigated both pro- and anti-inflammatory events 
following incubation of bovine neutrophils with Escherichia coli (E. coli) bacteria within the 
same in vitro study. The activity of the NF-κB p65 subunit increased within the first half hour 
of culture with E. coli, while no changes in activity were seen for control cells. High 
concentrations of interleukin (IL)-1 and IL-6 were secreted by phagocytic neutrophils from 
early time points on. These important pro-inflammatory cytokines were not detected in 
cultures of resting cells. At later time points, phagocytosis induced cell death since 
neutrophils incubated with E. coli displayed significantly more phosphatidylserine (PS) than 
control cells. Remarkably, caspase-3/7 activity was only observed in resting neutrophils and 
not in cells incubated with bacteria. Interestingly, phagocytosis was also associated with 
major morphological changes that were clearly different from the characteristic features 
observed in neutrophils undergoing spontaneous apoptosis. In conclusion, this kinetic study 
on the early pro-inflammatory capacity and the subsequent apoptosis induction program of 
bovine neutrophils following phagocytosis of E. coli, contributes to the general understanding 
of the establishment and resolution of acute inflammatory reactions to coliform infections. 
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1. Introduction 
 
Neutrophils play an essential role in the first line of defense against invading bacterial 
pathogens. These innate immune cells survive only a few days since they are destined to 
rapidly undergo spontaneous apoptosis. Still, their limited life span is highly susceptible to 
modulation. During an inflammatory response, the apoptotic process is delayed, thereby 
promoting neutrophil combat towards pathogens. On the other hand, neutrophil apoptosis 
needs to be accelerated in order to resolve the inflammatory process properly. Activation-
induced cell death prohibits leakage of high amounts of toxic compounds thereby reducing 
damage to the surrounding tissues (Marshall et al., 2007). 
 
Upon bacterial challenge, neutrophils are recruited to the site of infection and become 
activated. Several host- and pathogen-derived stimuli including pro-inflammatory cytokines 
and chemokines, growth factors and bacterial molecules like lipopolysaccharide (LPS) are 
known to trigger neutrophil recruitment and activation (Sabroe et al., 2005; Kato and 
Kitagawa, 2006). As a result, neutrophil functions such as chemotaxis, phagocytosis and 
bacterial killing via oxygen-dependent and -independent mechanisms are increased and a 
remarkably high number of genes are expressed (Subrahmanyam et al., 2001; Fessler et al., 
2002; Tsukahara et al., 2003; Zhang et al., 2004; Kobayashi et al., 2002 and 2003b; 
Kobayashi and Deleo, 2004). Incubation of these phagocytes with some of the 
abovementioned stimuli or with whole bacteria results in the synthesis of numerous 
inflammatory cell-surface receptors and mediators, as well as stress and signaling molecules 
and proteins promoting neutrophil survival. 
 
The alteration in gene expression profiles in response to inflammation is mediated in part by 
the transcription factor NF-κB (Li and Verma, 2002; Cloutier and McDonald, 2003). In 
resting cells, NF-κB family members are retained in the cytoplasm through binding with their 
inhibitors, which belong to the IκB family. Upon cell activation, IκB proteins become 
phosphorylated, ubiquitinated and degraded by the proteasome. Subsequently, NF-κB can 
enter the nucleus and bind to the DNA in order to promote transcription (Hayden and Ghosh, 
2004). The most intensively studied NF-κB complex is the p65/p50 heterodimer. In 
neutrophils, NF-κB activation has been reported upon exposure to pro-inflammatory 
cytokines and chemokines as well as to LPS and whole bacteria (McDonald and Cassatella, 
1997; McDonald et al., 1997; Vollebregt et al., 1998; Kettritz et al., 2004). In addition, the 
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expression of pro-inflammatory and anti-apoptotic proteins is increased in response to these 
stimuli, and transcription of most of these factors is NF-κB dependent (Pahl, 1999). 
 
Following the establishment of neutrophil-mediated inflammation as an early response to 
bacterial infection, the resolution of the inflammatory process is initiated. Due to 
phagocytosis, mechanisms which induce cell death are turned on. Recent studies show an 
acceleration of neutrophil apoptosis following ingestion of different pathogens (Watson et al., 
1996; Rotstein et al., 2000; Engelich et al., 2001; Perskvist et al., 2002; Sim et al., 2005). The 
onset of neutrophil programmed cell death coincides well with functional impairment (Whyte 
et al., 1993) and with a decrease in the expression of pro-inflammatory and anti-apoptotic 
molecules induced in the early stages of inflammation. Moreover, factors that are able to 
participate in the initiation and execution of apoptosis are up-regulated (Kobayashi et al., 
2002, 2003a/c, 2004). 
 
The molecular mechanisms of neutrophil activation-induced cell death are currently 
intensively investigated. It is well established that reactive oxygen species generated upon 
phagocytosis promote the onset of neutrophil apoptosis by triggering cell surface changes that 
result in macrophage recognition and subsequent engulfment of the phagocytic cells (Watson 
et al., 1996; Fadeel et al., 1998, Wilkie et al., 2007). However, in activation-induced cell 
death, the contribution of caspases, generally accepted as the key executors of the apoptosis 
program, is still a matter of debate (Fadeel et al., 1998; Perskvist et al., 2002; Zhang et al., 
2003; Wilkie et al., 2007). 
 
Pro- and anti-inflammatory events following neutrophil activation and phagocytosis have 
been mainly studied in human neutrophils. Bovine neutrophils are entailed in the host defense 
mechanisms of several important infectious diseases in cattle. Increased bovine neutrophil 
functions were observed following in vitro incubation with pro-inflammatory stimuli (Sample 
and Czuprynski, 1991; Persson, et al., 1993; Swain et al., 1998; Galligan and Coomber, 2000; 
Rainard et al., 2000; Borgquist et al., 2002) and bacterial toxins (Czuprynski et al., 1991; 
Maheswaran et al., 1992; Narayanan et al., 2002). Enhanced expression of the CD18 subunit 
of β2 integrin inflammatory receptors is described as well (Rainard et al., 2000; Leite et al., 
2002). However, NF-κB activation in bovine neutrophils within these inflammatory 
conditions has not yet been reported. In previous work, we showed a basal NF-κB p65 
activity in freshly isolated bovine neutrophils which promotes survival until the initiation of 
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spontaneous apoptosis (Notebaert et al., 2005). In agreement with observations in human 
cells, apoptosis in bovine neutrophils leads to functional impairment (Van Oostveldt et al., 
2002). To the best of our knowledge, reports on induced apoptotic cell death in bovine 
neutrophils following phagocytosis are not available. Clearly, imperative information on the 
molecular effects of bovine neutrophil activation and phagocytosis are still missing. In the 
current study, both the pro-inflammatory response and the subsequently induced cell death of 
activated bovine neutrophils were examined. An important role in the regulation of the bovine 
innate immune response following E. coli phagocytosis is apparent for the transcription factor 
NF-κB but not for the effector caspases-3 and -7. 
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2. Experimental procedures 
 
2.1. Isolation of bovine neutrophils 
 
Healthy heifers of the Holstein-Friesian breed were selected from the Ghent University dairy 
farm (Biocentrum Agri-Vet, Melle, Belgium). Bovine neutrophils were isolated as previously 
described (Notebaert et al., 2005). Peripheral blood was collected from the jugular vein using 
sterile tubes (IMI, Montegrotto Terme, Italy) pre-filled with an equal volume of Alsever as an 
anticoagulant solution (3 mM citric acid monohydrate, 27 mM trisodium citrate dihydrate, 72 
mM sodium chloride and 125 mM D-glucose, pH 6.1). Plasma and the buffy coat were 
removed following centrifugation at 300 g for 15 min. Erythrocytes were lysed during 
incubation with an ice-cold isotonic ammonium chloride solution (138 mM ammonium 
chloride and 21 mM Tris, pH 7.4) for 10 min. The remaining cell suspension was washed 
twice in phosphate buffered saline (PBS) at 200 g for 10 min. Contaminating mononuclear 
cells were then removed by density gradient centrifugation at 1,000 g for 20 min using 1.094 
g/ml Percoll (Sigma-Aldrich, Bornem, Belgium). The remaining cells were again washed 
twice with PBS. Over 98 % of the isolated cells were granulocytes with less than 5 % 
eosinophils. 
 
2.2. Phagocytosis of E. coli by bovine neutrophils 
 
Isolated neutrophils were resuspended in sterile RPMI 1640 with 10 % fetal calf serum (both 
from Invitrogen, Merelbeke, Belgium) at a final concentration of 5 x 106 cells/ml. Living E. 
coli P4:O32 bacteria were supplemented to the neutrophil cultures at a ratio of 5:1 following 
overnight growth in Brain Heart Infusion broth (Oxoid, Drongen, Belgium). Incubation was 
performed at 37 °C with mild rotation. Phagocytosis was stopped by placing the cells on ice. 
Samples were analysed immediately afterwards. 
 
2.3. NF-κB activation in bovine neutrophils 
 
Cultured neutrophils were centrifuged at 200 g for 10 min and lysed on ice in RIPA lysis 
buffer (150 mM sodium chloride, 20 mM Hepes, 2 mM EDTA, 0.5 % sodium deoxycholate 
and 1 % NP-40, pH 7) with a cocktail of protease inhibitors (Calbiochem, La Jolla, USA). 
After centrifugation at 8,000 g for 10 min, the supernatant was collected and the protein 
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concentration was determined using the Bio-Rad Protein Assay (Bio-Rad Life Science, 
Nazareth, Belgium), based on the method of Bradford. To determine NF-κB p65 activity, the 
TransAMTM Transcription Factor Assay Kit (Active Motif, Rixensart, Belgium) was used 
according to the manufacturer’s protocol. Ten µg of each protein lysate was incubated for 1 h 
in a 96-well plate containing an immobilized NF-κB consensus oligonucleotide. After 
washing, the NF-κB complex bound to the oligonucleotide was identified using the supplied 
anti-p65 antibody. Addition of a secondary antibody conjugated to horseradisch peroxidase 
(HRP) allowed a chemiluminescent readout (Fluoroskan Ascent FL; Thermo Fisher 
Scientific, Zellik, Belgium) expressed in relative light units per second (RLU/s). 
 
2.4. Cytokine secretion by bovine neutrophils 
 
2.4.1. IL-6 secretion 
 
Supernatants obtained after pelleting cultured neutrophils were used to determine secreted 
cytokine levels. IL-6 was measured in a bio-assay as a hybridoma growth factor for mouse 
7TD1 cells (Landegren, 1984). Briefly, cells were cultured for 72 h in medium with different 
dilutions of the samples. A colorimetric hexosaminidase reaction reflects the number of cells 
which is related to the amount of IL-6 in the media. As no recombinant bovine IL-6 is 
commercialy available, human reference standards were included in the assay. Analysis was 
based on the half-maximal proliferation of the cells. 
 
2.4.2. IL-1 secretion 
 
To determine IL-1 concentrations in the supernatants, a bio-assay using growth factor-
dependent murine D10(N4)M cells was employed (Helle et al., 1988). In brief, cells were 
cultured for 48 h in medium with different dilutions of the human standard and the samples. 
Addition of [3H]-thymidine allowed incorporation following proliferation. The scintillation 
counts reflect the number of cells which is correlated to the amount of IL-1. Analysis was 
based on the half-maximal proliferation of the cells. 
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2.4.3. TNF-α secretion 
 
TNF-α levels were determined in the supernatants by using a bio-assay with TNF-α-sensitive 
mouse L929 cells (Mosmann, 1983). Briefly, cells were cultured for 24 h in medium with 
different dilutions of the standard and the samples together with actinomycin D. A 
colorimetric reaction with MTT reflects the number of cells which is inversily correlated to 
the amount of TNF-α in the media. Analysis was based on the half-maximal cell death. 
 
2.5. Apoptosis of bovine neutrophils 
 
2.5.1. PS exposure 
 
Following culture, 1 x 106 neutrophils were centrifuged at 200 g for 10 min and resuspended 
in incubation buffer (10 mM Hepes, 140 mM sodium chloride and 5 mM calcium chloride, 
pH 7.4) with annexin-V-fluos labeling reagent (Roche Diagnostics, Vilvoorde, Belgium) and 
propidium iodide (PI, 50 µg/ml; Sigma-Aldrich). After a 10 min incubation in the dark, PBS 
was added and samples were analysed using a FACSCantoTM flow cytometer (Becton 
Dickinson Biosciences, Erembodegem, Belgium). Ten thousand events were collected and 
analysed using the FACSDiva software (Becton Dickinson Biosciences). Debris was gated 
out before analysis. Cells positive for annexin-V were defined as apoptotic. Early apoptosis 
was seen in annexin-V-positive but PI-negative cells, while late apoptotic cells were 
characterized by combined annexin-V- and PI-positivity. 
 
2.5.2. Caspase-3/7 activation 
 
Neutrophils were centrifuged at 200 g for 10 min and lysed on ice in a caspase lysis buffer 
(200 mM sodium chloride, 10 mM Tris, 5 mM EDTA, 10 % glycerol and 1 % NP-40, pH 7.5) 
supplemented with protease inhibitors (0.15 µM aprotinin, 2.1 µM leupeptin and 100 nM 
phenylmethylsulfonyl fluoride; all from Sigma-Aldrich) and glutathione (1 mM, Sigma-
Aldrich). After centrifugation at 8,000 g for 10 min, the supernatant was collected and the 
protein concentration was determined using the Bio-Rad Protein Assay (Bio-Rad Life 
Science). To determine caspase-3/7 activity, the Caspase-Glo® Assay (Promega, Leiden, The 
Netherlands) was used according to the manufacturer’s protocol. In a 96-well plate, 10 µg of 
the protein lysate was diluted with lysis buffer to a final volume of 100 µl and an equal 
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amount of Caspase-Glo reagent containing DEVD-aminoluciferin as a substrate for caspases-
3 and -7 was added. After 1 h incubation at room temperature, chemiluminescence was 
measured with a luminometer (Fluoroskan Ascent FL, Thermo Fisher Scientific) and 
expressed in RLU/s. 
 
2.6. Morphological analysis of bovine neutrophils 
 
At different time points during incubation, 2 x 105 neutrophils were harvested and cytospins 
were prepared by centrifugation at 55 g for 5 min. Slides were air dried, fixed in methanol and 
stained with Hemacolor (Merck, Darmstadt, Germany). 
 
2.7. Statistical analysis 
 
Data are expressed as the mean ± standard error of the mean (SEM). The SPSS Software 
(SPSS Belux, Brussels, Belgium) was used to perform the non-parametric Friedman’s test for 
repeated measures. The Dunett’s test for multiple comparisons with the control group was  
also employed (Zar, 1984). 
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3. Results 
 
3.1. NF-κB activation following E. coli phagocytosis 
 
The activity of the transcription factor NF-κB p65 was analysed in bovine neutrophils at 
different time points (0, 10, 20, 30, 60 and 180 min) following culture with or without E. coli 
bacteria (Figure 1). No changes in activity were seen for neutrophils cultured without 
bacteria, while for cells incubated with E. coli bacteria a time-dependent activation was 
observed. At 20 min of culture, the p65 activity was significantly increased for phagocytic 
neutrophils as compared to resting cells. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: NF-κB activity of p65 in bovine neutrophils after isolation and following 10, 20, 30, 60 and 180 min of 
incubation with or without E. coli bacteria. Data are means ± SEM of 10 cows. Statistically significant 
differences are indicated with an asterisk. 
 
 
3.2. Cytokine secretion following E. coli phagocytosis 
 
3.2.1. IL-6 secretion 
 
At different early and later time points (0, 20, 60 and 180 min; 0, 6 and 24 h) IL-6 
concentrations were measured in the supernatants of bovine neutrophil cultures supplemented 
with or without E. coli bacteria (Figure 2A). For control cells, values remained undetectable, 
* 
Chapter 2 
 111 
0
500
1000
1500
IL
-
1 
co
n
ce
n
tr
at
io
n
 
(pg
/m
l)
0 20 60 180 0 6 24
(min) (h)
Incubation time
- E. coli
+ E. coli
0
500
1000
1500
IL
-
6 
co
n
ce
n
tr
at
io
n
 
(pg
/m
l)
0 20 60 180 0 6 24
(min) (h)
Incubation time
- E. coli
+ E. coli
while for neutrophils incubated with bacteria, IL-6 concentrations in the medium gradually 
increased from the start up to 24 h of incubation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Cytokine concentrations of IL-6 (panel A) and IL-1 (panel B) in supernatants of bovine neutrophil 
cultures with or without E. coli bacteria. Data are means of 10 (after isolation and following 20, 60 and 180 min 
of incubation) and 6 cows (after isolation and following 6 and 24 h of incubation). Statistically significant 
differences are indicated with an asterisk. 
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3.2.2. IL-1 secretion 
 
At the same time points, supernatants were also analysed for the presence of IL-1 (Figure 2B). 
Again, this cytokine was not detected in the medium of control cells. For neutrophils 
incubated with bacteria, secreted values started to increase after 3 h and reached a maximum 
at 6 h of incubation. At 24 h of culture, no additional secretion was observed. 
 
3.2.3. TNF-α secretion 
 
At the early and later time points, TNF-α concentrations were also measured in the 
supernatants. For both control cells and cells incubated with E. coli bacteria, values remained 
undetectable. 
 
3.3. Apoptosis following E. coli phagocytosis 
 
3.3.1. PS exposure 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Percentage of cell surface exposure of phosphatidylserine in bovine neutrophils after isolation and 
following 3, 6, 20 and 24 h of culture with or without E. coli bacteria. Data are means ± SEM of 6 cows. 
Statistically significant differences are indicated with an asterisk.. 
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PS exposure in bovine neutrophils was measured directly after isolation and at different time 
points (3, 6, 20 and 24 h) following incubation with or without E. coli bacteria (Figure 3). In 
both conditions, the percentage of annexin-V-positive neutrophils increased over time up to 
24 h of incubation. However, from 3 h on, the rate of PS exposure was significantly higher in 
the presence of E. coli bacteria as compared to control. 
 
3.3.2. Caspase-3/7 activation 
 
Caspase-3/7 activity was measured in bovine neutrophils after isolation and at 6 and 24 h 
following incubation in the presence or absence of E. coli bacteria (Figure 4). In all samples 
of freshly isolated neutrophils, caspase activity was minimal. Cells incubated with bacteria 
maintained basal levels up to 24 h of culture, while control cells had a significantly increased 
caspase activity at 6 h which was even more pronounced at 24 h of culture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Caspase-3/7 activity of bovine neutrophils after isolation and following 6 and 24 h of incubation with 
or without E. coli bacteria. Data are means ± SEM of 6 cows. Statistically significant differences are indicated 
with an asterisk. 
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3.4. Morphological analysis following E. coli phagocytosis 
 
The morphology of neutrophils was studied following incubation with or without E. coli 
bacteria (Figure 5). After 30 min of culture, phagocytic neutrophils appeared as freshly 
isolated cells with bacteria present at the cell surface or in phagosomes (panel A and B). 
Following 2 h of incubation with E. coli, many neutrophils had lost their characteristic 
multilobulated nuclei and instead displayed nuclei that were swollen and irregular in shape 
(panel C). These features became apparent in all cells up to 6 h of culture with bacteria (data 
not shown), while at that time point most control cells still had a normal cell morphology and 
some showed condensed nuclei (panel D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Representative cytocentrifuge preparations at a magnification of 1,000 x of freshly isolated bovine 
neutrophils (A), neutrophils after 30 min (B) and 2 h (C) of culture with E. coli and following 6 h of culture 
without bacteria (D). The arrow indicates an apoptotic cell. 
 A 
  10 µm 
 B 
  10 µm 
 C 
  10 µm 
 D 
  10 µm 
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4. Discussion 
 
Neutrophil phagocytosis leads to a number of molecular events which are currently 
intensively investigated. Our present findings characterize both a pro- and anti-inflammatory 
response of bovine neutrophils following phagocytosis of E. coli bacteria. Coliform pathogens 
are known to be involved in several important diseases in cattle such as enteritis, endometritis 
and mastitis (Mouricout, 1991; Bradley, 2002; Singh et al., 2007). Bovine neutrophils play a 
role in the pathogenesis of these infections. In the current in vitro study, E. coli bacteria were 
supplemented to bovine neutrophil cultures at a ratio of 5:1. Ratios employed in other in vitro 
studies ranged from 2 up to 50 bacteria, yeast particles or latex beads per neutrophil. Since 
only a few living bacteria are required to start an in vivo infection, a relatively low ratio was 
also chosen in our study. 
 
At first, the activation of the p65 subunit of NF-κB was observed as a very fast and transient 
response in bovine neutrophils following incubation with E. coli bacteria. This finding has not 
yet been reported either for bovine phagocytes or for their counterparts of human origin. Still, 
NF-κB was also rapidly and temporary activated in human neutrophils in response to LPS or 
following incubation with Staphylococcus aureus (S. aureus) bacteria or yeast particles 
(McDonald and Cassatella, 1997; Vollebregt et al., 1998). In these studies, the induced NF-κB 
complex mainly consisted of p65/p50 dimers as determined by supershift experiments with 
the electrophoretic mobility shift assay (EMSA). Besides the p65 subunit, the presence of NF-
κB p50 was also examined in the activated NF-κB complexes observed in our study using the 
ELISA-based assay. No significant difference in p50 activity between bovine neutrophils 
incubated with or without E. coli bacteria was apparent (data not shown). It should be 
remarked that as p50 could thus not be detected in the basal (Notebaert et al., 2005) nor in the 
inducible NF-κB complexes, it is now likely that the anti-human p50 antibody does not 
recognize the protein of bovine origin. Therefore, we conclude that at least p65 is involved in 
activated NF-κB complexes from bovine neutrophils. 
 
The NF-κB activation turned out to be significant albeit modest. This observation is in 
agreement with a report in which the authors suggest that the limited activation is either due 
to a substantial background activity as a consequence of the cell preparation or to a response 
of only a subset of cells (Vollebregt et al., 1998). We rather underline the importance of the 
regulation of NF-κB activity by post-translational modifications (Perkins, 2006; Neumann 
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and Naumann, 2007), which can not be measured by using either the ELISA-based kit or 
EMSA. Nevertheless, the rapid and transient NF-κB activation observed in our study is 
consistent with its role in the regulation of the innate immune response. It leads to NF-κB 
mediated gene expression and the subsequent production of pro-inflammatory and anti-
apoptotic proteins. Neutrophils thereby initiate and execute the acute inflammatory reaction 
towards bacterial invasion. NF-κB activation in response to E. coli can be mediated by several 
interactions between neutrophil’s receptors and bacterial components. The recognition of LPS 
by the major endotoxin receptor Toll-like receptor 4 is probably the best known example 
(Sabroe et al., 2005). 
 
Secondly, we observed an increase in concentration of IL-6 and IL-1 in the medium of bovine 
neutrophils following incubation with E. coli as compared to control cells. However, no TNF-
α production was observed following phagocytosis. Neutrophils might avoid the production 
of TNF-α which is able to promote neutrophil apoptosis and then does not stimulate the 
immune response towards infection. On the contrary, IL-6 and IL-1 clearly exert a pro-
inflammatory function. Both products are expressed under the control of NF-κB, which was 
also activated in our study. Remarkably, in vitro cytokine production by neutrophils in 
response to E. coli bacteria has not yet been reported. The up-regulation of the genes 
encoding for IL-1α and β has been demonstrated for human neutrophils (Subrahmanyam et 
al., 2001; Hochegger et al., 2007). In both studies, these changes in mRNA expression level 
were observed within the first hours of culture with E. coli bacteria. In response to activators 
such as LPS (Cicco et al., 1990; Marucha et al., 1990) or following phagocytosis of latex 
beads (Kobayashi et al., 2003c), genes encoding both cytokines were also up-regulated from 
early time points on. Furthermore, the secreted proteins were detected following exposure to 
LPS (Cicco et al., 1990; Marucha et al., 1990). In the current study, IL-6 concentrations were 
measured within the first half hour while IL-l levels increased only after a few hours of 
culture. Since IL-1β is initially transcribed as a proform which still remains to be processed 
before the active protein can be released (Matsushima et al., 1986), this time delay in 
secretion of both interleukins can at least be partially explained. Between 6 and 24 h of 
culture, IL-6 is still produced and secreted while IL-1 is no longer synthesized. Interestingly, 
anti-inflammatory effects mediated by interleukins such as IL-6 have been reported and 
include for example the inhibition of NF-κB (Ahmed and Ivashkiv, 2000). In any case, the 
finding that cytokines are still produced after 24 h of in vitro culture of isolated neutrophils is 
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also physiologically irrelevant, given that apoptotic neutrophils would already be recognized 
and cleared by macrophages at that time point in vivo. 
 
Thirdly, bovine neutrophil apoptosis is accelerated following phagocytosis of E. coli bacteria 
since the rate of PS exposure in activated cells is significantly increased as compared to 
control cells undergoing spontaneous apoptosis. This observation is in agreement with recent 
studies on neutrophil apoptosis following ingestion of different pathogens (Watson et al., 
1996; Rotstein et al., 2000; Engelich et al., 2001; Perskvist et al., 2002; Sim et al., 2005). 
Clearly, by this means the resolution of the inflammatory process is initiated. Interestingly, 
this phagocytosis-induced cell death occured independently from the activity of caspases-3 
and -7. On the contrary, both effector caspases were as expected involved in the constitutive 
apoptosis process observed in about half of the control cells after 24 h of culture. These 
findings do not corroborate those from human neutrophils incubated with E. coli, where 
caspase-3 activation was demonstrated (Zhang et al., 2003). However, caspase-independent 
apoptosis has been reported in human neutrophils following activation with phorbol 12-
myristate 13-acetate (Fadeel et al., 1998). In addition, a recent report on neutrophils cultured 
with S. aureus also describes a caspase-independent cell death and their subsequent clearance 
by macrophages (Wilkie et al., 2007). The authors suggest that the apparent discrepancy 
between their observations and those from Zhang et al. (2003) might be related to the nature 
of the micro-organism used to activate the neutrophils. Since for E. coli, both a caspase-
dependent (Zhang et al., 2003) as well as an -independent neutrophil cell death are now 
reported, the abovementioned explanation can be ruled out. We therefore conclude that 
additional experiments are required in order to identify the pathways orchestrating apoptosis 
following phagocytosis. 
 
Finally, bovine phagocytic neutrophils lost their characteristic multilobulated nuclei and 
instead displayed nuclei that were swollen and irregular in shape. This nuclear morphology is 
very distinct from the one of neutrophils undergoing spontaneous apoptosis, which is 
characterized by the appearance of condensed and shrunken nuclei. Still, similar 
morphological changes were reported for human neutrophils cultured with S. aureus (Wilkie 
et al., 2007). On the contrary, nuclear condensation was observed in bovine neutrophils 
following phagocytosis of S. aureus during in vivo infection (Rysanek and Sladek, 2006) as 
well as in human neutrophils incubated with E. coli (Watson et al., 1996). In these studies, 
morphology was assessed at much later time points. The observed morphology in our study 
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and the one of Wilkie et al. (2007) might therefore be preceding the characteristic apoptotic 
appearance. In any case, due to this apparent inconsistency, it has been suggested not to use 
changes in nuclear morphology to assess apoptosis in phagocytic neutrophils (Wilkie et al., 
2007). 
 
In summary, complementary to our former observation and characterization of the basal NF-
κB activity in resting bovine neutrophils (Notebaert et al., 2005), we now demonstrate the 
existence of an inducible p65-containing NF-κB complex which most likely accounts for the 
early pro-inflammatory response to phagocytosis of E. coli, in part by producing and secreting 
the major signaling cytokines IL-1 and IL-6. In addition, as a later event, when NF-κB 
activity is no longer apparent, a caspase-independent cell death is induced, ensuring an anti-
inflammatory response. Kinetic studies such as the current one in which both stages of the 
phagocyte’s life are subsequently investigated, provide insight in the molecular pathways that 
are turned on following neutrophil phagocytosis. 
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Abstract 
 
Escherichia coli (E. coli) infections in mouse mammary glands are rarely described and 
poorly characterized. In order to investigate the host immune response during coliform 
mastitis, several inflammatory parameters were evaluated at 24 and 48 h following 
inoculation of mouse mammary glands with E. coli. Successfully challenged mice showed 
high values of the acute phase protein serum amyloid A (SAA) in blood. Systemic 
concentrations of the major inflammatory cytokines tumor necrosis factor (TNF)-α and 
interleukin (IL)-6 were also increased as compared to control mice, while IL-1 levels 
remained negligible. Infected mammary glands showed a significant increase of all cytokine 
levels as compared to control glands. In accordance, mammary expression of the biologically 
inactive proform of IL-1β was strongly up-regulated. Remarkably, data obtained in wild type 
as well as caspase-1 knockout mice showed that IL-1β maturation seemed to occur 
independently from caspase-1. Finally, E. coli infection also triggered activation of the 
nuclear transcription factor (NF)-κB in the mammary gland. In conclusion, the current study 
provides novel insights on the contribution of major regulatory proteins to the acute 
inflammatory host response at the local and systemic level during E. coli mastitis in mice. 
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1. Introduction 
 
Mastitis is an infectious disease of the mammary gland, which is frequently diagnosed among 
breastfeeding women and causes considerable economic losses in the dairy industry. This 
intramammary inflammation can be provoked by various microbial pathogens such as 
Staphylococcus aureus (S. aureus) and E. coli. Even though mastitis is well-studied in cows, 
performing experiments in cattle has become less attractive due to major costs and 
management problems. Therefore, mouse models are increasingly used as an alternative for 
the study of intramammary infections. 
 
A mouse model of infectious mastitis was first described by Chandler in the 1970s (1969 and 
1970). Since then, this model has been used with a variety of pathogens to gain knowledge 
about different aspects of the disease. These include not only the pathogenesis of mastitis and 
the pathogen’s mode of action, but also the control of intramammary infections by new drugs 
and vaccines (Notebaert and Meyer, 2006). 
 
With the mouse model of mastitis, mainly intramammary infections caused by S. aureus have 
been studied (Brouillette and Malouin, 2005). Among the environmental pathogens, E. coli 
has been used occasionally. Clinical signs and observations as well as general aspects of 
coliform mastitis in mice such as bacterial growth, neutrophil response and histological 
changes in the infected mammary gland, have been demonstrated long ago (Chandler, 1970; 
Anderson, 1979 and 1983). Furthermore, the model has been used to clarify bacterial 
adherence and virulence mechanisms of the pathogen (Anderson et al., 1977; Anderson, 
1978). Finally, control strategies such as the application of antibiotics (Chandler, 1971; 
Anderson and Craven, 1984; Yancey et al., 1987) and immunomodulating agents (Cooray and 
Jonsson, 1990; Lee et al., 2003) were also tested in mice inoculated with E. coli. In these few 
reports dealing with E. coli mastitis in mice, imperative information involving inflammatory 
mediators characterizing the host immune response is lacking. 
 
The present study focuses on the local and systemic host defense mechanisms during acute 
murine mastitis experimentally induced by E. coli. The inflammatory response is evaluated by 
the production of the acute phase protein amyloid A and the major inflammatory cytokines, 
TNF-α, IL-6 and IL-1. Since IL-1β is processed in the recently discovered and currently 
intensively studied inflammasome (Mariathasan and Monack, 2007), the role of caspase-1 or 
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IL-1β converting enzyme (ICE) in its maturation was also studied by using both wild type and 
caspase-1 knockout mice. In addition, the contribution of NF-κB, a transcription factor known 
to play a key role in the inflammatory response to several diseases, was assessed through its 
most relevant family members p65 and p50. In conclusion, the characterization of the early 
inflammatory response upon E. coli mouse mastitis no longer remains unaddressed and the 
obtained knowledge may contribute to the field of mastitis research. 
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2. Experimental procedures 
 
2.1. Bacteria 
 
For the intramammary inoculation, E. coli strain P4:O32 was used, which was originally 
isolated from a clinical case of bovine mastitis (Bramley, 1976) and which has been used in 
various studies of induced mammary infection in both cows (Vangroenweghe et al., 2004) 
and mice (Lee et al., 2003). Bacteria were grown overnight at 37 °C in Brain Heart Infusion 
medium (Oxoid Limited, Hampshire, United Kingdom). To verify their purity, bacteria were 
streaked onto a blood agar plate (Oxoid Limited). Bacterial concentration of the culture was 
determined using a standard curve plotting colony forming units (CFUs) as a function of the 
absorbance at 550 nm. Sterile phosphate buffered saline (PBS) (Invitrogen, Merelbeke, 
Belgium) was applied to further dilute the culture until the desired concentration of 2 x 104 
CFU/ml. The actual number of CFU injected was confirmed by spreading the inoculum onto 
an agar plate and counting the colonies after overnight incubation. The number of bacteria 
recovered from mammary glands 24 or 48 h after inoculation was determined similarly after 
preparing serial dilutions of the mammary gland homogenates which were then also spread 
onto agar plates. 
 
2.2. Intramammary inoculation 
 
Ten lactating C57BL/6 mice were challenged 5 to 10 days after parturition. Mammary glands 
of two additional mice were used for western blot analysis and one extra female mouse was 
inoculated for histological studies. The control group consisted of four lactating females. In 
addition to the wild type animals, caspase-1 knockout mice in C57BL/6 background were also 
used. 
 
The intramammary inoculation technique was based on the method described by Brouillette 
and Malouin (2005). The offspring was removed at the time of inoculation. Mice were 
anaesthetised using a mixture of ketamin (80-100 mg/kg mouse) (Eurovet, Heusden-Zolder, 
Belgium) and xylazin (10 mg/kg mouse) (VMD, Arendonk, Belgium). After disinfecting the 
teats of the fourth pair of mammary glands, found from head to tail, the very near end of the 
teats was cut with small scissors. A 32 G needle (Dyna Medical Corporation, London, 
Canada) with a blunt end was then inserted into the teat canal and a volume of 50 µl was 
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slowly injected. Challenged mice received 103 CFU of E. coli in the right mammary gland 
(R4) and an equal volume of sterile PBS (Invitrogen) in the left mammary gland (L4) while 
control mice were inoculated with PBS in both glands. Mice were allowed to recover in their 
cage. The protocol was approved by the Ethical Committee of the Faculty of Veterinary 
Medicine, Ghent University, Belgium. 
 
2.3. Clinical observations 
 
Inoculated mice were examined twice a day for generalized and local reactions. The latter 
included redness of the teat, swelling of the mammary gland and the appearance of a sunken 
abdomen. Generalized reactions such as awareness of the environment, activity and 
grooming, weakness and mortality were observed as well. In addition, food and water uptake 
and body weight were monitored with the same frequency. 
 
2.4. Blood sampling and plasma preparation 
 
At 24 (n = 5 for challenged mice and n = 2 for control mice) or 48 h (n = 5 for challenged 
mice and n = 2 for control mice) after inoculation, mice were anaesthetised using ketamin and 
xylazin. Following cardiac puncture with a 26 G needle (Terumo, Medical Corporation, 
Leuven, Belgium), blood was slowly withdrawn into a syringe filled with approximately 50 U 
of heparin (LEO Pharma, Wilrijk, Belgium). Subsequently, mice were killed by cervical 
dislocation. Plasma was prepared by centrifugation of the blood at 2,300 g and 4 °C for 15 
min. 
 
2.5. Preparation of mammary gland homogenates 
 
After sacrificing, mice were dissected to expose the mammary glands. The fourth pair of 
glands was examined for signs of infection such as swelling, discolouration, rigor and abscess 
formation. Mammary glands were then removed, weighed and homogenized in sterile PBS 
(Invitrogen) supplemented with a cocktail of protease inhibitors (Calbiochem, La Jolla, USA). 
To make serial dilutions for CFU determination, a small volume of the sample was used. The 
remaining homogenate was centrifuged at 16,000 g and 4 °C for 30 min. After removing the 
creamy top layer, the supernatant was frozen at -80 °C until further analysis and the cell pellet 
was resuspended in RIPA lysis buffer (20 mM Hepes, 150 mM sodium chloride, 2 mM 
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EDTA, 0.5 % sodium deoxycholate and 1 % Nonidet P-40, pH 7) with protease inhibitors 
(Calbiochem). After a 10 min incubation period on ice and a 10 min centrifugation step at 
16,000 g and 4 °C, the supernatant was frozen as a protein lysate until further use. 
 
2.6. Preparation of histological sections 
 
Dissected mammary glands were fixed in 3.5 % phosphate-buffered formaldehyde (VWR 
International, Leuven, Belgium) immediately after necropsy. Histological paraffin sections 
with a thickness of 8 µm were made and stained with haematoxylin and eosin. 
 
2.7. Serum amyloid A (SAA) quantification 
 
SAA proteins were quantified by means of an ELISA (Tridelta Development Limited, 
Maynooth, Ireland) according to the manufacturer’s protocol. Briefly, a 96-well plate was 
used with an antibody for mouse SAA coated onto the surface. Standards with a known SAA 
concentration and plasma samples or mammary gland supernatants were incubated for 1 h 
together with a secondary antibody labeled with horseradish peroxidase (HRP). After 
extensive washing, a HRP substrate was added and a coloured product was formed which 
allowed a colorimetric measurement at 450 nm. 
 
2.8. Cytokine analysis 
 
TNF-α was detected and quantified using a sandwich ELISA (eBioscience, San Diego, USA) 
according to the manufacturer’s protocol. In brief, 100 µl of standards and samples were 
incubated overnight at 4 °C in a 96-well plate containing a capture anti-mouse antibody for 
TNF-α. Then, a biotin-conjugated detection antibody was added for 1 h. After incubation with 
avidin-bound HRP for 30 min, the addition of a HRP substrate solution allowed a colorimetric 
read-out at 450 nm. 
 
IL-6 was measured in a bio-assay (Landegren, 1984) as a hybridoma growth factor for mouse 
7TD1 cells. Briefly, cells were cultured for 72 h in medium with different dilutions of the 
samples. A colorimetric hexosaminidase enzyme reaction reflects the number of cells which 
is related to the amount of IL-6 in the media. Reference standards were included in the assay. 
Analysis was based on the half-maximal proliferation of the cells. 
Chapter 3 
 134
IL-1 was quantified in a bio-assay (Helle et al., 1988) using growth factor-dependent murine 
D10(N4)M cells. In brief, cells were cultured for 48 h in medium with different dilutions of 
the standard and samples. Addition of [3H] thymidine allowed incorporation following 
proliferation. The scintillation counts reflect the number of cells which is correlated to the 
amount of IL-1. Analysis was based on the half-maximal proliferation of the cells. 
 
2.9. Western blotting 
 
For the detection of IL-1β and the proteolytic activation of caspase-1, mouse mammary 
glands were homogenized directly into lysis buffer (10 mM Tris HCl pH 7.4, 200 mM sodium 
chloride, 5 mM EDTA, 1mM oxidized glutathion, 10 % glycerol and 1 % NP-40) 
supplemented with protease inhibitors (0.15 µM aprotinin, 2.1 µM leupeptin and 100 nM 
phenylmethylsulphonyl fluoride; Sigma-Aldrich, Bornem, Belgium). The remaining lysate 
was centrifuged at 20,000 g and 4 °C for 10 min. Laemmli buffer (final concentration of 62.5 
mM Tris HCl pH 6.8, 100 mM β-mercaptoethanol, 2 % sodium dodecyl sulphate, 0.1 % 
bromophenolblue and 10 % glycerol) was added to the supernatant after determination of the 
protein concentration using the Bio-Rad Protein Assay (Bio-Rad Life Science, Nazareth, 
Belgium), based on the method of Bradford. Samples were boiled for 15 min and loaded onto 
a polyacrylamide gel. Following electrophoresis, proteins were transferred to a nitrocellulose 
membrane (Schleicher & Schuell, ‘s-Hertogenbosch, The Netherlands) by semi-dry blotting. 
Membranes were blocked and then incubated with a primary antibody against IL-1β (R&D 
Systems, Abingdon, United Kingdom) and caspase-1 (Centre d’Economie Rurale, Marloie, 
Belgium). The anti-β-actin antibody was purchased from ICN Biomedicals (Costa Mesa, 
USA). A secondary antibody conjugated to HRP was applied and immuno-reactive proteins 
were visualised using chemiluminescence reagent (PerkinElmer, Massachusetts, USA). 
 
2.10. NF-κB activation assay 
 
For the detection and quantification of the NF-κB p65 and p50 subunit activities in the RIPA 
protein lysates of the mouse mammary gland homogenates, the TransAMTM Transcription 
Factor Assay Kits (Active Motif, Rixensart, Belgium) were used according to the 
manufacturer’s protocol. Beforehand, protein concentrations were determined using the Bio-
Rad Protein Assay (Bio-Rad Life Science). For each sample, 40 µg was incubated for 1 h in a 
96-well plate containing immobilized NF-κB consensus oligonucleotide. After extensive 
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washing, the NF-κB complex bound to the oligonucleotide was identified using the supplied 
anti-p65 antibody. For the detection of activated p50, an alternative anti-p50 antibody (sc-
8414) (Santa Cruz Biotechnology, Heidelberg, Germany) was used since the antibody 
provided by Active Motif is not known to recognize the mouse protein. For both antibodies 
used, reactivity towards mouse NF-κB was tested with mouse cell-extracts (Active Motif) 
before further analysis (data not shown). Addition of a secondary antibody conjugated to HRP 
allowed a chemiluminescent readout (Fluoroskan Ascent FL, Thermo Labsystems) expressed 
in relative light unit per second (RLU/s). 
 
2.11. Statistical analysis 
 
Data are expressed as the mean ± standard error of the mean (SEM). Comparisons between 
the control (left, L4) and infected (right, R4) mammary gland samples were made using the 
non-parametric Mann-Whitney U test. Differences between challenged and control mice and 
mice killed at 24 or 48 h post-infection were analysed similarly. Changes in body weight were 
statistically examined by the non-parametric Wilcoxon matched pairs test. The correlation 
studies were conducted according to Spearman. The SPSS Software (SPSS Belux, Brussels, 
Belgium) was used for all analyses. 
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3. Results 
 
3.1. Clinical and post-mortem observations 
 
Following challenge with 103 CFU of E. coli, mice showed minor indications of illness at 12 
h post-inoculation. Obvious signs of infection became apparent at 24 h after injection: animals 
were inactive and weak, some mice had a hunched back and a ruffled coat, many were not 
able to walk on their right hind leg. Food and water uptake were diminished and a 
concomitant loss in body weight was observed (on average 14.3 ± 2.1 %, n = 9, P < 0.01). 
Macroscopically, the inoculated mammary glands (R4) were swollen, whereas the control 
glands (L4) showed a normal appearance. Most of these symptoms continued to be visible at 
48 h after inoculation. One mouse was excluded from subsequent analyses since no disease 
symptoms were evident. Clinical signs of infection were also absent in the control group of 
mice at 24 or 48 h post-inoculation. 
 
Upon necropsy at either 24 (n = 4) or 48 h (n = 5) post-inoculation, R4 glands were enlarged, 
hardened and darkened or even bloody in appearance. L4 glands were normal in size, smooth 
and coloured like normal lactating glands (Figure 1). When isolated, infected glands also 
weighed significantly more than control glands with an average difference between R4 and 
L4 of 201.2 ± 22.3 mg (n = 9, P < 0.01). Control mice had two normal appearing lactating 
glands which were not significantly different in weight. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Macroscopic appearance of the fourth pair of mammary glands of a representative mouse upon 
necropsy 24 h after challenge with E. coli in R4 and PBS in L4. 
 
E. coli 
PBS 
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3.2. Bacteriology 
 
Both at 24 and 48 h post-inoculation, significantly large numbers of bacteria were recovered 
from the mammary glands inoculated with E. coli, with on average 3.3 ± 1.2 x 109 CFU/gland 
(n = 9). None of the control gland homogenates revealed bacterial growth after overnight 
incubation, nor did the homogenates of the control group of mice. 
 
3.3. Histology 
 
The mammary glands of one additional challenged mouse were utilized at 48 h post-
inoculation for histological analysis. Microscopically, massive neutrophil infiltration 
surrounding and inside the alveoli was seen throughout the infected gland (R4) together with 
cell fragments possibly due to apoptosis (Figure 2B). In marked contrast, strong dilated 
alveoli filled with milk protein and lipid droplets and the presence of only a few immune cells 
characterized the control gland (L4) (Figure 2A). 
 
 
 
 
 
 
 
 
 
 
Figure 2: Microscopic images of mammary glands of a representative mouse at 48 h of infection (magnification: 
600 x): panel A represents the control gland and panel B shows the infected gland. Arrows indicate infiltrated 
neutrophils and cell death fragments are marked by arrow heads. 
 
 
 
 
 
 
 A   B 
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3.4. Inflammatory response 
 
3.4.1. Acute phase protein amyloid A 
 
The acute phase protein SAA was quantified in plasma samples and in the mammary gland 
homogenate supernatants of the infected mice at 24 (n = 4) and 48 h (n = 5) post-inoculation. 
Systemic concentrations were also determined in the control group. For all challenged mice, 
very high concentrations were detected in plasma (on average 9.8 ± 2.9 mg/ml, n = 9) in 
comparison with values for control mice (89.0 ± 43.1 µg/ml, n = 4). Low levels were also 
observed in all supernatants (on average 0.9 ± 0.1 µg/ml for R4 and 1.1 ± 0.1 µg/ml for L4, n 
= 9). Consequently, no significant difference in local concentrations between the infected and 
the control glands was visible. 
 
3.4.2. Cytokines 
 
Plasma samples and mammary gland homogenate supernatants were also analysed for the 
presence of cytokines. In challenged mice, TNF-α was detected in plasma at an average 
concentration of 70.1 ± 22.1 pg/ml (n = 9) while this cytokine was nearly absent in blood of 
control mice (3.3 ± 3.3 pg/ml, n = 4). Furthermore, TNF-α levels were significantly increased 
in the supernatants of infected glands as compared to those of control glands (on average 9.1 
± 2.1 ng/ml for R4 and 0.9 ± 0.1 ng/ml for L4, n = 9, P < 0.01). 
 
Regarding IL-6, elevated concentrations (on average 1.6 ± 0.7 ng/ml, n = 9) were measured in 
all plasma samples of challenged mice as compared to control mice (below detection limit, n 
= 4). In addition, high concentrations were detected in the R4 mammary glands (on average 
103.6 ± 34.7 ng/ml, n = 9), while the L4 glands did not contain detectable amounts of this 
cytokine (n = 9). A significant correlation was obtained between IL-6 levels in plasma and R4 
glands of infected animals (r = 0.803, P < 0.01). 
 
IL-1 concentrations in plasma of challenged (n = 9) and control mice (n = 4) were 
undetectable. Levels were significantly increased in the supernatants of infected glands as 
compared to those of control glands (24.3 ± 5.4 ng/ml for R4 and below detection limit for 
L4, n = 9, P < 0.01). 
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3.4.3. Cytokine processing 
 
Protein lysates of infected and control mammary glands of two mice killed at 24 h post-
inoculation were used to determine the expression levels of pro IL-1β. In contrast to the 
control glands, the infected glands showed high amounts of pro IL-1β and also small 
quantities of the biologically active mature cytokine (Figure 3A). To investigate the 
mechanism of IL-1β maturation, protein lysates were examined for the presence of the p20 
and p10 active subforms of caspase-1. As only pro caspase-1 was detected, no activation 
could be demonstrated in the challenged glands (Figure 3B). Interestingly, increased 
expression levels of pro IL-1β and its mature form were also observed in caspase-1 knockout 
mice following intramammary inoculation with E. coli (Figure 3B). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Expression of the proform and the mature form of IL-1β (panel A) and the proform of caspase-1 (panel 
B) in the fourth pair of mammary glands following inoculation with E. coli or PBS. Both panels show results of 
two representative mice at 24 h post-infection. All animals are wild type mice except mouse number two of panel 
B, which is a representative caspase-1 knockout mouse. β-Actin protein levels were determined to provide a 
loading control. 
 
 
3.5. NF-κB activation 
 
NF-κB p65 and p50 activities were measured in the RIPA protein lysates of the fourth pair of 
mammary glands of infected mice isolated at necropsy. As shown in figure 4, both NF-κB 
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proteins were significantly more activated in the infected mammary glands than in the control 
glands (n = 9, P < 0.01 for p65 and P < 0.05 for p50). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: NF-κB p65 and p50 activities in the infected and control mammary glands. Data are means ± SEM of 
9 mice. Statistically significant differences are indicated with an asterisk. 
 
 
3.6. Kinetics of inflammation 
 
Changes in parameters of challenged mice sacrificed at 24 h (n = 4) were compared to those 
of mice killed 48 h post-inoculation (n = 5). Loss in body weight and increases in bacterial 
counts, cytokine concentrations and NF-κB activity in the infected glands in comparison with 
the control glands, were not significantly different between mice killed at the two different 
time points. 
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4. Discussion 
 
The mouse model of induced mastitis is commonly used as a practical approach for the study 
of bovine intramammary infections (Brouillette and Malouin, 2005; Notebaert and Meyer, 
2006). S. aureus is most frequently inoculated in the mouse mammary gland, while E. coli is 
relatively rarely used in the mouse model, even though this agent causes severe clinical 
mastitis in cattle, making it an important and well-studied disease in cows (Burvenich et al., 
2003). In addition to clinical signs of illness, inflammation is generally characterized by high 
bacterial counts, increased neutrophil numbers and histological changes. In the present study, 
these features were also examined following inoculation of the R4 mammary gland of 
lactating mice with E. coli. From 24 h after bacterial inoculation on, challenged mice showed 
obvious disease symptoms such as the appearance of a hunched back and a ruffled coat, 
weakness and inactivity, loss of appetite and a concomitant decrease in body weight. These 
severe clinical signs persisted at least up to 48 h post-infection. At necropsy, clear indications 
of inflammation such as swelling, rigor and discolouration were observed in the inoculated 
mammary gland. Our bacteriology data demonstrated the presence of high numbers of E. coli, 
while massive neutrophil infiltration additionally confirmed the successful induction of acute 
mastitis in mice. 
 
Our major objective was to characterize the host inflammatory response during the acute 
phase reaction of intramammary infections in mice caused by E. coli. First, we demonstrated 
high plasma concentrations of SAA, a major positive acute phase protein in mice, at 24 and 
48 h post-infection. It is well documented that the hepatic biosynthesis of this protein is 
dramatically up-regulated during inflammation, mainly in response to pro-inflammatory 
cytokines such as TNF-α, IL-1 and IL-6 (Uhlar and Whitehead, 1999). SAA is involved in 
repair processes minimizing tissue damage and thereby permitting rapid restoration of normal 
physiological function (Jensen and Whitehead, 1998). SAA has never been studied in a mouse 
model of mastitis. Still, in other mouse infection models, SAA concentrations exceeding 1 
mg/ml are frequently observed (Uhlar and Whitehead, 1999; Cho et al., 2004; Martinez et al., 
2005). In addition, large increases of SAA concentrations in blood following experimentally 
induced or naturally occurring E. coli intramammary infections in cattle have been published 
(Pyörälä, 2003; Petersen et al., 2004). 
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Even though the liver is the major site of acute phase protein synthesis, extra-hepatic 
production of these inflammatory mediators is documented as well (Uhlar and Whitehead, 
1999). For cattle, it has been suggested that SAA may be produced locally within the 
mammary gland and should therefore be called milk amyloid A (MAA) (Eckersall et al., 
2001). Alternatively, increased amyloid A levels in the bovine gland may also result from 
leakage of SAA through the blood-milk barrier due to its increased permeability (Jacobsen et 
al., 2005). Our data in mice revealed no significant difference in the amyloid A concentrations 
from the E. coli inoculated mammary gland as compared to the control gland. This 
observation does not corroborate previous observations in cows, where milk of infected 
quarters contained higher levels of MAA than milk of uninfected quarters (Lehtolainen et al., 
2004; Nielsen et al., 2004; Jacobsen et al., 2005). Furthermore, in mouse mammary glands 
receiving LPS, a major up-regulation in mRNA expression for amyloid A was observed 
(Zheng et al., 2006). A possible explanation for these apparently contrasting data lies within 
the reactivity of the antibody used. In contrast to the anti-bovine antibody, the anti-mouse 
SAA antibody of the ELISA kit probably does not cross react with the locally produced 
amyloid A isoform. Detection of mouse MAA at the protein level therefore remains to be 
demonstrated. 
 
Secondly, major inflammatory cytokines such as TNF-α, IL-1 and IL-6 were studied at the 
local and systemic level in the E. coli mouse mastitis model. The concentrations of TNF-α 
and IL-6 were increased in blood at 24 and 48 h post-inoculation as compared to control mice. 
Negligible values were obtained for unchallenged mammary glands whereas both 
inflammatory mediators were clearly present in infected glands. For IL-1, no increase in 
blood levels was observed but bacterial inoculation also led to high concentrations in the 
mammary gland. Cytokines are produced and released by immune cells at the E. coli infection 
site following activation by LPS or other inflammatory mediators. Our histological data 
confirmed the attendance of neutrophils in the infected gland. In addition, leakage of these 
molecules into circulation might elicit the observed acute phase response. In accordance with 
our results, one group has previously shown elevated TNF-α levels in E. coli infected glands 
of mice (Lee et al., 2003). Following intramammary challenge with LPS, mRNA levels of the 
interleukins were also up-regulated (Zheng et al., 2006). No reports on systemic 
concentrations in mastitic mice are available so far. Still, values within the same order of 
magnitude were obtained for the selected cytokines in other mouse infection models (Abram 
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et al., 2000). In addition, similar observations were made in studies on bovine mastitis 
(Nakajima et al., 1997; Hagiwara et al., 2001; Bannerman et al., 2004; Lee et al., 2006). 
 
Of the cytokines analysed in the current study, only IL-1 is known to be expressed as a 
biologically inactive proform. Significantly increased local levels of this protein were 
demonstrated following bacterial inoculation. It is well accepted that the generation of mature 
IL-1β requires the activity of ICE or caspase-1 (Thornberry and Molineaux, 1995). Caspases 
are expressed as inactive zymogens which are cleaved upon activation into p20 and p10 
subunits thereby forming a catalytic tetramer (Shi, 2004). In the infected mouse mammary 
glands, caspase-1 activation could not be demonstrated. Our results therefore do not 
corroborate those obtained for bovine mammary glands inoculated with E. coli at the 
transcription level (Long et al., 2001). Still, elevated mRNA levels of ICE do not necessarily 
implicate higher activity at the protein level. Since caspase-1 knockout mice also showed high 
levels of pro IL-1β and maturation to the active cytokine, a caspase-1 independent processing 
of the proform is apparent. Cleavage of pro IL-1β by other enzymes than ICE, such as 
neutrophil elastase and cathepsin, has been reported (Black et al., 1991; Coeshott et al., 1999). 
In addition, caspase-1 independent IL-1β maturation has been suggested in other infection 
models in mice (Rowe et al., 2002). 
 
Finally, in the mouse mammary gland, activation of NF-κB was demonstrated through its 
most important family members p65 and p50 following inoculation with E. coli. Increased 
NF-κB activity was also demonstrated in isolated milk cells of cows infected with other 
mastitis pathogens (Boulanger et al., 2003). Pathogen perception leads to activation of this 
transcription factor via the well-known Toll-like receptors (TLRs), of which TLR4 recognizes 
the LPS cell wall component of E. coli (Akira and Takeda, 2004). Next to pathogen 
recognition, activation of NF-κB is also triggered by pathogen engulfment or phagocytosis 
(McDonald and Cassatella, 1997; Vollebregt et al., 1998). In addition, active complexes are 
found in immune cells exposed to pro-inflammatory mediators released at the infection site 
(McDonald et al., 1997; Hotta et al., 2001). In the context of inflammation, NF-κB regulates 
gene expression of cytokines and chemokines, immunoreceptors and cell adhesion molecules, 
acute phase and stress-related proteins and apoptosis regulators (Pahl, 1999). In our interest, 
the transcription of TNF-α and IL-6 are under control of NF-κB. Elevated cytokine levels 
observed in infected glands can therefore be explained by locally increased NF-κB activity. 
Furthermore, the synthesis of the inactive precursor of IL-1β requires NF-κB activity. The 
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elevated IL-1 concentrations following inoculation with E. coli are thus explained by both an 
increase in expression of the precursor by NF-κB as well as an enhanced cleavage by other 
enzymes than caspase-1. 
 
In conclusion, we characterized the host immune response during E. coli intramammary 
infection in mice by providing new information on the participation of acute phase proteins, 
cytokines, inflammatory enzymes and transcription factors in this mouse model of 
inflammation. These key proteins can serve as markers which can easily be monitored in 
future mouse mastitis studies evaluating treatments with antimicrobial or novel 
immunomodulatory compounds. Still, our study also reveals potential differences between 
mouse and cow, thereby emphasizing that the extrapolation of findings in mice to other 
species should be made with caution. However, by using genetically modified mice, we have 
demonstrated the great potential of the rodent model to elucidate molecular mechanisms and 
cellular processes involved in the host immune response towards mammary gland infections. 
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Abstract 
 
In mammary gland infections, the contribution of nuclear factor-κB (NF-κB) is not well 
defined and was therefore investigated following intramammary inoculation of Escherichia 
coli (E. coli). Non-invasive real-time in vivo imaging of the transcription factor activation was 
performed in mammary glands of transgenic mice expressing luciferase under the control of 
NF-κB. Bacterial inoculation resulted in a major increase in luminescence as compared to 
control glands. This activation was confirmed by immunohistochemical nuclear staining of 
the NF-κB p65 subunit in mammary epithelium of infected glands, while nuclear p50 was not 
detected. The systemic response to the intramammary inoculation of E. coli was also studied. 
NF-κB activation in the liver increased over time and a relatively mild but longer lasting 
response was observed as compared to the acute hepatic response of mice receiving 
lipopolysaccharide (LPS). This systemic reaction was confirmed by increased circulating 
levels of the acute phase protein serum amyloid A (SAA), tumor necrosis factor (TNF)-α and 
interleukin (IL)-6. In addition, high concentrations of both cytokines in the mammary gland 
inoculated with bacteria showed that the infection was also well established at the local level. 
These results indicate that in vivo monitoring of NF-κB activation is an attractive novel 
approach to study mammary gland inflammation and that this transcription factor is 
imperative in the early stages of the host immune response towards coliform intramammary 
infections, both at the local and systemic level. 
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1. Introduction 
 
Immune and inflammatory responses are often orchestrated by the transcription factor NF-κB 
(Li and Verma, 2002). In resting cells, NF-κB family members are sequestered in the 
cytoplasm, bound to their inhibitors, which belong to the IκB family. Upon cell activation, 
IκB proteins become phosphorylated, ubiquitinated and degraded by the proteasome. 
Subsequently, NF-κB can enter the nucleus and bind to the DNA in order to promote 
transcription (Baeuerle and Baltimore, 1996). NF-κB can be activated by many distinct 
stimuli, including pro-inflammatory cytokines, bacteria and bacterial toxins such as LPS. NF-
κB alters the transcription of a large number of target genes of which the proteins are involved 
in host response processes to foreign challenge or tissue injury (Pahl, 1999). 
 
Mastitis is defined as an inflammation of the mammary gland mainly caused by microbial 
pathogens, such as Staphylococcus aureus (S. aureus) and E. coli (Watts, 1988). In 
breastfeeding women, mastitis is quite common (Fetherston, 2001) and in the dairy industry, 
intramammary infections are of great economical importance (Hillerton and Berry, 2005). 
Consequently, the control and pathogenesis of this infectious disease has been studied 
intensively. However, molecular studies regarding the role of NF-κB in mastitis are scarce. 
Only a few in vitro studies demonstrate NF-κB activation in murine or bovine mammary 
gland cells following incubation with E. coli, LPS or TNF-α (Safieh-Garabedian et al., 2004; 
Strandberg et al., 2005; Szperka et al., 2006; Yang et al., 2006; Fitzgerald et al., 2007). In 
addition, isolated milk cells of cows with mastitis mainly caused by S. aureus, contained 
increased levels of activated NF-κB (Boulanger et al., 2003). These active NF-κB complexes 
frequently consisted of the p65 and p50 subunits, which are considered to be the most relevant 
NF-κB family members. 
 
To assess NF-κB activity, various methods have been used covering the measurement of 
mRNA levels of genes containing NF-κB binding elements in their promotor or in vitro 
reporter gene expression under the control of NF-κB, the determination of free NF-κB 
complexes able to bind a specific oligonucleotide using the classical electrophoretic mobility 
shift assay (EMSA) or enzyme-linked immunosorbent assay (ELISA)-based methods, and the 
quantification of phosphorylated proteins in nuclear extracts by western blot or 
immunohistochemical analysis (Carlsen et al., 2004). 
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For the first time, real-time in vivo imaging of the NF-κB activity was performed in mammary 
glands of intact animals following challenge with E. coli bacteria. Transgenic mice expressing 
luciferase under the control of NF-κB were used for this purpose. This novel approach to 
detect mammary gland NF-κB activity in vivo allowed us to investigate the kinetics of 
inflammation during bacterial challenge. The results thus obtained underline the importance 
of this transcription factor in the pathogenesis of E. coli induced mammary gland infections. 
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2. Experimental procedures 
 
2.1. Bacteria 
 
For the intramammary inoculation, E. coli strain P4:O32 was used as previously described 
(Notebaert et al., 2008). Bacteria were grown overnight at 37 °C in Brain Heart Infusion 
medium (Oxoid Limited, Hampshire, United Kingdom). To verify their purity, bacteria were 
streaked onto a blood agar plate (Oxoid Limited). Bacterial concentration of the culture was 
determined using a standard curve plotting colony forming units (CFUs) as a function of the 
absorbance at 550 nm. Sterile phosphate buffered saline (PBS) (Invitrogen, Merelbeke, 
Belgium) was applied to further dilute the culture until the desired concentration of 2 x 105 
CFU/ml. The actual number of CFU injected was 2.2 ± 0.6 x 104 as determined by spreading 
the inoculum onto a blood agar plate and counting the colonies after overnight incubation. 
 
2.2. Intramammary inoculation of E. coli in transgenic mice 
 
All animal experiments were approved by the Ethical Committee of the Faculty of Veterinary 
Medicine, Ghent University, Belgium. The 3x-κB-luc transgenic mice were generated as 
previously described (Carlsen et al., 2002). Mice were housed in a controlled light, humidity 
and temperature environment and were provided food and water ad libitum. Female mice 
were challenged 5 to 10 days after parturition. The intramammary inoculation technique was 
carried out as previously described for wild type mice (Notebaert et al., 2008). In brief, mice 
were anaesthetised using a mixture of ketamin (80-100 mg/kg mouse) (Eurovet, Heusden-
Zolder, Belgium) and xylazin (10 mg/kg mouse) (VMD, Arendonk, Belgium). After 
disinfecting the teats of the fourth pair of mammary glands, the very near end of the teats was 
cut with small scissors. A 32 G needle with a blunt end was then inserted into the teat canal 
and a volume of 50 µl was slowly injected. Challenged mice received 104 CFU E. coli in the 
right fourth mammary gland (R4) and an equal volume of sterile PBS in the left fourth 
mammary gland (L4). As an alternative, mice received LPS from E. coli (5 µg in 50 µl; 
Sigma-Aldrich, Bornem, Belgium) in the right mammary gland. The offspring was removed 
before mice returned to their cage to recover. 
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2.3. In vivo and ex vivo imaging of NF-κB activity 
 
Before imaging, mice were anaesthetised by inhalation of isoflurane (Abbott Laboratories, 
Kent, United Kingdom) and shaved on their ventral and lateral sides. Mice were injected 
intraperitoneally with D-luciferin (Biosynth, Staad, Switzerland; 120 mg/kg dissolved in PBS, 
pH 7.4) (Figure 1B) and placed in a light-sealed imaging chamber connected to an ultra 
sensitive CCD camera of the IVIS imaging device (Caliper Life Sciences, Hopkinton, USA) 
(Figure 1A and C). Gray scale images were obtained before luminescence imaging to localize 
the fourth pair of mammary glands. A small fraction of the gland is observed at the ventral 
side of the body while the largest part is visible at the lateral sides. Luminescence was 
recorded 5 min after the injection of D-luciferin. Exposed or excised mammary glands were 
imaged in the same way immediately after dissection. Images were analysed with the Living 
Image software (Caliper Life Sciences). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
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Figure 1A: The IVIS imaging device of Caliper Life Sciences, B: The intraperitoneal injection of D-luciferin in 
an anaesthetised mouse before imaging and C: Anaesthetised mice in the light-sealed imaging chamber of the 
device. 
 
 
2.4. Immunohistochemical analysis of NF-κB activity 
 
Excised mammary glands were fixed in 3.5 % phosphate-buffered formaldehyde (VWR 
International, Leuven, Belgium) immediately after imaging. Histological paraffin sections 
with a thickness of 5 µm were prepared. After deparaffinization and hydration, antigens were 
unmasked using a pressure cooker and a microwave oven. Endogenous peroxidase activity 
was quenched with hydrogen peroxide in methanol for 5 min. After rinsing in Tris buffered 
saline (TBS), non-specific binding sites were blocked by goat serum for 30 min. The sections 
were then incubated overnight at 4 °C with rabbit anti-p65 (sc-372; Santa Cruz, Heidelberg, 
Germany) or rabbit anti-p105/p50 (ab7971; Abcam, Cambridge, United Kingdom) diluted in 
TBS with bovine serum albumin. The samples were washed with TBS and then incubated 
with a biotinylated goat anti-rabbit secondary antibody (Dako, Heverlee, Belgium) for 1 h. 
After another wash, a mixture of avidin and biotinylated horseradish peroxidase (HRP) or 
streptavidin coupled to HRP (both from Dako) was used for the detection of p65 and 
p105/p50 respectively. Subsequently, the samples were stained with diaminobenzidine 
solution (Dako) for 5 min and rinsed with distilled water. After counterstaining with 
hematoxylin, the slides were again washed, dehydrated and mounted. Inactive NF-κB 
B C 
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complexes were visualized by brown staining of the cytoplasm while brown nuclei reflected 
active complexes. 
 
2.5. Clinical and post-mortem observations 
 
Following intramammary inoculation, mice were examined for generalized and local 
reactions. The latter included redness of the teat, swelling of the mammary gland and the 
appearance of a sunken abdomen. Generalized reactions such as awareness of the 
environment, activity and grooming, weakness and mortality were observed as well. In 
addition, food and water uptake and body weight were monitored with the same frequency. 
After sacrificing, mice were dissected to expose their mammary glands. The fourth pair of 
glands was examined for signs of infection such as swelling, discolouration, rigor and abscess 
formation. 
 
2.6. Blood sampling and plasma preparation 
 
Mice were anaesthetised using ketamin and xylazin. Following cardiac puncture with a 26 G 
needle (Terumo, Medical Corporation, Leuven, Belgium), blood was slowly withdrawn into a 
syringe filled with approximately 50 U of heparin (LEO Pharma, Wilrijk, Belgium). 
Subsequently, mice were killed by cervical dislocation. Plasma was prepared by 
centrifugation of the blood at 2,300 g and 4 °C for 15 min. 
 
2.7. Preparation of mammary gland samples 
 
After sacrificing, mice were dissected and mammary glands were removed, weighed and 
homogenized in PBS (Invitrogen) supplemented with a cocktail of protease inhibitors 
(Calbiochem, La Jolla, USA). The homogenate was then centrifuged at 16,000 g and 4 °C for 
30 min. After removing the creamy top layer, the supernatant was frozen at -80 °C until 
further analysis. 
 
2.8. Serum amyloid A quantification 
 
SAA proteins were quantified by means of an ELISA (Tridelta Development Limited, 
Maynooth, Ireland) according to the manufacturer’s protocol. Briefly, a 96-well plate coated 
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with an anti-mouse SAA was used. Standards with a known SAA concentration and plasma 
samples were incubated for 1 h together with a secondary antibody labeled with HRP. After 
extensive washing, an HRP substrate was added and a coloured product was formed which 
allowed a colorimetric measurement at 450 nm. 
 
2.9. Cytokine analysis 
 
TNF-α was detected and quantified using a sandwich ELISA (eBioscience, San Diego, USA) 
according to the manufacturer’s protocol. In brief, 100 µl of standards and plasma and 
mammary gland samples were incubated overnight at 4 °C in a 96-well plate containing a 
capture anti-mouse antibody for TNF-α. Then, a biotin-conjugated detection antibody was 
added for 1 h. After incubation with avidin-bound HRP for 30 min, the addition of a HRP 
substrate solution allowed a colorimetric read-out at 450 nm. 
 
IL-6 was measured in a bio-assay (Landegren, 1984) as a hybridoma growth factor for mouse 
7TD1 cells. Briefly, cells were cultured for 72 h in medium with different dilutions of the 
plasma and mammary gland samples. A colorimetric hexosaminidase enzyme reaction 
reflects the number of cells which is related to the amount of IL-6 in the media. Reference 
standards were included in the assay. Analysis was based on the half-maximal proliferation of 
the cells. 
 
2.10. Statistical analyses 
 
Data are expressed as the mean ± SEM. By using the non-parametric Wilcoxon matched pairs 
test, comparisons between the E. coli inoculated gland (R4) and the control gland receiving 
PBS (L4) were made and changes in weight were analysed. Differences between challenged 
and control mice were statistically examined by the non-parametric Mann-Whitney U test. 
The SPSS Software (SPSS Belux, Brussels, Belgium) was used for all analyses. 
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3. Results 
 
3.1. In vivo NF-κB activity during intramammary E. coli challenge 
 
3.1.1. Time course in mouse mammary glands 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: In vivo imaging of NF-κB activity following intramammary inoculation. Transgenic mice received 104 
CFU E. coli in the R4 mammary gland and were then positioned on their left lateral side to image luciferase 
activity at different time points (0, 4, 6, 8, 10 and 24 h) following challenge. A transient increase in luminescence 
was located in the infected gland. Images are representative for all challenged mice. 
 
 
To study the intramammary kinetics of NF-κB activation, 6 transgenic female mice were 
challenged with 104 CFU E. coli in the right fourth mammary gland (R4) and PBS in the left 
fourth mammary gland (L4). Inoculated mice were imaged at the ventral and lateral sides at 
different time points during the course of infection (0, 4, 6, 8, 10 and 24 h post-inoculation). 
At the time of inoculation, low activities were found in both the right and the left mammary 
           
  
           
 0 h                            4 h                               6 h 
 8 h                            10 h                            24 h 
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gland. At later time points, luminescence of glands challenged with E. coli was significantly 
increased as compared to control glands receiving PBS (P < 0.05 for 4, 6, 8 and 10 h post-
inoculation, n = 6). Maximal activities were seen either at 6 or at 8 h post-inoculation. 
Luminescence recorded in ventral view was higher than the activity observed at the lateral 
sides of the body. At 24 h following inoculation, NF-κB activity of the R4 glands nearly 
regained basal levels, thereby approaching the activity of the L4 control glands (Figure 2 and 
Figure 3A and B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Average luminescence obtained during in vivo imaging of NF-κB activity of the mammary glands 
following intramammary inoculation. Six transgenic mice received 104 CFU E. coli in the R4 mammary gland 
and PBS in the L4 mammary gland. They were positioned dorsally (panel A) and on their lateral sides (panel B) 
to image luciferase activity at different time points (0, 4, 6, 8, 10 and 24 h) following challenge. Luminescence of 
the infected gland was transiently increased as compared to the control gland. An asterisk indicates the 
significant difference between both glands. 
A 
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3.1.2. Time course in the liver 
 
To study the reaction of the liver towards bacterial inoculation, 2 mice were challenged with 
104 CFU E. coli and chemiluminescence originated in the liver was determined at the 
indicated time points. As an alternative, 2 additional mice received 5 µg LPS in the R4 
mammary gland. At the time of inoculation, low NF-κB activities were found in the liver of 
both groups of mice. From 4 h post-inoculation on, luminescence increased for all mice. Mice 
challenged with LPS showed a stronger response than mice receiving E. coli. Inoculation with 
endotoxin resulted in a maximal liver chemiluminescence at 6 h post-inoculation, returning to 
basal levels at 24 h (Figure 4). NF-κB activity following bacterial challenge reached maximal 
levels at 8 h post-inoculation and remained high up to 24 h post-inoculation (Figure 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: In vivo imaging of NF-κB activity following intramammary inoculation. Transgenic mice received 5 
µg of LPS in the R4 mammary gland and were then positioned dorsally to image luciferase activity at different 
time points (0, 4, 6, 8, 10 and 24 h) following challenge. A transient increase in luminescence was located in the 
liver. Images are representative for all challenged mice. 
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Figure 5: Average luminescence obtained during in vivo imaging of NF-κB activity of the liver following 
intramammary inoculation. Two transgenic mice received 104 CFU E. coli in the R4 mammary gland (solid line) 
while two other transgenic mice were inoculated with 5 µg of LPS (dashed line). They were positioned dorsally 
to image luciferase activity at different time points (0, 4, 6, 8, 10 and 24 h) following challenge. A very high and 
transient activity was seen in the liver following LPS challenge while a more modest and longer lasting increase 
was apparent after inoculation of E. coli. 
 
 
3.2. Ex vivo NF-κB activity during intramammary E. coli challenge 
 
3.2.1. Chemiluminescence in mouse mammary glands 
 
In order to evaluate the NF-κB activity in exposed and isolated mammary glands following E. 
coli challenge, 6 transgenic female mice were inoculated and in vivo luminescence was 
followed over time until maximal levels of activity were reached. Similar observations as the 
time course in figure 3 were made up to 8 h post-inoculation. At that time point, glands 
challenged with bacteria showed significantly higher NF-κB activities as compared to control 
glands upon necropsy or excision (P < 0.05, n = 6) (Figure 6A and B). 
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Figure 6: Ex vivo imaging of NF-κB activity following intramammary inoculation. Six transgenic mice received 
104 CFU E. coli in the R4 mammary gland and PBS in the L4 mammary gland. At 8 h post-inoculation, they 
were sacrificed and dissected to expose their mammary glands. A: Average luminescence obtained during ex 
vivo imaging of NF-κB activity of the mammary glands upon necropsy. Mice were positioned dorsally to image 
luciferase activity following challenge. Luminescence of the infected gland was increased as compared to the 
control gland. An asterisk indicates the significant difference between both glands (P < 0.05). B: Ex vivo 
imaging of NF-κB activity of two representative pairs of mammary glands upon excision. Luminescence of the 
infected gland was increased as compared to the control gland. 
 
 
3.2.2. Immunohistochemical analysis of p65 and p50 subunits in mouse mammary glands 
 
In order to identify cells with activated NF-κB, sections of mammary glands isolated at 8 h 
post-inoculation were analysed histologically for the presence of p65 and p50 as well as the 
precursor of the latter, p105. Activated NF-κB was detected by the nuclear localization of p65 
only in mammary epithelial cells of the gland challenged with bacteria, while no nuclear 
signal was obtained for cells in control glands (Figure 7). In contrast, p50 was not observed in 
the nucleus of cells in either gland (Figure 8). 
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Figure 7: Immunohistochemical staining of the NF-κB p65 subunit following intramammary inoculation. 
Transgenic mice received 104 CFU E. coli in the R4 mammary gland and PBS in the L4 mammary gland. At 8 h 
post-inoculation, they were sacrificed and mammary glands were harvested. Control glands showed no signs of 
inflammation while in infected glands, neutrophil recruitment was apparent in many alveolar spaces which are 
lined up by the epithelial cells. Inactive NF-κB p65 was visualized in the cytoplasm of all cells of both glands 
while a strong activity was only observed in the nuclei of mammary epithelial cells of the infected gland. Images 
are representative for all challenged mice (magnification: 1,000 x). 
 
       E. coli           PBS 
 
Figure 8: Immunohistochemical staining of the p105/p50 subunit following intramammary inoculation. 
Transgenic mice received 104 CFU E. coli in the R4 mammary gland and PBS in the L4 mammary gland. At 8 h 
post-inoculation, they were sacrificed and mammary glands were harvested. Control glands showed no signs of 
inflammation while limited neutrophil recruitment was apparent in infected glands. Inactive NF-κB p105/p50 
was detected in the cytoplasm of all cells of both glands. In addition, activity was absent in the nuclei of all cells 
of both infected and control glands. Images are representative for all challenged mice (magnification: 1,000 x). 
 
  20 µm 
 
  20 µm 
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3.3. Acute phase reaction 
 
To confirm the systemic reaction to the intramammary inoculation of E. coli bacteria, the 
acute phase protein SAA was quantified in plasma samples of the 6 challenged mice 
sacrificed at 8 h post-inoculation. Plasma concentrations were significantly increased (on 
average 387 ± 148 µg/ml, n = 6) as compared to pre-challenge values (on average 10.03 ± 
0.61 µg/ml, n = 4; P = 0.01). 
 
3.4. Cytokine production 
 
To additionally confirm the inflammatory reaction, plasma samples and mammary gland 
homogenate supernatants were also analysed for the presence of cytokines. In challenged 
mice sacrificed at 8 h post-inoculation, TNF-α was detected in plasma at an average 
concentration of 32.24 ± 5.31 pg/ml (n = 6), while this cytokine was nearly absent in blood of 
control mice (3.52 ± 1.33 pg/ml, n = 4; P = 0.01). Furthermore, TNF-α levels were 
significantly increased in the supernatants of infected glands as compared to those of control 
glands (on average 3.18 ± 0.36 ng/ml for R4 and 1.28 ± 0.13 ng/ml for L4, n = 6, P < 0.05). 
 
Regarding IL-6, elevated concentrations (on average 1.98 ± 0.24 ng/ml, n = 6) were measured 
in all plasma samples of challenged mice as compared to pre-challenge values (on average 
0.25 ± 0.25 ng/ml, n = 4; P = 0.01). In addition, high concentrations were detected in the R4 
mammary glands (on average 81.76 ± 18.46 ng/ml, n = 6), while amounts of IL-6 as low as 
0.59 ± 0.29 ng/ml were detected in the L4 glands (n = 6, P < 0.05). 
 
3.5. Clinical and post-mortem observations 
 
The 6 mice killed at 8 h post-inoculation, showed no or only minor indications of illness: 
animals were active but a significant loss in body weight was observed (on average 7.0 ± 2.0 
%, P < 0.05, n = 6). Upon necropsy, early indications of inflammation were present: the right 
mammary glands inoculated with E. coli were pink and mildly hardened, while the left control 
glands were white, soft and full of milk. Infected glands also weighed more than control 
glands with an average difference of 57.0 ± 21.1 mg (0.1 < P < 0.05, n = 6). 
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The 6 mice followed up in time until 24 h post-inoculation, showed obvious signs of 
infection: they were less active and had slightly swollen inoculated glands. Body weights 
were significantly decreased (on average 12.0 ± 1.7 %, P < 0.05, n = 6). Following dissection 
of the mice, challenged glands were enlarged, hardened, darkened and sometimes bloody in 
appearance. Again, control glands looked normal in size, color and morphology. The average 
difference in weight between both glands was 121 ± 47.1 mg (P < 0.05, n = 6). 
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4. Discussion 
 
In the present study, a clear activation of the transcription factor NF-κB has been 
demonstrated under in vivo conditions in mouse mammary glands inoculated with E. coli 
bacteria. The transgenic mice used in our experiments have already proved their utility in the 
assessment of NF-κB activity in various tissues and under diverse physiological and 
pathological conditions (Carlsen et al., 2002). For the first time, we now show that this model 
is undoubtedly valuable to the study of mammary glands and intramammary infections as 
well. The major advantage of this non-invasive molecular imaging technique is the 
visualization of both the temporal and spatial regulation of NF-κB activity within the natural 
environment of an intact living animal, as it allows repetitive assessments within the same 
mouse. In addition, light generated upon injection of D-luciferin is directly correlated to the 
amount of transcriptionally active NF-κB. Alternative methods such as the traditionally used 
EMSA are not able to prove transcription, since modifications of NF-κB such as 
phosphorylation and acetylation, additionally regulate transcription after binding to the DNA 
(Carlsen et al., 2004). 
 
The importance of the transcription factor NF-κB in the early phase of the pathogenesis of 
mastitis is clearly established with this in vivo imaging approach. Until now, indications on its 
critical role were only obtained from in vitro experiments focusing on murine or bovine 
mammary tissue cells incubated with E. coli, LPS or TNF-α (Safieh-Garabedian et al., 2004; 
Strandberg et al., 2005; Szperka et al., 2006; Yang et al., 2006; Fitzgerald et al., 2007). 
Importantly, NF-κB activation was apparent within the first hours of culture. In addition, one 
ex vivo study demonstrated increased levels of activated NF-κB in milk cells isolated from 
natural cases of ruminant mastitis mainly caused by S. aureus (Boulanger et al., 2003). These 
results were obtained when the infection was already well established, as demonstrated by the 
culmination of neutrophil infiltration. In the current in vivo study, maximal NF-κB activity 
was achieved at 6 to 8 h post-inoculation. The contribution of neutrophils to this activity is 
minimal since their influx into the mammary gland this early in the inflammation process is 
still limited. In fact, the immunohistochemical analysis of infected mouse mammary glands 
showed that particularly epithelial cells are responsible for the high NF-κB activity observed 
by imaging. These findings are in agreement with the early NF-κB activation in bovine 
mammary epithelial cells following in vitro stimulation (Safieh-Garabedian et al., 2004; 
Strandberg et al., 2005; Yang et al., 2006; Fitzgerald et al., 2007). Still, NF-κB activation in 
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other cell types at later time points, as observed in milk neutrophils by Boulanger et al. 
(2003), can not be excluded. However, we believe this activation is very minimal in 
comparison with the strong activation observed in epithelial cells, as also been demonstrated 
in our previous work (Notebaert et al., 2008). 
 
Kinetic studies of experimentally induced mastitis in cows show that the inflammatory 
response is not initiated until bacterial concentrations reach a certain level in milk (Shuster et 
al., 1996). Bacterial growth is accompanied by the release of microbial products that can be 
recognized by the host as a danger signal. The LPS membrane component of Gram-negative 
bacteria such as E. coli, is known to be recognized by Toll-like receptor 4 (TLR4) (Miyake, 
2004). Mammary tissue expresses mRNA for TLR4 and this expression is increased in udders 
of cows suffering from infections (Goldammer et al., 2004). Signaling mediated by TLR4 
leads to the activation of NF-κB which results in the expression of several proteins involved 
in inflammatory processes (Doyle and O’Neill, 2006). Interestingly, a recent report showed 
that LPS and TLR4 signaling in mammary epithelium are not required to elicit the 
inflammatory response towards E. coli intramammary infections (Gonen et al., 2007). These 
authors suggest that other components of E. coli bacteria might play a role in the pathogenesis 
of coliform mastitis, such as lipoproteins, peptidoglycans, flagellins and CpG DNA, which are 
recognized by TLR1, -2, -5 and -9 respectively (Albiger et al., 2007). Although the specific 
molecular interaction between E. coli and the mammary epithelium remains to be elucidated, 
the NF-κB signaling pathway is activated in response to all TLRs thereby resulting in the 
expression of inflammatory mediators. 
 
Mammary epithelial cells thus generate cytokines and chemokines targeting neutrophils and 
mononuclear cells (Rainard and Riollet, 2006). These secondary mediators include TNF-α 
and IL-6, of which the expression is known to be dependent upon NF-κB (Hayden et al., 
2006). In the current study, both cytokines are clearly up-regulated in infected glands as 
compared to control glands. We previously also observed high local concentrations of TNF-α 
and IL-6 upon E. coli intramammary infection in wild type mice (Notebaert et al., 2008). 
Following in vitro culture with LPS or E. coli, several cytokines and chemokines are 
produced by bovine mammary epithelial cells, as shown at the mRNA and protein level 
(Boudjellab et al., 1998; Okada et al., 1999; Wellnitz and Kerr, 2004; Pareek et al., 2005; 
Strandberg et al., 2005, Lahouassa et al., 2007). In mammary epithelial cells from cows 
experimentally infected with E. coli, these inflammatory proteins are increased (McClenahan 
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et al., 2006) and secreted in milk as well (Riollet et al., 2000). In addition, NF-κB activation 
seemed to be essential for the production of bactericidal peptides following in vitro culture of 
bovine and murine mammary epithelial cells with E. coli (Yang et al., 2006). 
 
Interestingly, in the current study only the NF-κB p65 subunit was activated in epithelial cells 
of infected mouse mammary glands, while p50 did not seem to contribute to the observed NF-
κB activation. We suggest an induction of p65 homodimers in mouse mammary gland 
infections instead of an involvement of the classical p65/p50 heterodimers. This hypothesis is 
in agreement with previous findings in epithelial cells of different origins and derived from 
various species. In bovine mammary epithelial cells, p65 homodimers were induced in 
response to TNF-α (Fitzgerald et al., 2007). In addition, bronchial epithelial cells from 
heaves-affected horses contained p65 homodimers as activated NF-κB complexes (Bureau et 
al., 2000). In human gastric epithelial cells infected with Helicobacter pylori (Wada et al., 
2001) and in colon or cervical epithelium incubated with enteropathogenic bacteria or their 
toxins (Philpott et al., 2000; Schulte et al., 2000; Kim et al., 2006), these homodimers were 
observed as well. This uncommon NF-κB complex is thought to be crucial for the 
transcription of a limited number of genes, such as those encoding for IL-8 and the 
intracellular adhesion molecule-1 or ICAM-1 (Kunsch and Rosen, 1993; Ledebur and Parks, 
1995). These two molecules are known to participate in neutrophil chemotaxis, diapedesis and 
transmigration (Kunsch and Rosen, 1993; Rahman et al., 1999). In early inflammatory 
conditions arising from bacterial infections, p65 homodimers thus seem to be imperative for 
subsequent neutrophil participation. 
 
Our clinical and post-mortem observations show that the intramammary infection was well 
established in the transgenic mice. To investigate the severity of infection, NF-κB activity 
was additionally examined in the liver by in vivo imaging. A clear reaction of the liver 
following E. coli intramammary inoculation was observed. It is generally suggested that 
cytokines produced during the inflammatory process are the primary cause of the systemic 
effects observed during intramammary infections. We demonstrated increased concentrations 
of IL-6 and TNF-α in blood of infected mice in comparison with control mice. In addition, the 
same observation was previously made for wild type animals (Notebaert et al., 2008). As a 
potent inducer of NF-κB, at least TNF-α can target this transcription factor in cells throughout 
the body. Elevated plasma levels of the positive acute phase protein SAA were also 
demonstrated in the present study in analogy with E. coli infected wild type mice (Notebaert 
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et al., 2008). NF-κB controls the biosynthesis of SAA, which is dramatically up-regulated in 
the liver during inflammation (Uhlar and Whitehead, 1999). Interestingly, the liver response 
towards E. coli challenge was relatively mild, slow and longer lasting as compared to the very 
strong reaction in mice inoculated with LPS. The LPS dose chosen is of the same order of 
magnitude as used in other studies with mice (Gonen et al., 2007). In cows, the intramammary 
challenge with LPS is frequently employed to study inflammation of the bovine mammary 
gland due to its resemblance to E. coli challenge (Lohuis et al., 1988a and 1988b). Still, the 
more dynamic release of LPS during bacterial growth and killing in the E. coli mastitis model 
is in clear contrast with the single dose administration during endotoxin challenge and might 
explain the observed differences in the liver response curves. 
 
In conclusion, we demonstrate the elegant possibility to monitor NF-κB activity in mammary 
glands in real time. During the early hours of bacterial infection, activation of this 
transcription factor was apparent and was localized within the mammary epithelium. We 
identified p65 as being the key player in NF-κB mediated transcription. In addition, a 
systemic reaction was confirmed through the molecular imaging of the NF-κB activity within 
the liver and by measurement of circulating levels of NF-κB dependent acute phase proteins 
and cytokines. This first in vivo study regarding the role of NF-κB in the pathogenesis of 
mastitis emphasizes the importance of investigating early events in infected mammary glands. 
As most research within the field of mammary gland infections has been carried out upon 
diagnosis, it has mainly focused on the role of neutrophils thereby relatively underestimating 
the active contribution of mammary epithelial cells. We demonstrate that mammary 
epithelium is not just a passive physical barrier, but a critical regulator within the 
establishment of the immune response towards mastitis, via major activation of the 
transcription factor NF-κB. 
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GENERAL DISCUSSION 
 
The transcription factor NF-κB regulates many physiological processes, including innate and 
adaptive immune responses, inflammation, cell death and proliferation (Liou, 2002). Because 
of the diversity in its function, a tightly controlled NF-κB activation is mandatory. Moreover, 
aberrant regulation is associated with the development of chronic inflammation, autoimmune 
disorders and different types of cancer (Yamamoto and Gaynor, 2001; Garg and Aggarwal, 
2002; Kumar et al., 2004). In particular, an increased and sustained NF-κB activation is 
mainly involved in the pathogenesis of diseases like asthma, rheumatoid arthritis, diabetes and 
multiple sclerosis, and in the onset of malignancies. Therefore, the inhibition of NF-κB has 
been of major interest in pharmacological interventions (Garg and Aggarwal, 2002; Calzado 
et al., 2007). However, in order to treat diseases more effectively, an extensive understanding 
of the role of NF-κB in health and disease is indispensable (Campbell and Perkins, 2006). 
 
The pathophysiological function of NF-κB has been studied mainly in the context of human 
diseases. As a practical approach, cell culture systems and animal models have been used 
besides individual patients (Kumar et al., 2004). However, some diseases like intramammary 
infections have received little attention in man, even though the incidence and complications 
of mastitis among breastfeeding women should not be underestimated (Fetherston, 2001; 
Michie et al., 2003). In contrast and not unexpectedly, intramammary infections have been a 
major concern in the dairy industry (Bradley, 2002). Intensive research has therefore been 
carried out mainly during lactation, which is the final stage of the mammalian reproductive 
cycle. Still, molecular approaches to the study of veterinary medicine are not yet fully 
exploited (Binns, 1993). Consequently, very limited research has been conducted to reveal the 
contribution of NF-κB to the pathogenesis of clinical mastitis. This Ph.D. work examined 
specific molecular aspects of the relationship between pathophysiological conditions and NF-
κB activation in the mammary gland. Because an in-depth discussion focusing on a particular 
facet of our research is presented in each chapter, the following paragraphs will merely deal 
with some of the more general findings that became apparent during our experimental work. 
 
In vitro studies carried out to examine NF-κB activation in bovine neutrophils necessitated the 
purification of these cells from peripheral blood (chapters 1 and 2). In this way, mechanisms 
involved in neutrophil activation and apoptosis could be elucidated, while influences of 
contaminating cells on these processes were eliminated. For example, it is well known that the 
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presence of mononuclear cells, particularly monocytes, delays neutrophil apoptosis (Sabroe et 
al., 2005). Various neutrophil isolation procedures with differences in the average amount of 
harvested cells and in their viability and activation status have been described in literature 
(Grisham et al., 1985). Our choice was based on reports describing purification methods for 
bovine cells that yielded populations of more than 95 % of highly viable and functional 
neutrophils (Roth and Kaeberle, 1981; Chambers et al., 1983). The use of the selected density 
gradient based purification, however, imposes a considerable sample preparation time prior to 
the specific neutrophil experiments. Also, our preference to use blood neutrophils of heifers 
instead of circulating cells from lactating cows is motivated by the absence of variables such 
as stage of lactation, parity and the hormonal and metabolic status of the animal that might 
influence neutrophil responses (Burvenich et al., 2003). 
 
Bovine neutrophils represent the first line of defense against intramammary E. coli bacteria 
(Paape et al., 2003; Burvenich et al., 2004). Their proliferation and maturation occur in the 
bone marrow prior to their release into circulation. In the absence of an invading pathogen, 
neutrophils migrate into tissues such as the liver, lungs and spleen where they rapidly undergo 
spontaneous apoptosis (Paape et al., 2003). We found that this programmed form of cell death 
can be induced in resting bovine neutrophils through the application of gliotoxin as an NF-κB 
inhibitor (chapter 1). Characteristic apoptotic features such as plasma membrane exposure of 
phosphatidylserine, effector caspase activation and stereotypical morphological changes 
involving cell shrinkage and nuclear chromatin condensation were observed. In order to 
confirm the process of apoptosis, a range of techniques was required since some of its 
markers are not entirely specific as they also occur to various degrees in other types of cell 
death (Savill et al., 2002). Apoptosis in resting neutrophils is thus prevented by a constitutive 
NF-κB activition. Cell viability is essential for leukocytes in circulation where they must be 
perceptive for signs of infection. However, in the absence of a trigger that mediates migration 
into infected tissues, neutrophils probably lose this basal NF-κB activity. Since this 
transcription factor is involved in the expression of anti-apoptotic proteins of the Bcl-2 family 
(Akgul et al., 2001; Dutta et al., 2006), pro-apoptotic members are able to take over control 
when NF-κB is no longer involved. Consequently, caspase activation occurs which then leads 
to the execution of the apoptotic process, that probably also includes caspase-mediated 
cleavage of NF-κB (Kucharczak et al., 2003). 
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In human neutrophils, apoptosis is similarly induced by agents known to inhibit NF-κB (Ward 
et al., 1999). A wide variety of both natural and synthetic compounds exists which act at 
different levels of the NF-κB activation pathway (Gilmore and Herscovitch, 2006). NF-κB 
activation can be inhibited by blocking its nuclear translocation or its binding to specific κB 
sites on the DNA. More upstream strategies include the interference with IKK and the 
proteasome thereby preventing IκB phosphorylation and its degradation, respectively. 
Gliotoxin is reported to block both the proteasome-mediated degradation of IκB (Kroll et al., 
1999) and the NF-κB DNA binding activity (Pahl et al., 1996). However, it has also been 
suggested that the redox-cycling of gliotoxin accounts for its immunosuppressive activity 
(Gardiner et al., 2005). Consequently, one might argue that other proteins than NF-κB could 
also be affected by gliotoxin and the use of more specific NF-κB inhibitors is therefore 
recommended. As mentioned before, targeting the NF-κB activation pathway is recognized as 
a potential therapy for many inflammatory diseases and cancer (Garg and Aggarwal, 2002; 
Calzado et al., 2007). It is noteworthy that some NF-κB inhibitors are currently tested on 
patients in phase II clinical trials, like NF-κB decoys which are double-stranded 
oligonucleotides that compete for binding of the transcription factor with κB sites of target 
genes thereby attenuating NF-κB-mediated transcription (Isomura and Morita, 2006). 
However, for many potential drug molecules, clinical side effects might become a subject of 
concern. Clearly, complete or prolonged inhibition of NF-κB is detrimental since this 
transcription factor is required to maintain normal functioning of the body (Fraser, 2006). 
Furthermore, interfering with the NF-κB activation pathway undoubtedly affects major 
alternative signaling cascades due to their intricate crosstalk. Cooperative interactions of NF-
κB with other DNA-bound transcription factors are well described. In addition, IκB was 
found to associate with several other proteins than NF-κB in order to modulate their function. 
Finally, other substrates than the NF-κB inhibitors are now identified for IKK. Remarkably, 
this also implies that therapeutic effects of blocking IKK are not exclusively assigned to the 
inhibition of NF-κB activation. For a more detailed discussion on the mechanisms that link 
the NF-κB pathway to other signaling cascades, we would like to refer to the latest review 
written by Perkins (2007). 
 
Complementary to the observation of a basal NF-κB activity in resting bovine neutrophils, an 
inducible NF-κB complex was demonstrated in additional in vitro work with activated cells 
(chapter 2). This NF-κB activation has not been described before for bovine neutrophils 
incubated with E. coli bacteria. Until recently, it has been assumed that the main functions of 
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neutrophils are phagocytosis and killing of invading bacteria. However, our results indicate 
that neutrophils might also actively regulate the early pro-inflammatory response through NF-
κB-mediated gene transcription. In human neutrophils, NF-κB activation has been 
demonstrated in response to several phagocytic and pro-inflammatory stimuli (McDonald et 
al., 1997; McDonald and Cassatella, 1997). Moreover, the involvement of alternative 
transcription factors in activated neutrophils supports the concept of their regulatory role other 
than their defense function (Cloutier and McDonald, 2003; McDonald, 2004). Among those 
factors, the signal transducer and activator of transcription (STAT) family members have 
been studied in bovine neutrophils as well (Boutet et al., 2004). Following in vitro incubation 
with granulocyte-macrophage colony-stimulating factor (GM-CSF), a delay in apoptosis was 
observed in these cells as a result from the STAT-mediated expression of anti-apoptotic Bcl-2 
family members. Interestingly, the contribution of both NF-κB and STAT signaling pathways 
to the pathogenesis of bovine mastitis caused by bacteria other than E. coli has already been 
investigated (Boulanger et al., 2003; Boutet et al., 2004). Active STAT and NF-κB complexes 
found in milk cells of infected cows were suggested to be of importance to the establishment 
of the local inflammatory reaction mediated by neutrophils. 
 
The expression of the major cytokines IL-1 and IL-6 is known to be dependent upon NF-κB 
(Libermann and Baltimore, 1990; Hiscott et al., 1993; Mori and Prager, 1996) and their pro-
inflammatory activities are well described (Feghali and Wright, 1997). These interleukins are 
likely to be involved in the NF-κB-mediated regulation of the pro-inflammatory response of 
bovine neutrophils towards E. coli bacteria. In our in vitro study, NF-κB activation appeared 
to be a very fast event in bovine neutrophils exposed to E. coli bacteria. Consequently, IL-1 
and IL-6 could also be detected at early time points following NF-κB activation (chapter 2). 
This immediate neutrophil response is required in in vivo situations where neutrophils that 
sense the presence of a pathogen need to quickly inform and prepare other inflammatory cells 
by transducing signals before they are removed by macrophages. The induced NF-κB 
complex also disappears very rapidly. Persistent NF-κB activation could lead to the 
development of chronic inflammatory diseases and cancer and must therefore be avoided 
(Kumar et al., 2004). This transient NF-κB activation might be regulated by IκB-α, which is 
rapidly degraded in response to stimuli but also quickly resynthesized under control of NF-κB 
itself (Hayden and Ghosh, 2004; Perkins and Gilmore, 2006). Resynthesized IκB-α can enter 
the nucleus and transport DNA-bound NF-κB back to the cytoplasm. Interestingly, IκB-β can 
also interact with NF-κB complexes bound to κB sites of target genes but, unlike IκB-α, does 
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not displace them, leading to a sustained NF-κB activation. As an alternative, NF-κB-
mediated transcription might also be terminated by specific NF-κB modifications that 
decrease DNA binding activity or target the transcription factor for degradation (Perkins, 
2006). 
 
The NF-κB family member p65 has been identified as part of both the constitutively active 
and the inducible NF-κB complex present in resting and activated bovine neutrophils, 
respectively (chapters 1 and 2). Provided that transient NF-κB activation is regulated by IκB-
α, one might expect the contribution of p50 as well, at least to the inducible NF-κB complex, 
since IκB-α preferentially binds p65/p50 heterodimers (Hayden and Ghosh, 2004). 
Unfortunately, we were unable to detect p50 in bovine neutrophils with an ELISA-based 
method and could therefore not demonstrate its involvement. One of the major practical 
complications of molecular research in the bovine species is the lack of specific anti-bovine 
antibodies. Still, cross-reactivity of anti-human antibodies might occur since the bovine 
genome is fairly homologous to human DNA. Indeed, more than 90 % identity is apparent 
between the primary protein sequences of the precursor p105 of both species. Nevertheless, 
cross-reactivity implies the use of relative instead of absolute values, as the antibody might 
bind the bovine protein with a lower affinity than the human antigen. Clearly, by using 
polyclonal antibodies, a greater chance of antigen detection is likely since more than one 
epitope can be recognized. The anti-p50 antibody provided by the manufacturer however is 
monoclonal and is reported to strongly bind human p50 and weakly the mouse and rat protein. 
Cross-reactivity with the bovine protein has not been described but seemed likely since the 
antibody recognizes an epitope that lies within the Rel homology domain which is highly 
conserved among vertebrates (Hayden and Ghosh, 2004). As the results were poor, an extra 
attempt was made with another antibody that has similar characteristics and worked well for 
western blot detection of p50 in resting bovine cells. Again, ELISA results were not 
satisfactory and were therefore not included in this Ph.D. thesis. Interestingly, the use of the 
latter antibody is reported to be effective in several techniques like flow cytometry, 
immunofluorescence and of course western blot analysis but not in ELISA. Indeed, antibodies 
frequently may not perform in all immunoassays. It is well realized that an unequivocal 
detection of p50 is also quite difficult to obtain in other cells and thus remains a major 
challenge in bovine neutrophils too. 
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Next to the early NF-κB activation and cytokine production in response to E. coli bacteria, an 
activation-induced neutrophil cell death occurred as a late event in our in vitro study (chapter 
2). Even though we showed exposure of phosphatidylserine following phagocytosis, caspase 
activation could not be demonstrated and morphological features were very distinct from 
those typical for apoptotic cells. It thus remains to be investigated which type of cell death 
takes place in activated bovine neutrophils. However, in a study with similar findings for 
human neutrophils, apoptosis is still suggested to occur (Wilkie et al., 2007). The diagnosis in 
the latter paper is based on the demonstration of neutrophil recognition and engulfment by 
macrophages, which are both key features of the apoptotic process (Savill et al., 2002). 
Indeed, in the assessment of apoptosis, classical morphological changes and caspase 
activation may have become less important than initially postulated. For the latter, this might 
be due to the fact that also caspase-independent apoptosis pathways have been increasingly 
described (Hail et al., 2006). Moreover, for activated neutrophils it has been suggested that 
caspase activation is prevented by ROS (Fadeel et al., 1998; Wilkie et al., 2007). Following 
phagocytosis, these antimicrobial molecules are produced by neutrophils in order to kill the 
pathogen. Furthermore, both ROS and RNS seem to participate as key regulators of diverse 
signaling pathways. In our interest, ROS are able to modulate Fc receptor function and 
regulate signaling events downstream of this receptor (Fialkow et al., 2007). In addition, 
oxidants influence NF-κB activation since many proteins of its signaling pathway are redox-
sensitive. For more detailed discussions on this topic, we would like to refer to reviews 
written by Gloire et al. (2006) and Pantano et al. (2006). However, it is worth mentioning that 
ROS activity is also under control of NF-κB (Bubici et al., 2006). Finally, ROS participate in 
the regulation of neutrophil apoptosis (Fialkow et al., 2007). 
 
The observed activation-induced neutrophil cell death is essential to ensure the appropriate 
termination of the inflammatory response (Marshall et al., 2007). Signaling pathways and 
transcription factors that regulate the initiation of inflammation need to be repressed while 
other mechanisms mediating its resolution are turned on. However, for some key players 
within innate immunity both a pro- and anti-inflammatory function has been revealed. Even 
though NF-κB is known to mediate the expression of pro-inflammatory genes during the 
onset of inflammation (Liou, 2002), a role for this transcription factor within the resolution of 
the inflammatory response has been described as well (Rossi et al., 2007). Results of both in 
vitro and in vivo experiments suggest that there are at least two important waves of NF-κB 
activation in inflammatory loci (Ward et al., 2004). While the first wave leads to the 
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production of pro-inflammatory mediators and the promotion of neutrophil survival, the 
second one causes the synthesis of anti-inflammatory proteins that induce granulocyte 
apoptosis. It is most likely that different NF-κB complexes are responsible for the diversity in 
gene expression profile during the two stages of inflammation. Homodimers of p50 are 
reported to predominate during the resolution of inflammation (Lawrence et al., 2001). This 
complex is known to repress pro-inflammatory gene transcription (Bohuslav et al., 1998), but 
might also enhance gene expression in the presence of Bcl-3 (Bours et al., 1993; Fujita et al., 
1993). In addition, homodimers of p50 are suggested to support other transcription factors in 
the expression of anti-inflammatory proteins that induce apoptosis (Lawrence et al., 2001). As 
the inhibition of NF-κB during the resolution of inflammation prevents apoptosis and thus 
protracts the inflammatory response, the timing of any therapeutic intervention involving NF-
κB inhibition is very crucial for successful treatment of inflammatory diseases. Furthermore, 
the elucidation of anti-inflammatory pathways might be useful to the understanding of chronic 
inflammatory conditions. In relation to our study, it would be of interest to investigate 
whether NF-κB also exerts an anti-inflammatory function in activated bovine neutrophils 
besides its observed pro-inflammatory role. 
 
Even though in vitro studies are useful to investigate specific cellular responses, cell culture 
conditions remain artificial and thus can not replicate all biological processes that occur in 
intact animals. In addition, findings obtained under simplified in vitro conditions can not be 
extrapolated directly to the more complex in vivo situation. It is therefore necessary to 
perform in vivo experiments both to validate in vitro data and to extend the knowledge 
relevant to in vivo conditions. In our in vivo experiments, the experimental mouse model of 
mastitis was employed to study the role of NF-κB in the pathogenesis of E. coli 
intramammary infections (chapters 3 and 4). This model is considered to be a very suitable 
tool for the investigation of bovine mastitis because of major similarities between both 
species (Brouillette and Malouin, 2005; Notebaert and Meyer, 2006). Besides anatomical and 
functional properties of the mammary gland, these also include basic observations during 
intramammary infections. Moreover, one of the main advantages of a rodent model is the 
possibility to utilize genetically modified animals as an alternative strategy within research. 
For many years now, the use of these animals has been shown to be a powerful tool to unravel 
the pathogenesis of several diseases and to develop novel therapies (Bhogal and Combes, 
2006). 
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In our first in vivo study, we investigated how NF-κB might be involved in the establishment 
of the local inflammatory environment and the systemic acute phase response following 
inoculation of E. coli bacteria in the mouse mammary gland (chapter 3). At 24 and 48 h post-
inoculation, NF-κB activation and the NF-κB-mediated expression of important cytokines 
were clearly demonstrated for infected mammary glands. Next to IL-1 and IL-6, which were 
both analyzed in our in vitro experiments as well, TNF-α was also evaluated. Additionally, 
the infection resulted in an acute phase response, demonstrated by high circulating levels of 
SAA. The synthesis of SAA is mainly localized within the liver and is also under control of 
NF-κB. Systemic TNF-α might cause the increased expression of SAA as this cytokine is a 
potent inducer of NF-κB. Our findings regarding the cytokine and acute phase protein up-
regulation are in accordance with those of studies in cows with E. coli intramammary 
infections (Hirvonen et al., 1999; Burvenich et al., 2003; Van Merris et al., 2004). Still, the 
contribution of NF-κB to the acute inflammatory response has never been studied in these 
animals. Only one ex vivo report deals with the role of NF-κB in the pathogenesis of natural 
cases of bovine mastitis caused by bacteria other than E. coli (Boulanger et al., 2003). 
 
As an acute inflammatory reaction develops within the first days following bacterial invasion, 
we choose the 24 and 48 h time points for sampling in the mouse model of E. coli mastitis. 
The main cell types present in infected mouse mammary glands in these stages of infection 
are epithelial cells, macrophages and infiltrated neutrophils. As demonstrated in clinically 
infected cows, the migration of lymphocytes, especially T cells, to the mammary gland might 
then also have started (Mehrzad et al., 2008). T helper cells are imperative during mastitis as 
they activate other leukocytes through cytokine production (Sordillo and Streicher, 2002). A 
well documented example is their ability to promote neutrophil function (Riollet et al., 2000). 
Cytotoxic T lymphocytes may also play a role as they remove old or damaged cells that 
increase the susceptibility of the mammary gland to infections (Taylor et al., 1994). Finally, B 
lymphocytes are of importance due to their antibody production and their role as antigen-
presenting cells (Sordillo and Streicher, 2002). All of the abovementioned cells are able to 
produce pro-inflammatory cytokines like IL-1, IL-6 and TNF-α. Moreover, they all may 
account for the observed local NF-κB activation. Further studies need to be conducted in 
order to identify the nature and contribution of these cell-specific responses. In addition, it 
would be of interest to focus on both earlier and later time points of the infection process. 
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Among the evaluated cytokines, only IL-1β is known to be expressed as a biologically 
inactive proform. We showed that an increased expression of the proform and its subsequent 
processing accounts for elevated levels of the mature form in infected mouse mammary 
glands. It is well accepted that the generation of mature IL-1β requires the activity of IL-1 
converting enzyme or caspase-1 (Thornberry and Molineaux, 1995). Indeed, while most 
caspases are involved in the apoptotic process, some members of this family like caspase-1, 
also play a role in other biological processes such as inflammation (Martinon and Tschopp, 
2007). We used caspase-1 knockout mice to demonstrate that IL-1β processing occurs 
independently from this enzyme (chapter 3). It has been described that other proteins might 
mediate the cleavage of the IL-1β proform (Black et al., 1991; Coeshott et al., 1999). How 
this processing is regulated in the mouse model of E. coli mastitis remains to be investigated. 
Interestingly, caspase-1 has been reported to regulate other pro-inflammatory events than the 
IL-1β cleavageas well, such as the activation of NF-κB (Lamkanfi et al., 2004). Remarkably, 
the proteolytic activity of caspase-1 is not required for this activation. Further studies in this 
research domain are thus an exciting prospect too. In any case, our experiments with the 
caspase-1 knockout mice are a clear example of the use of genetically modified animals as an 
elegant tool to elucidate molecular events that occur upon infection. 
 
The knockout technology has been applied to individual components of the NF-κB signaling 
pathway too. Not only conventional knockouts but also conditional gene targeting has been 
indispensable to the current understanding of the diverse functions of NF-κB. Conditional 
knockouts are particularly useful when the classical knockout results in early lethality or in 
very complex phenotypes involving more than one tissue or cell type. The contribution of a 
certain protein to the NF-κB signaling pathway can also be studied through the application of 
specific modifications to its gene by means of the knock-in technology. Furthermore, 
transgenic overexpression of NF-κB regulators leading to a permanent NF-κB inhibition or 
constitutively activation has provided invaluable information as well. A more detailed 
description of these technologies is given by Pasparakis et al. (2006). Finally, transgenesis 
also offers the attractive possibility to visualize NF-κB activation by placing a reporter gene 
under the control of NF-κB. Various proteins have been used to report for NF-κB activation, 
like β-galactosidase (Bhakar et al., 2002), green fluorescent protein (Magness et al., 2004) and 
luciferase (Carlsen et al., 2002). 
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In order to study kinetics of NF-κB activation during the acute inflammatory reaction towards 
intramammary inoculation of E. coli bacteria, transgenic mice expressing luciferase under 
control of NF-κB were used in an additional in vivo experiment (chapter 4). Indeed, while 
wild type animals need to be sacrificed to obtain samples for NF-κB analysis at a certain time 
point, the use of transgenic mice allow repetitive measurements of NF-κB activation within 
the same animal over a long period of time (Carlsen et al., 2002). In addition, their 
exploitation enables the simultaneous visualisation of the transcription factor activation in 
different tissues of one animal. In our study, a gradual increase in NF-κB activation was 
observed both within the mammary gland and the liver upon the induction of E. coli mastitis. 
Maximal activation in the infected gland was achieved at 6 to 8 h post-inoculation, when the 
infection was not yet well established. NF-κB-dependent cytokine and acute phase protein 
expression was demonstrated for these early hours too. The evaluation of the NF-κB 
activation at 24 h post-inoculation revealed an important signal reduction. This finding 
coincides well with the observation of a minor NF-κB activation at that time point in our first 
in vivo study with wild type animals. 
 
Immunohistochemical analysis of infected glands at 8 h post-inoculation revealed that mouse 
mammary epithelial cells are responsible for the observed NF-κB activation. Remarkably, 
only p65 and not p50 could be identified as a key role player in this event. We suggest that 
activated p65 homodimers mediate the epithelial expression of proteins that primarily induce 
neutrophil infiltration into infected mammary glands. Since NF-κB activation in epithelial 
cells decreases once neutrophil influx has begun, we suggest that infiltrated leukocytes take 
over their role to further establish the inflammatory reaction. In this event, NF-κB 
undoubtedly plays a role as well, but its activation will probably never be that strong as in 
mammary epithelium given the modest transcription factor activation observed both in bovine 
neutrophils following phagocytosis of E. coli and in infected mouse mammary glands from 24 
h on. Indeed, even though neutrophils are capable of performing gene transcription, the 
degree of transcriptional activity is much lower than that of other cells (Cassatella et al., 
1991). Still, it should also be remarked that the comparison of quantitative data obtained with 
the ELISA-based method with those of the in vivo imaging technique must be made with 
caution. In addition, species differences are to be taken into account. 
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CONCLUSIONS 
 
In our in vitro studies, we first demonstrated that NF-κB inhibition induces bovine neutrophil 
apoptosis. We suggest that a basal NF-κB activity contributes to cell viability in circulation. 
However, the possibility that the transcription factor promotes neutrophil survival via the 
expression of anti-apoptotic Bcl-2 family members, remains to be examined. In addition, 
when bovine neutrophils encounter E. coli bacteria, an inducible NF-κB complex seems to be 
responsible for the initiation of a pro-inflammatory response via the expression of important 
cytokines. Nevertheless, activated neutrophils also rapidly undergo apoptosis in order to be 
eliminated by macrophages. We conclude that both the activation of NF-κB and the induction 
of apoptosis in bovine neutrophils are essential in order to obtain a clear establishment and 
proper resolution of the acute inflammatory reaction towards E. coli bacteria. 
 
By using the in vivo mouse model of E. coli mastitis, we found clear indications that NF-κB 
activation is crucial to the establishment of the inflammatory response and the acute phase 
reaction in infected mammary glands and the liver, respectively. Even more so than 
infiltrating neutrophils, mammary epithelial cells are undoubtedly involved in the initiation of 
the local inflammation. It has recently been shown that this inflammatory process also occurs 
in the absence of LPS/TLR4 signaling (Gonen et al., 2007). Therefore, it would be of interest 
to further investigate what kind of molecular interaction between E. coli bacteria and cells 
present in the mammary gland leads to the activation of NF-κB. Furthermore, in addition to 
the inflammatory proteins in our studies, the identification and role of other gene products 
transcribed by NF-κB in infected mammary glands need to be elucidated. Finally, the NF-κB-
mediated reaction of the liver should not be underestimated as local inhibition of NF-κB was 
previously shown to result in high susceptibility to bacterial infection (Lavon et al., 2000). 
 
Finally, we have exploited the possibility of using genetically modified mouse strains to gain 
insight in molecular mechanisms regulating the inflammatory reaction during E. coli mastitis. 
Importantly, the mouse model of intramammary infections also offers the unique opportunity 
to screen multiple potential drug molecules for the treatment of mastitis. Nowadays, treatment 
of bovine mastitis almost completely relies on the use of antibiotics, which is often criticized 
due to possible implications for animal and human health (Hillerton and Berry, 2005). 
Alternative approaches are therefore mandatory. Recently, one research group demonstrated 
the effectiveness of an NF-κB inhibitor to reduce severity of intramammary S. aureus 
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infections in mice (Boulanger et al., 2007). Clearly, strategies that modulate NF-κB activation 
should also be tested in the intramammary E. coli infection model as a first step to reveal if 
some of these inhibitors hold promise to be implemented in the treatment of bovine coliform 
mastitis as well. 
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SUMMARY 
 
Nuclear factor (NF)-κB plays a central role in the host immune response towards bacterial 
infections. The transcription factor regulates the expression of numerous genes of which the 
products are involved in innate immunity and inflammation. Consequently, NF-κB activation 
has been implicated in many infectious diseases. However, its involvement in the 
pathogenesis of intramammary Escherichia coli (E. coli) infections remains to be elucidated. 
Therefore, a detailed investigation into the role of NF-κB is essential in mammary gland cells 
and neutrophils, which are the most important leukocytes within innate immune responses 
towards E. coli mastitis. 
 
Throughout this doctoral thesis, several specific objectives were considered. First, the 
presence of NF-κB in bovine blood neutrophils and its function under normal conditions and 
during in vitro incubation with E. coli bacteria were investigated. Additionally, in vivo 
experiments were performed to gain insight in the mechanisms by which NF-κB mediates the 
host immune response in mice with E. coli mastitis. By using NF-κB reporter mice, kinetics 
of NF-κB activation were also studied so that critical time points within the infection process 
could be defined. Finally, the cellular localization of NF-κB activation was determined in 
order to identify key role players in the innate immune response towards intramammary E. 
coli infections. 
 
The in vitro part of the work covers the investigation of NF-κB activation in bovine 
neutrophils. For the purpose of these experimental studies, an adequate isolation procedure 
was developed in order to obtain highly purified blood leukocytes. For this cell population, 
the presence of the important NF-κB subunits p65 and p50 was demonstrated at the mRNA 
and the protein level with PCR and Western blot analysis, respectively. A possible role for 
NF-κB in bovine neutrophil survival was also examined in the first chapter. The apoptotic 
process was clearly accelerated upon inhibition of NF-κB. Apoptosis was assessed by means 
of a dual-color flow cytometric method with staining of exposed phosphatidylserine by 
annexin V-FITC and of cellular DNA by propidium iodide. In addition, enzyme activity 
assays for the effector caspases-3 and -7 were employed and morphological analysis by light 
microscopy was also carried out. It was concluded that a constitutive NF-κB p65 activition in 
resting bovine neutrophils promotes their survival. 
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In the second chapter, a role for NF-κB in activated bovine blood neutrophils was explored. 
Upon exposure to E. coli bacteria, a fast and transient NF-κB p65 activation was measured 
using an ELISA in which only active NF-κB complexes are detected with anti-p65 and anti-
p50 antibodies, that bind to immobilized oligonucleotide sequences with κB sites. In addition, 
by means of biological assays it was demonstrated that the NF-κB-dependent expression of 
the major cytokines IL-1 and IL-6 by bovine neutrophils was increased following 
phagocytosis of E. coli bacteria. It was thus suggested that NF-κB regulates the pro-
inflammatory response of activated neutrophils, in part through cytokine production. In 
marked contrast, an acceleration of neutrophil cell death also occurred as a late event 
following phagocytosis. Again, phosphatidylserine exposure was demonstrated, while no 
activity of caspases-3 and -7 was apparent and morphological features were atypical of 
apoptosis. It was suggested that the early pro-inflammatory capacity and the subsequent 
apoptosis induction program of bovine neutrophils are both necessary in order to obtain a 
clear establishment and proper resolution of the acute inflammatory reaction towards E. coli 
bacteria. 
 
The in vivo part deals with the study of the involvement of NF-κB in the pathogenesis of 
intramammary E. coli infections in mice. For these experiments, the intramammary 
inoculation technique was established for mice. In the third chapter, NF-κB p65 and p50 
activation was observed in mouse mammary glands at 24 and 48 h following inoculation with 
E. coli bacteria. Furthermore, an increased expression of the abovementioned interleukins and 
TNF-α was found for infected glands. High concentrations of IL-6, TNF-α and the positive 
acute phase protein SAA were also measured in blood of infected animals. In conclusion, NF-
κB seems to mediate both the local pro-inflammatory response and the systemic acute phase 
reaction towards E. coli mastitis in mice. Importantly, the mouse model of intramammary 
infections also offers the elegant opportunity of using genetically modified animals for the 
molecular study of inflammatory mediators. As also reported in the third chapter, caspase-1 
knockout mice were helpful to the understanding of IL-1β maturation in infected mouse 
mammary glands. The processing of its proform clearly occurs independently from caspase-1, 
which is classified as an inflammatory instead of a cell death caspase. 
 
In the fourth chapter, in vivo experiments with transgenic mice expressing luciferase under 
control of NF-κB are described. These mice were valuable to explore NF-κB kinetics in order 
to determine critical time points within the early hours of infection. The in vivo imaging 
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technique has not been applied before in the context of mastitis. NF-κB reporter mice showed 
a gradual increase in NF-κB activation in mammary glands following intramammary 
inoculation of E. coli bacteria. Maximal activation was achieved at 6 to 8 h post-inoculation, 
which is much earlier than the time points that were focused on in the first in vivo study with 
wild type animals. Within these early hours, the infection was not yet well established as 
shown by minor neutrophil influx. Still, the expression of the pro-inflammatory cytokines IL-
6 and TNF-α was again increased locally. Immunohistochemical analysis of infected glands 
utilizing anti-p65 and anti-p50 antibodies was carried out to obtain the cellular localization of 
the NF-κB activation. By these means, mammary epithelial cells were revealed to be key role 
players in the establishment of the local pro-inflammatory reaction towards E. coli mastitis. 
Furthermore, p65 appeared to be the major NF-κB family member in this process. During 
real-time in vivo imaging, NF-κB proteins in the liver were found to be activated as well. The 
observed increased systemic levels of SAA are likely to be explained by this liver NF-κB 
activation. These results indicate that NF-κB activation is imperative also in the early stages 
of inflammation both at the local and systemic level. 
 
Taken together, NF-κB plays an important role in the regulation of the bovine neutrophil life 
span and its mediated immune response towards E. coli bacteria. In addition, NF-κB 
activation is crucial to the establishment of the local inflammatory environment and the 
systemic acute phase response during intramammary infection with E. coli bacteria in mice. 
Besides neutrophils, an even more prominent role for mammary epithelial cells in local 
immune responses has been revealed. Furthermore, the observed NF-κB activity in the liver 
indicates significant events in organs other than the infection hearth. The results from these in 
vitro and in vivo studies form a basis for future research concerning the role of NF-κB in the 
pathogenesis of intramammary E. coli infections. This transcription factor might also hold 
promise as a potential therapeutic target in the treatment and control of mastitis. 
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SAMENVATTING 
 
De nucleaire factor (NF)-κB speelt een cruciale rol in de immuunrespons van de gastheer 
tegenover bacteriële infecties. Deze transcriptiefactor reguleert de expressie van een groot 
aantal genen waarvan de genproducten bijdragen tot inflammatie en de aangeboren 
immuniteit. NF-κB activatie is dan ook betrokken bij vele infectieuze aandoeningen. Toch is 
zijn rol in de pathogenese van intramammaire Escherichia coli (E. coli) infecties nauwelijks 
bestudeerd. Een grondig onderzoek naar de functie van NF-κB in melkkliercellen en in 
neutrofielen als de belangrijkste leukocyten binnen de aangeboren immuunrespons tegenover 
E. coli mastitis, is derhalve aangewezen. 
 
In dit doctoraal proefschrift werden verschillende specifieke doelstellingen nagestreefd. 
Vooreerst werd de expressie van NF-κB in boviene bloedneutrofielen nagegaan en werd de 
functie ervan bepaald in deze cellen zowel in afwezigheid van een stimulus als bij in vitro 
incubatie met E. coli bacteriën. Vervolgens werden in vivo experimenten uitgevoerd om 
inzicht te verwerven in de mechanismen waarmee NF-κB de immuunrespons in muizen met 
E. coli mastitis reguleert. Door gebruik te maken van NF-κB reporter muizen werd de kinetiek 
van NF-κB activatie bestudeerd, waardoor kritische tijdstippen binnen het infectieproces 
konden worden gedefiniëerd. Tenslotte werd ook de cellulaire localisatie van de NF-κB 
activatie bepaald zodat celtypes met een belangrijke functie in de aangeboren immuunrespons 
tegenover intramammaire E. coli infecties werden geïdentificeerd. 
 
In het in vitro deel van dit proefschrift wordt het onderzoek rond NF-κB activatie in boviene 
neutrofielen beschreven. Voor deze studies werd een geschikte isolatieprocedure ontwikkeld 
om een sterk opgezuiverde neutrofielpopulatie te verkrijgen. In deze geïsoleerde 
bloedneutrofielen werd de aanwezigheid van de voornaamste NF-κB familieleden p65 en p50 
aangetoond op mRNA- en eiwitniveau met respectievelijk PCR en Western blot analyse. In 
het eerste hoofdstuk werd ook een mogelijke rol voor NF-κB in de overleving van boviene 
neutrofielen bestudeerd. Bij inhibitie van NF-κB werd het apoptose proces onmiskenbaar 
versneld. Apoptose werd geëvalueerd aan de hand van een flowcytometrische techniek 
waarbij getransloceerd fosfatidylserine wordt gedetecteerd met behulp van FITC gelabeld 
annexine V en cellulair DNA met propidium jodide. Daarnaast werden ook testen gebruikt die 
de enzymactiviteit van de effector caspasen-3 en -7 bepalen terwijl ook een morfologische 
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analyse werd uitgevoerd. Deze studie leidde tot het besluit dat een constitutieve NF-κB p65 
activatie essentieel is voor de overleving van ongestimuleerde boviene neutrofielen. 
 
In een tweede hoofdstuk werd de rol van NF-κB in geactiveerde boviene bloedneutrofielen 
nagegaan. In aanwezigheid van E. coli bacteriën werd een snelle en tijdelijke NF-κB p65 
activatie gemeten met een ELISA die enkel actieve NF-κB complexen detecteert via anti-p65 
en anti-p50 antilichamen, die binden op geïmmobiliseerde oligonucleotidesequenties met κB 
sites. Verder werd door middel van biologische assays aangetoond dat de NF-κB gemediëerde 
expressie van de belangrijke cytokines IL-1 en IL-6 toeneemt in boviene neutrofielen na 
fagocytose van E. coli bacteriën. Bijgevolg werd verondersteld dat NF-κB de pro-
inflammatoire respons van geactiveerde neutrofielen reguleert, gedeeltelijk door 
cytokineproductie. Er werd daarentegen ook een versnelling in celdood opgemerkt als een laat 
gevolg van fagocytose. Opnieuw werd de translocatie van fosfatidylserine aangetoond, 
ditmaal echter niet in combinatie met caspase-3 en -7 activiteit. Ook de morfologische 
kenmerken van de cellen waren niet karakteristiek voor het apoptose proces. Zodoende werd 
gesuggereerd dat de vroege pro-inflammatoire capaciteit en het daaropvolgende apoptose-
inductieproces van boviene neutrofielen onmisbaar zijn voor zowel de inductie als de 
efficiënte beëindiging van de acute inflammatoire reactie tegenover E. coli mastitis. 
 
Het in vivo deel handelt over de betrokkenheid van NF-κB in de pathogenese van 
intramammaire E. coli infecties bij de muis. Voor deze proeven werd de intramammaire 
inoculatietechniek op punt gesteld voor muizen. In het derde hoofdstuk werd de activatie van 
NF-κB p65 en p50 vastgesteld in melkklieren van muizen op 24 en 48 uur na inoculatie van 
E. coli bacteriën. Een verhoogde expressie van de bovengenoemde interleukines en TNF-α 
werd ook aangetoond voor geïnfecteerde klieren. Daarnaast werden hoge waarden voor IL-6, 
TNF-α en het positieve acute fase eiwit SAA gemeten in bloed van geïnfecteerde dieren. 
Hieruit werd geconcludeerd dat NF-κB zowel de lokale pro-inflammatoire respons als de 
systemische acute fase reactie tegenover E. coli mastitis in muizen reguleert. Van belang is 
ook dat het muismodel van intramammaire infecties de elegante mogelijkheid biedt om 
gebruik te maken van genetisch gemodificeerde dieren voor de moleculaire studie van 
inflammatoire mediatoren. Zoals ook beschreven werd in het derde hoofdstuk waren de 
caspase-1 knockout muizen geschikt om inzicht te verwerven in de IL-1β maturatie in 
geïnfecteerde melkklieren van de muis. De verknipping van de IL-1β provorm gebeurt zonder 
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twijfel onafhankelijk van caspase-1, een signaalproteïne dat eerder als een inflammatoir dan 
als een celdood caspase wordt beschouwd. 
 
In het vierde hoofdstuk worden in vivo experimenten beschreven met transgene muizen die 
luciferase onder de controle van NF-κB tot expressie brengen. Deze muizen waren van nut in 
de opheldering van de kinetiek van NF-κB activatie waarbij kritische tijdstippen binnen de 
vroege fase van het infectieproces konden worden bepaald. De in vivo imaging techniek werd 
nog niet toegepast in de context van mastitis. NF-κB reporter muizen vertoonden een 
geleidelijke lokale toename in NF-κB activatie na intramammaire inoculatie van E. coli 
bacteriën. Maximale activatie werd bekomen op 6 tot 8 uur na inoculatie, veel vroeger dan de 
tijdstippen waarop er in de eerste in vivo studie met wild-type dieren werden gemeten. In deze 
eerste uren is de infectie nog beperkt, zoals blijkt uit de nog geringe neutrofielinflux. Toch 
was de expressie van de pro-inflammatoire cytokines IL-6 en TNF-α opnieuw lokaal 
toegenomen. Een immunohistochemische analyse waarbij gebruik gemaakt wordt van anti-
p65 en anti-p50 antilichamen werd uitgevoerd op geïnfecteerde melklieren om de NF-κB 
activatie cellulair te lokaliseren. Hierdoor konden mammaire epitheelcellen worden aangeduid 
als hoofdrolspelers in de inductie van de lokale pro-inflammatoire reactie tegenover E. coli 
mastitis. Bovendien bleek p65 het belangrijkste NF-κB familielid betrokken bij dit proces. 
Tijdens de real-time in vivo imaging waren NF-κB proteïnen in de lever ook duidelijk 
geactiveerd. De toegenomen systemische waarden van SAA kunnen waarschijnlijk worden 
verklaard door deze NF-κB activatie in de lever. Deze resultaten wijzen erop dat NF-κB 
activatie zowel lokaal als systemisch ook vereist is in de vroege stadia van inflammatie. 
 
Algemeen beschouwd kan gesteld worden dat NF-κB een belangrijke rol speelt in de regulatie 
van de levensduur van boviene neutrofielen en in de immuunrespons van deze cellen 
tegenover E. coli bacteriën. Daarenboven is NF-κB activatie essentieel voor de ontwikkeling 
van de lokale inflammatoire omgeving en de systemische acute fase respons tijdens 
intramammaire infecties van E. coli bacteriën in de muis. Meer zelfs dan de neutrofielen 
treden hier de mammaire epitheelcellen op de voorgrond. Bovendien wijst de NF-κB activatie 
in de lever op een belangrijke invloed op andere organen dan de infectiehaard. De resultaten 
die in deze in vitro en in vivo studies werden bekomen, vormen een basis voor verder 
onderzoek naar de rol van NF-κB in de pathogenese van intramammaire E. coli infecties. Ook 
in de controle en behandeling van mastitis is deze transcriptiefactor mogelijks beloftevol als 
potentieel therapeutisch doelwit. 
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DANKWOORD 
 
Het is me gelukt… Apetrots ben ik op ‘mijn thesis’ die nu in jullie handen ligt. Dolgelukkig 
met het resultaat van zes jaar wetenschappelijk onderzoek. Doctoreren heeft me zelfs letterlijk 
veel bloed, zweet en tranen gekost, maar aan de eindstreep besef ik dat het wel de moeite 
waard was. Ik wens dan ook iedereen te bedanken die de voorbije jaren zijn steentje heeft 
bijgedragen tot de totstandkoming van dit proefschrift. 
 
Evelyne, bedankt omdat je me begin 2002 de kans hebt geboden om in de toenmalige 
vakgroep Fysiologie, Biochemie en Biometrie als assistent een doctoraatsonderzoek te starten. 
Als promotor volgde je mijn wetenschappelijk werk steeds heel nauwlettend op. Je bleek een 
onuitputtelijke bron van suggesties met betrekking tot zowel de experimentele proeven alsook 
bij het nalezen van de manuscripten. Dank je wel voor de vele uren van je tijd die ik in beslag 
heb genomen. We hebben samen goede momenten gekend maar ook minder goede waarbij 
het niet altijd is gelopen zoals ik had gehoopt, maar ik ben uiteindelijk toch gekomen waar ik 
wilde zijn. Ik wens de onderzoeksgroep Biochemie een sterke groei en wetenschappelijke 
output toe in de nabije toekomst. 
 
Bedankt Kristel! Gedurende al die jaren was jij een onmisbare hulp in de stal, in het labo en 
tijdens de practica. Je hebt voor mij ongelooflijk veel werk verzet, niets was jou teveel. Mede 
door jouw onuitputtelijk enthousiasme heeft de onderzoeksgroep Biochemie midden 2005 de 
mutatie naar de huidige vakgroep probleemloos doorstaan. Meer nog, met ons drietjes waren 
we sindsdien sterker dan ooit tevoren. Dank je wel voor de steun, het advies, je luisterend oor, 
de leuke babbels, de fantastische momenten samen. We hebben doorheen die jaren lief en leed 
gedeeld. Maar we hebben ons vooral goed geamuseerd. We waren een fantastisch duo! Merci! 
 
Jella en Bert, jullie hadden ons groepje van drie nog maar net vervoegd toen mijn 
assistentschap ten einde liep. Jammer dat wij niet wat meer tijd hebben gekregen om elkaar 
beter te leren kennen. De sterke toewijding aan jullie doctoraat had ik wel al opgemerkt. Ik 
wens jullie veel succes met het onderzoek de komende jaren. Bert, ook bedankt om vanaf nu 
met evenveel liefde zorg te dragen voor de muisjes… 
 
Ook de andere professoren van de vakgroep Farmacologie, Toxicologie, Biochemie en 
Orgaanfysiologie wil ik graag bedanken. Prof. De Backer en Siska, jullie interesse in mijn 
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onderzoek wordt sterk geapprecieerd. Stanislas ben ik een speciaal woordje van dank 
verschuldigd. Je maakte immers altijd met plezier tijd voor een oprechte babbel. Bedankt voor 
de bemoedigende woorden die ik van tijd tot tijd wel kon gebruiken. 
 
Aan alle andere leden van de vakgroep, een welgemeende dankjewel voor de toffe sfeer. 
Sandra, Tim, Eva, Virginie, Barbara, Tinne en Sofie, jullie zijn nu aan de beurt. Probeer 
ondanks alle teleurstellingen en tegenslagen de moed niet te laten zakken. Ook Kris, Sigrid, 
Ann, Nathalie, Noël, Maggy, Pasquale, Dieter, Marc, Karl, Kris, An en Sabrina bedank ik 
graag voor de amusante gesprekken. 
 
Dank aan de leden van de begeleidings-, lees- en examencommissie voor het kritisch nalezen 
van dit proefschrift en voor hun constructieve opmerkingen, waardevolle suggesties en 
interessante vragen. 
 
Harald, I am grateful to you in particular since you gave me the opportunity to work with your 
transgenic mice. Daniel and I also very much appreciated your sympathy and kindness during 
our stay in Oslo. Back then, we fell in love with beautiful Scandinavia. We will definitely 
return to your homeland for a holiday in the near future. 
 
Linda, ook jij verdient een belangrijke plaats in dit dankwoord. Onder jouw vleugels heb ik 
destijds de NF-κB microbe te pakken gekregen. Mijn gedrevenheid heb ik vooral aan jou te 
danken daar je voor mij een groot voorbeeld was en nog steeds bent. 
 
En Sarne, jou zou ik speciaal willen bedanken omdat je steeds veel interesse hebt getoond in 
het muis mastitis model. Naast de koeien op de melkveebedrijven horen deze knaagdieren 
misschien ook ooit eens tot jouw onderzoeksdomein. 
 
Ik mag de vele doctorandi van de faculteit niet vergeten waar ik het labo mee heb gedeeld of 
met wie ik vaak heb gepraat terwijl hun stalen door de flowcytometer in het lokaaltje naast 
mijn bureau werden geanalyseerd. Sofie, jij was de eerste die bij ons over de vloer kwam om 
de strijd aan te gaan met dat door jou vaak vervloekte toestel. Jouw wilskracht en 
doorzettingsvermogen vielen mij meteen op. We hebben heel wat afgelachen. We hebben bij 
elkaar ook vaak ons hart gelucht. Het deed deugd om met jou te dromen over een zorgeloze 
toekomst. 
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Veel ex-collega’s wens ik te bedanken voor wat nu soms al ver achter ons ligt. De leden van 
de vakgroep Fysiologie en Biometrie, merci voor de praatjes die we de laatste jaren maakten 
als we elkaar nog eens tegenkwamen in de gang. Voor hen die de faculteit ondertussen 
hebben verlaten, bedankt voor de vele mooie herinneringen. Christel, ik wens je het allerbeste 
toe, wat de toekomst voor jou ook in petto heeft. Ilse, Inge, Adelheid en Stefanie, bedankt 
omdat het afscheid eerder een tot ziens was dan een vaarwel. Cheli and Jalil, good luck with 
your career and in your private life. Edith en Etienne, een welverdiend pensioen toegewenst. 
Ik herinner me nog levendig de niet ongevaarlijke ritten naar de proefhoeve in de meer dan 15 
jaar oude Golf van ‘onzen Etienne’. Kristel en ik hebben nog vaak aan jou gedacht tijdens 
onze bloedstaalnames. 
 
Bedankt aan diegene met wie ik verder nog heb samengewerkt. Prof. Van den Broeck en Prof. 
Chiers, jullie professionele beoordeling van de histologische preparaten van melkklierweefsel 
kon ik best gebruiken. Prof. Favoreel, u liet me kennismaken met de veelbelovende life cell 
imaging techniek. Ook aan Eef bedankt voor de mooie resultaten die we tot nog toe hiermee 
hebben behaald. Wilma en Ann van het VIB, merci voor de vele stalen die jullie met de 
biologische assays hebben geanalyseerd. En Dieter, bedankt voor jouw belangrijke bijdrage in 
mijn onderzoek. Ik wil je nog veel succes toewensen met het verdere verloop van je doctoraat. 
 
Bedankt ook aan Sarah en Peter. Jullie stagebegeleiding was voor mij een bijzonder leerrijke 
en ook aangename ervaring. 
 
Aan al mijn vrienden en familieleden, een dikke merci. 
 
Ook een welgemeende dankjewel aan mijn zussen, broer, schoonbroers en schoonzus Eveline, 
Nele, Stijn, Geert, Bram en Eva. Omdat jullie steeds weer vroegen wanneer het proefschrift 
nu eindelijk klaar zou zijn. Hoewel mijn onderzoek niet bepaald jullie vakgebied is, brachten 
jullie toch steeds veel interesse aan de dag. 
 
Ook mijn schoonouders Ghislain en Irmgard verdienen een speciaal woordje van dank. Jullie 
deur staat altijd voor ons open. Jullie vriendschap doet me deugd. 
 
Beste mama en papa, bedankt voor de kansen die jullie me hebben gegeven. Voor de goede 
zorgen. Voor jullie onvoorwaardelijke steun. Voor duizend en één dingen, bedankt! 
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Liefste Daniel, toen ik zes jaar geleden aan mijn assistentschap begon, wist ik niet wat me 
overkwam toen ik jou tegen het lijf liep. Je werd mijn beste vriend, mijn echtgenoot. Bedankt 
voor alles! Zonder jouw geduld, begrip en steun had ik het nooit gehaald. Dit werk draag ik 
dan ook graag op aan jou. Want je bent het beste wat me ooit is overkomen. Ik zie je 
ongelooflijk graag. 
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